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Summary 
The lipid composition of biological membranes can differ significantly between organisms 
and even between organelles of the same cell in terms of lipid compounds and specific 
ratios of lipid classes. Referring to this, every membrane features a characteristic lipid 
composition that is thought to regulate its physicochemical properties and cellular function 
by providing lipid environments supporting the integrity of membrane-localized protein 
machinery and membrane-associated processes. Chapter I gives a brief overview of the 
interlinkage between the chemical nature of membrane lipids, the structural and functional 
organization as well as the physicochemical properties of lipid bilayers and their influence 
on membrane-embedded proteins. 
Studies to gain detailed knowledge on how membrane lipid composition influences the 
physiology of cells and regulates cellular processes require tools to manipulate lipid 
composition in vivo. By employing metabolic engineering approaches based on titratable 
gene expression tools, sets of Saccharomyces cerevisiae strains in which membrane lipid 
composition is under experimental control were engineered. The study described in 
Chapter II addresses OLE1, encoding for the sole fatty acid desaturase of budding yeast, 
to control the extent of acyl unsaturation of fatty acids incorporated in phospholipids. This 
approach revealed cellular roles for the physical state of cell membranes, so called 
membrane fluidity, on yeast flocculation and hypoxic growth. It is shown, how the 
endogenous lipid homeostasis machinery of budding yeast is adapted to carry out a broad 
response to oxygen limitation (hypoxia) and how it activates a non-canonical yeast 
flocculation pathway involving FLO1, which encodes for cell wall glycoproteins that mediate 
cell-cell-interactions by binding cell wall mannose residues of adjacent cells. 
In Chapter III, the previously generated strain in which expression of OLE1 is under 
experimental control was used as a cellular platform to assay the activity of heterologously 
expressed stearoyl-CoA desaturases (SCDs). Putative SCDs from human pathogens 
T. brucei and T. cruzi were functionally expressed in S. cerevisiae, thereby additionally 
confirming their SCD activity in vivo. The presented assay might also provide a tool to 
screen for inhibitors of SCDs, which are interesting drug targets in the treatment of bacterial 
and parasitic infections in humans. 
The study presented in Chapter IV addresses ERG9, an essential gene involved in the 
ergosterol biosynthetic pathway and used a metabolic engineering approach to achieve 
control over the total sterol biosynthetic activity of the cell. Cells that allowed for 
manipulating the native sterol homeostasis were employed to unveil physiological effects of 
ergosterol and total sterol depletion on the cell’s general viability as well as on fundamental 
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membrane associated processes such as protein sorting and endo- and exocytosis. By 
combining this metabolic engineering approach and the powerful method of marker-free 
CRISPR/Cas9-mediated gene tagging, it was possible to establish a cellular system for 
investigating the impact of sterol depletion on the lateral distribution pattern of lipid-raft 
associated GFP-tagged membrane proteins within the plasma membrane of yeast. 
Chapter V introduces a novel set of all-in-one constitutive and inducible CRISPR/Cas9 
vectors that allow for a very easy and highly convenient application of the technology in 
S. cerevisiae. The simplicity of the inducible system is based on the possibility of introducing 
a desired gRNA targeting sequence with homologous recombination-mediated assembly of 
overlapping single-stranded oligonucleotides. The inducible Cas9 expression approach 
also introduces the novel concept of chronologically separating the cloning procedure from 
the actual genome editing step by preloading cells with an all-in-one CRISPR/Cas9 plasmid. 
This way, CRISPR/Cas9-supported genome editing can be obtained with high efficiency 
and effectivity by just transforming a desired preloaded target strain with donor DNA to be 
genomically integrated without the need of co-introducing any of the CRISPR system 
components. These novel CRISPR/Cas9 systems will help to overcome limitations often 
observed for challenging metabolic and genetic engineering approaches that can be e.g. 
used for following studies to reveal physiological roles of membrane lipids for budding yeast.
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Zusammenfassung 
Biologische Membranen unterschiedlicher Organismen, aber auch von Zellen des gleichen 
Organismus und sogar Organellen der gleichen Zelle können sich hinsichtlich ihrer 
spezifischen Lipidzusammensetzung deutlich voneinander unterscheiden. Jede Membran 
weist dabei eine charakteristische Lipidkomposition auf, die sowohl die physikochemischen 
Eigenschaften als auch die biologische Funktion dieser Membran maßgeblich bestimmt, 
indem spezifische Lipid-Umgebungen zur Verfügung gestellt werden, die für die Integrität 
der Membran-lokalisierten Protein-Maschinerie und Membran-assoziierter zellulärer 
Prozesse essentiell ist. Kapitel I gibt einen kurzen Überblick über die chemische Struktur 
prominenter Membranlipide, die damit eng verbundenen physikochemischen 
Eigenschaften membranärer Lipid-Bilayer, sowie die Beeinflussung der Funktion Membran-
inkorporierter Proteine durch diese Membrancharakteristika. 
Studien zur Aufklärung des Einflusses der Lipidkomposition auf die allgemeine 
Zellphysiologie sowie Regulation zellulärer Prozesse benötigen effiziente Methoden zur 
Manipulation der Lipidkomposition in vivo. Metabolic Engineering Ansätze in Verbindung 
mit Methoden zur Regulation von Genexpression wurden dabei genutzt, um 
Saccharomyces cerevisiae Stämme zu generieren, die eine gezielte und experimentell 
kontrollierbare Veränderung ihrer Lipidkomposition erlauben. Die in Kapitel II beschriebene 
Studie adressiert dabei die einzige in S. cerevisiae vorkommende Fettsäure-Desaturase 
(codiert durch OLE1), um experimentelle Kontrolle über den Sättigungsgrad Phospholipid-
inkorporierter Fettsäuren und somit der Gesamtheit des Hefelipidoms zu erlangen. Dieser 
Ansatz offenbarte zelluläre Funktionen eines wichtigen physikalischen 
Membranparameters, der sogenannten Membranfluidität, für Prozesse wie die Ausbildung 
eines Flockulierungsphänotypes sowie Anpassung an hypoxische 
Wachstumsbedingungen. Die präsentierte Studie zeigt, wie die Hefe-endogene Lipid-
Homöostase-Maschinerie dazu genutzt wird, eine umfangreiche zelluläre Antwort auf 
Sauerstoff-limitierende Umgebungsbedingungen (Hypoxie) einzuleiten und Zell-Zell-
Aggregation in Form von Flo1p-vermittelter Flockulierung zu induzieren. Dieser 
Aggregationsphänotyp basiert dabei auf der von Flo1p als Zellwand-verankertes 
Glykoproteins vermittelten Fähigkeit zur spezifischen Bindung der von der Zellwand 
benachbarter Hefezellen präsentierten Mannosylseitenketten. 
Die in Kapitel III beschriebene Studie nutzt die zuvor generierten Stämme mit experimentell 
kontrollierbarer OLE1-Expression als zelluläre Plattform zum Nachweis der enzymatischen 
Aktivität heterolog exprimierter Stearoyl-CoA-Desaturasen (SCDs). Mutmaßliche SCDs der 
beiden humanpathogenen Parasiten T. brucei und T. cruzi wurden dabei funktional in 
S. cerevisiae exprimiert und auf diese Weise gleichsam ihre Stearoyl-CoA Desaturase-
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Aktivität in vivo nachgewiesen. Das vorgestellte Assay eignet sich daher ebenfalls als 
Werkzeug zum Hefe-basierten Screening von SCD-Aktivität inhibierenden Substanzen, die 
als vielversprechende Medikamente zur Behandlung bakterieller und parasitärer 
Infektionen des Menschen gelten und teilweise bereits Einsatz finden. 
Kapitel IV beschreibt die Nutzung eines ERG9-adressierenden Metabolic Engineering 
Ansatzes, um experimentelle Kontrolle über die Sterol-Biosythese-Aktivität von 
S. cerevisiae zu erlangen. ERG9 codiert für eine Squalen-Synthase, die als sogenanntes 
„Gate-Keeper Enzym“ den Metabolit-Flux in Richtung des linearen Ergosterol-
Biosyntheseweges zu regulieren in der Lage ist. Zellen mit manipulierbarer Sterol-
Homöostase und verringertem Ergosterol-Gehalt wurden dazu genutzt, um den Einfluss 
von Membransterolen auf die generelle Zell-Viabilität aber auch auf fundamentale 
Zellmembran-assoziierte Prozesse wie Protein Sorting sowie Endo- und Exocytose zu 
untersuchen. Durch Kombination dieses Metabolic Engineering Ansatzes und 
CRISPR/Cas9-vermittelter Marker-freier Genom-Editierung war es zudem möglich, ein 
zelluläres System zur Untersuchung des Einflusses einer Verarmung von Membransterolen 
auf das laterale Verteilungsmuster Lipid-Raft-assoziierter GFP-getaggter Membranproteine 
in der Plasmamembran der Bäckerhefe zu etablieren. 
In Kapitel V wird ein neuartiges, induzierbares oder konstitutives all-in-one CRISPR/Cas9-
Plasmidsystem zur einfachen und komfortablen Anwendung dieser Technologie in 
S. cerevisiae vorgestellt. Die Einfachheit des vorgestellten induzierbaren Systems liegt 
dabei in der Möglichkeit zur bequemen Einklonierung einer gewünschten, in der gRNA 
codierenden Sequenz enthaltenen Protospacer-Sequenz begründet. Die Einführung der 
Protospacer-Sequenz beruht dabei alleine auf einer wenig arbeitsintensiven homologen 
Rekombinations-vermittelten Assemblierung von einzelsträngigen DNA-Oligonukleotiden in 
vivo. Gleichsam führt das vorgestellte induzierbare CRISPR/Cas9-System, mit dem zu 
modifizierende Zellen vor dem eigentlichen Genom-Editierungsschritt vorgeladen werden 
können, ein neuartiges Konzept der chronologischen Separierung essentieller Arbeitsschritt 
(Plasmidklonierung, Genom-Editierung), gepaart mit hoher Transformationseffizienz sowie 
einfacher Anwendbarkeit, ein.  Eine hohe Effizienz und Effektivität der Genom-Editierung 
wird dadurch gewährleistet, dass Komponenten des CRISPR/Cas9-Systems sowie die 
genomisch zu integrierende Donor-DNA zeitlich getrennt in die Zelle eingeschleust werden 
können, wodurch eine multiplikative Verknüpfung unvorteilhafter 
Einzeltransformationseffizienten umgegangen wird. Dieses neuartige Plasmid-basierte 
CRISPR/Cas9-System eignet sich folglich dazu, Transformationseffizienz-bedingte 
Limitierungen von Metabolic und Genetic Engineering Ansätzen zu überwinden, die 
wiederum für nachfolgende Studien zur Aufklärung physiologischer Funktionen von 
Membranlipiden von Nutzen sind.  
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1. Chapter I: General introduction 
1.1. Biological membranes 
Biological membranes are essential structures of cellular systems. Their primary function 
consists in the physical separation of cell internal structures from the external environment 
[1]. Due to their physicochemical properties, they build up an almost impermeable barrier 
for hydrophilic and charged molecules and ions. Specialized membrane embedded proteins 
or fusion and fission of membrane material are required to mediate and control the 
exchange of substances and energy between cells and their environment by active or 
passive transport processes, thereby emphasizing the regulatory function of biological 
membranes [2]. In an equivalent manner, cell membranes are involved in the exchange of 
information, perception of extracellular signals and cell-cell communication [1]. Specialized 
proteins within biological membranes register specific messenger molecules [3] and 
immaterial signals and stimuli such as electromagnetic radiation (light [4], infrared (thermal) 
radiation [5]) or electric potential differences [6] and respond in a coordinated manner by 
undergoing changes in protein conformation or spatial organization in order to transmit 
signals into the cell’s interior. Eukaryotic cells feature additional internal membrane 
structures, thereby constituting separated cellular compartments that enable to spatially 
segregate chemical reactions for the purpose of providing optimal reaction conditions to 
ensure maximal biochemical efficiency as well as restricted dissemination of generated 
reaction products [2]. 
From a chemical point of view, cellular membranes are constituted by amphiphilic 
(amphipathic) lipids that form a double layer (bilayer) in which membrane proteins are 
embedded in by means of hydrophobic, electrostatic or non-covalent interactions. Lipid 
bilayers are typically ~40 Å thick, however, the exact thickness depends on the composition 
of the membrane and varies between organelles [7]. The principle organization of biological 
membranes as lipid bilayers was already hypothesized in 1925 by Gorter and Grendel [8]. 
However, this model did not take into account that biological membranes are equipped with 
proteins that determine the biological function of the membrane. The fluid mosaic model by 
Singer and Nicolson from 1972 [9] described biological membranes as a fluid lipid bilayer 
in which membrane proteins can be fully embedded in (integral proteins), are associated 
with or only penetrate peripheral regions of the bilayer (peripheral proteins) or are anchored 
to the membrane as they are covalently attached to strongly hydrophobic molecules such 
as lipids (lipid anchored proteins). Proteins and lipids can freely diffuse within the two 
dimensional bilayer, thus forming a homogenous protein-lipid mixture. Although, the fluid 
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mosaic model is still a well-accepted model [10], it cannot be fully correct as it will be 
discussed later.  
The structured organization of membrane lipids in bilayers is guaranteed by their hydrophilic 
and lipophilic properties which allows them to undergo a thermodynamically/entropically 
driven spontaneous self-association in an aqueous milieu. The hydrophobic moieties of 
membrane lipids face to the interior of the bilayer thereby forming a hydrophobic core of the 
membrane whereas lipophobic parts of membrane lipids face towards to hydrophilic 
external milieu and constitute the surface of the membrane. The driving force of this 
spontaneous self-assembly is the interaction of hydrophilic parts of the lipids with the 
aqueous milieu and not the association of their non-polar structural elements. This effect 
referred to as “hydrophobic effect” [11] originates from the fact that non-polar molecules are 
not able to form hydrogen bonds with water, thereby disrupting the hydrogen bonding 
network between water molecules in the aqueous phase [12]. Water molecules in close 
contact of hydrophobic elements of membrane lipids are reoriented in order to minimize the 
disruption of the hydrogen bonding network. Due to this reorientation and additional 
limitation of interaction partners at the non-polar surface to form hydrogen bonds, water 
molecules get caged and feature restricted translational and rotational degrees of freedom 
thus leading to an overall reduced entropy of the system which makes the process 
unfavorable in terms of free energy. From thermodynamics, it is therefore favorable to 
reduce the amount of hydrophobically hydrated non-polar molecules, or rather that non-
polar molecules reduce the area exposed to water e.g. by self-aggregation. Thus, self-
assembly of membranous bilayers with hydrophobic parts of lipid molecules interacting with 
each other allows to effectively maximize the free energy of the system [13]. This way, polar 
structural elements of membrane lipids shield the hydrophobic core of the bilayer from the 
aqueous solvent. 
1.2. Membrane lipids 
The main lipids of cellular membranes are glycerophospholipids, sphingolipids, sterols and 
cardiolipins [1]. Glycerophospholipids contain a central glycerol moiety whose hydroxyl 
groups in sn-1 and sn-2 position are esterified with two fatty acids. The hydroxyl group in 
sn-3 position is esterified to a phosphoric acid group that can be further esterified to different 
alcohols that determine the functional and physicochemical properties of the polar head 
group. Alcohols often found to be incorporated in glycerophospholipid head groups are 
ethanolamine, serine, choline glycerol and inositol but also a free phosphate group exists 
as in case of phosphatidic acid [1]. The enormous diversity of this class of membrane lipids 
arises from the combination of different head group alcohols and glycerophospholipid-
incorporated fatty acids with different length and degree of unsaturation as well as the 
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specific positions of double bonds. Fatty acids in bacteria can even feature branched acyl 
chains [14]. The most abundant glycerophospholipids of S. cerevisiae are phosphatidic acid 
(PA), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) 
and phosphatidylserine (PS) (Fig. I-1A). The fatty acid composition of these lipids is mostly 
limited to palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0) and oleic acid 
(C18:1) and only traces of fatty acids with shorter and longer carbon chains are found [15]. 
 
Fig. I-1: Chemical structures of representatives from abundant membrane lipid classes of 
S. cerevisiae.  (A) Indicated are representatives of glycerophospholipids featuring different head 
groups. Glycerophospholipids contain a central glycerol moiety that is esterified with two fatty acids 
and a phosphoric acid group that is further esterified with an alcohol such as choline 
(phosphatidylcholine (PC)) or ethanolamine (phosphatidylethanolamine (PE)). Phospholipids from 
S. cerevisiae often contain monounsaturated fatty acids with a chain length of 16- and 18- carbon 
atoms (C16:1 and C18:1). (B) Sphingolipids are composed of a central sphingosine molecule that is 
linked to a mostly very long chain saturated fatty acid (e.g. C26:0) via an amide bond. 
Sphingomyelins feature head groups identical to glycerophospholipids (phosphocholine or 
phosphoethanolamine) and are therefore ranked among the class of phospholipids. Abundant 
sphingolipids of S. cerevisiae are inositol-phosphorylceramid (IPC) and mannosyl-inositol-
phosphorylceramide (MIPC). These sphingolipids contain phytoshingosine as long chain base 
(instead of sphingosine) which is further linked to a α-hydroxylated very long chain fatty acid. (C) 
Ergosterol is the most prominent sterol of yeast cells. Chemical structures were generated with the 
LIPID MAPS Online Tools [16] and visualized by MoleculeSketch (version 1.6.2). 
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Sphingolipids feature a sphingosine (or derivatives) backbone that already contains a long 
saturated hydrocarbon chain (therefore called long chain bases) and is further linked to a 
primary saturated fatty acid via an amide bond. The C1 hydroxyl group of the central 
sphingosine backbone can be, similar to glycerophospholipids, esterified to a phosphoric 
acid group that can be also further esterified to different alcohols (mainly ethanolamine and 
choline) [1]. Due to this characteristic architecture, these sphingomyelines (Fig. I-1B) are 
ranked among the group of phospholipids. In contrast to that, ceramides feature an 
unmodified sphingosine C1 hydroxyl group, whereas the respective HO group is 
glycosidically linked to single sugars or sugar chains in glycosphingolipids (cerebrosides 
and gangliosides). The yeast sphingolipidome mainly consists of inositol-
phosphorylceramide (IPC), mannosyl-inositol-phosphorylceramide (MIPC) and mannosyl-
di-(inositolphosphoryl)ceramide (M(IP)2C). The ceramide backbone of these sphingolipids 
contains phytosphingosine (instead of sphingosine) which is linked to a very long chain fatty 
acid (mostly α-hydroxylated C26:0) via an amide bond [15] (Fig. I-1B). 
Another class of membrane lipid that is found in almost all eukaryotic cellular membranes 
and even in membranes of some prokaryotes are sterols. The most prominent sterol of 
animal cells is cholesterol, whereas fungi such as S. cerevisiae synthesize a highly similar 
sterol, ergosterol, instead (Fig. I-1C). All membrane sterols feature similar physicochemical 
properties and play therefore identical roles for the organization of biological membranes. 
The hydrophobic, planar chemical structure of sterols allows them to intercalate between 
phospholipids and to favorably interact with their hydrocarbon chains. The hydroxyl group 
of membrane sterols is typically faced towards the polar surface of the bilayer thereby 
allowing to interact with the polar head groups of phospholipids via hydrogen bonds. 
According to the umbrella model [17], sterols preferentially interact with sphingolipids whose 
head groups physically shield them from the aqueous phase on both sides of the bilayer. 
Since sphingolipids contain saturated, trans-configured hydrocarbon chains, they are able 
to form taller cylinders that can pack more tightly compared the glycerophospholipids 
containing unsaturated, stably cis-configured fatty acids. Sterols intercalating between the 
straight hydrocarbon chains of sphingolipid-rich membrane areas break up their tight 
packing, thus functioning as fluidizers in tightly packed membranes [2, 18]. On the other 
hand, sterols condense loosely-packed membranes by reducing the average area covered 
by each molecule within the lipid bilayer [19, 20] and increasing membrane surface density 
and rigidity [21], which affects e.g. the water permeability of the bilayer [22]. The condensing 
effect is closely related to the so-called ordering effect of sterols on fluid phase membranes. 
This effect is characterized by a reduced content of sterically hindering gauche and eclipse 
conformations and an increased percentage of stabilized trans conformations of the C-
chains torsion angles within the long hydrocarbon chains of saturated fatty acids when 
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interacting with the smooth α-faces of sterols [23]. This way, straightened hydrocarbon 
chains can pack more tightly thereby rigidifying highly fluid membranes and reducing the 
average volume of a lipid molecule. These opposite functions emphasize the dual nature of 
membrane sterols and their roles for regulating membrane fluidity and phase behavior as 
well as broadening the temperature range in which transition between the solid-ordered 
(solid-gel) and liquid-disordered (liquid-crystalline) phase behavior takes place [24].  
1.3. Lipid domains and phase behavior 
The phase behaviors of biological membranes are determined to a great extent by the 
chemical structures of their components as well as by their thermal energization. 
At low temperatures, the hydrocarbon chains of fully saturated fatty acids are as much 
expanded as possible, with sterically preferable all single C-C bonds in trans conformation 
(all-trans; also anti conformation) thereby maximizing van-der-Waals intermolecular 
interactions. The high proportion of straightened fatty acyl chains as well as the network of 
van-der-Waals interactions lead to a densely packed, highly ordered membrane structure 
[25]. These bilayers are characterized by a high order parameter of their lipids as well as 
an extremely small lateral (translational) diffusion coefficient (DT = ~10-3 µm2·s-1) [2], 
therefore impeding lateral diffusion of membrane lipids and embedded proteins. This lipid 
phases are designated as solid-ordered (so; solid gel) phases which is thought to not 
support biological function in general, although proteins such as the Ca2+-ATPase can show 
low activities in gel phase lipid bilayers [26]. 
With increasing temperature (higher than the thermotropic phase transition temperature 
Tm), solid-ordered membrane phases are converted into membranes with so-called liquid-
disordered (Ld; liquid-crystalline) phase behavior [25]. This conversion results from rotations 
of C-atoms around the C-C single bond axes within the hydrocarbon chains of saturated 
fatty acids, the so-called trans-gauche isomerization [27] (Fig. I-2A). These rotations are 
accompanied by thermodynamically unfavorable, sterically hindering gauche and eclipse 
conformations that are facilitated in a higher energized (thermal energy) system. C-C single 
bonds with eclipse/gauche conformation are pseudo cis-configured, thus introducing a 
kinked structure of fatty acid hydrocarbon chains which strongly impedes a dense lipid 
packing and ordering. Such liquid-disordered membranes are therefore characterized by a 
low ordering parameter and a high lateral diffusion coefficient (DT = ~1 µm2·s-1) [2], thus 
enabling fast translational and rotational diffusion of membrane components (Fig. I-2B) 
which is considered to be essential for the integrity of membrane associated biological 
processes. 
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Fig. I-2: Schematic illustration of the dynamics of membrane lipids. (A) Straight fatty acid chains 
of fully saturated fatty acids with all-trans conformation undergo thermally induced conformational 
changes (trans-gauche isomerization). C-C single bonds with gauche conformation induce a kinked 
structure of the fatty acids acyl chains which strongly impedes a dense lipid packing and ordering. 
Temperatures higher than the thermotropic phase transition temperature (Tm) strongly affect the 
conformational order of lipid molecules thereby inducing a transition of the phase state of biological 
membranes. Newman projections of C-C single bonds with trans and gauche conformations are 
shown as an example. Blue circles represent the head groups of phospholipids and jagged lines 
depict the hydrocarbon chains of phospholipid-incorporated fatty acids. (B) Lipids in biological 
bilayers undergo lateral, rotational and transversal diffusion. Lateral and rotational diffusion rates of 
lipids depend on the phase state of the bilayer. Highly-ordered bilayers impede lateral and rotational 
diffusion whereas fluid-disordered membranes allow lipid molecules to diffuse quickly. Adapted from 
[25]. 
Besides thermal energy, the phase behavior of biological membranes is determined to a 
great extent by the chemical character of the membrane lipids and their included fatty acids. 
Unsaturated fatty acids with cis-configured C-C double bonds possess conformationally 
stable kinked structures that are equivalent to those resulting from C-C single bonds with 
eclipse conformation but do not depend on the thermal energization of the membranous 
system. The incorporation of unsaturated fatty acids in membrane lipids can thus maintain 
a liquid-disordered phase state of membranes even at temperatures that do not support 
eclipse configured rotameric structures. 
Unsaturated fatty acids are mostly found in membrane glycerophospholipids so that these 
tend to form and be enriched in liquid-disordered phases, whereas sphingolipids that mostly 
contain long, saturated hydrocarbon chains adopt solid-ordered phases. Moreover, 
sphingolipids tend to segregate together because of thermodynamically favorable van-der-
Waals and hydrophobic interactions between their straight hydrocarbon chains [28]. 
Interactions between their polar, oligosaccharide-containing head groups can enhance this 
auto-assembly process [29] thus emphasizing the high tendency of sphingolipids to form 
solid-ordered lipid phases [30]. However, since sphingolipid-enriched membrane parts often 
contain sterols that do not form bilayer phases by themselves, no real solid-ordered but 
rather a third type of membrane phase, the liquid-ordered phase (Lo) is constituted [18]. 
This phase combines properties of the previously described solid and fluid membrane 
phases and is characterized by the high conformational order of a solid [31] but still features 
the high lateral mobility [32, 33] of a liquid (DT = ~1 µm2·s-1) [2]. In other words, the liquid-
ordered phase features characteristics of a transition phase between a solid-order and a 
liquid-disordered phase. 
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Fig. I-3: Physical membrane states adopted by lipid bilayers in biological systems. A solid-
ordered phase state (So) is characterized by a highly-ordered and dense lipid packing. Increasing 
temperatures induce conformational changes in the fatty acid acyl chains of membrane lipids thereby 
impeding a dense lipid packing. The resulting phase is designated as liquid-disordered (Ld) phase. 
Liquid-disordered phase behavior of biological bilayers is not only thermally induced but also occurs 
due to incorporating unsaturated fatty acids in membrane lipids. Liquid-ordered phases (Lo) feature 
characteristics of both previously mentioned phase states as they are characterized by a high 
conformational order (ordered) but still support fast lateral diffusion (liquid). Solid-ordered and liquid-
disordered membranes can be converted to liquid-ordered membranes by the incorporation of 
membrane sterols. Integration of sterols into highly-ordered bilayer breaks up their tight packing, thus 
functioning as fluidizers of membranes with solid-ordered phase state. In contrast, sterols condense 
loosely-packed membranes by straightening the fatty acid hydrocarbon chains, thus increasing the 
order parameter of a disordered bilayer. Adapted from [25]. 
1.4. Membrane fluidity and its significance for biological processes 
Membrane fluidity can be described as the extent of molecular disorder within a bilayer and 
its capability to support lateral and rotational motion of membrane components such as 
membrane lipids and membrane proteins. Membrane fluidity is therefore closely linked with 
the previously described phase behaviors of differently composed and energized bilayers. 
The fact that organisms have evolved means to maintain physiological membrane fluidity 
that supports the proper function of membrane associated processes, so called 
homeoviscous adaption [34], emphasizes that membrane fluidity plays an important role in 
cellular functions. Homeoviscous adaption is preferentially important for poikilothermic 
organisms such as bacteria, plants, and fungi. Common means to maintain physiological 
membrane fluidity are based on altering the membrane lipid composition as e.g. changing 
the degree of fatty acid unsaturation thereby directly influencing lipid packing and order [35]. 
Membrane proteins are mobile within a fluid lipid environment that supports translational 
and rotational motion, although lateral diffusion of membrane proteins is slower than 
expected by theory due to protein crowding in the membrane and restrictions caused by the 
aqueous phase on both sides of the lipid bilayer [36]. However, dynamics of membrane 
proteins is supported by their lipid environment as it is essential for their biological function. 
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Diffusion-based processes within biological membranes benefit from the 2D organization of 
their matrix since reduction of dimensionality enhances the likelihood for collisional 
encounters [36]. This means, on the other hand, that membrane fluidity and the lipid 
environment of participating membrane proteins have to support their lateral mobility. Under 
diffusion limiting conditions (such as in biological membranes), collisional encountering can 
become the rate limiting step of the overall reaction, which is why membrane-associated 
signal transduction processes are often diffusion-controlled [37]. In contrast to that, there 
are diffusion coupled membrane processes that are not controlled by the diffusion of 
interacting partners. Those reactions often contain interaction partners and mediating 
elements whose mobility is not restricted within the bilayer so that other steps of the reaction 
get rate limiting. An example for this phenomenon is the mitochondrial electron transport 
chain involving fast-diffusing ubiquinones that transfer electrons between the diffusion-
restricted respiratory complexes [38]. 
Another aspect of membrane protein dynamics is their conformational flexibility. Membrane 
proteins are no rigid structures but possess a certain conformational flexibility so that their 
actual structure is more a superposition of a countless number of different conformational 
substates [39]. An intrinsic property of enzymatically acting proteins is the continuous 
interconversion from one conformational substate to another. Additionally, motion of small 
substrate molecules into the inside of an enzyme might only be possible due to these 
conformational fluctuations [40]. It was shown, that the viscosity of the solvent influences 
the activation energy required for protein conformation changes [39] emphasizing that the 
lipid environment of proteins can influence the kinetics of protein conformational changes 
in a viscosity-dependent manner [41]. Proteins that carry out their function and thereby 
undergo changes in shape have to move at least some of their parts in the lipid solvent thus 
experiencing frictional forces. These frictional forces are directly linked with the viscosity of 
the lipid solvent, or its inverse, the fluidity of the lipid bilayer. The balance of the frictional 
forces and the mechanical restoring forces of the solvent (lipid bilayer) directly influence the 
mode of molecular motion of the protein (part) in the bilayer. Changes in prevailing frictional 
forces can thereby affect molecular vibrations within the protein and favor either 
overdamped (high frictional forces) or underdamped (low frictional forces) molecular 
motions [42]. These findings underline furthermore that membrane viscosity and thus 
membrane fluidity have a major impact on the conformational flexibility of membrane 
proteins which is crucial for their proper function. Membrane lipids might provide an 
environment to induce the optimal conformation for catalytic activity and breaks in the 
Arrhenius plots of membrane-embedded enzymes might be directly linked to the fluidity of 
the surrounding membrane [36]. Moreover, conformational interconversions and flexibility 
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was found to influence protein folding dynamics [43, 44], thereby emphasizing an essential 
role of the lipid environment for the kinetics of membrane protein constitution. 
Another membrane parameter that is closely related the chemical structure of membrane 
lipids (fatty acid unsaturation) and thus membrane fluidity is the thickness of the bilayer: 
Highly ordered membranes are significantly thicker as compared to bilayers featuring a low 
ordering parameter [45, 46]. Integral membrane proteins interact with the lipophilic core of 
the bilayer by means of the hydrophobic surface structures of their trans-bilayer parts 
whereas the hydrophilic protein parts interact with the polar lipid head-groups as well as 
with the aqueous milieu on both sides of the bilayer. Reducing the thickness of the 
membrane simultaneously decreases the hydrophobic interaction area between the bilayer 
core and the membrane protein so that non-polar parts of the protein get exposed to a polar 
environment. This way, proteins can be distorted [47] or can be forced to unfavorable 
conformations that can be further accompanied by a total or partial loss of function as shown 
for the Na+-K+-ATPase [48] and other membrane proteins [49, 50]. Alternatively, membrane 
proteins might be directed to membrane parts that provide optimal bilayer thickness in order 
to maximizing beneficial hydrophobic protein-bilayer interactions and preventing 
hydrophobic mismatches [51]. This way, membrane proteins with longer bilayer spanning 
parts would preferably locate in physiologically active membranes with liquid-ordered phase 
behavior. Alternatively, it is suggested that rather the lipid bilayer is distorted in order to 
match the hydrophobic region of a membrane protein and thus to minimize hydrophobic 
mismatches [7, 52, 53]. 
Besides membrane fluidity and the thickness of the bilayer, lipid head groups and their 
differences in hydrogen bonding potential as well as their shape and the closely linked 
membrane curvature and lateral pressure profiles of the membrane might be important 
factors in determining the effects of lipids on protein activities [42]. 
1.5. Sensing of membrane fluidity by the OLE pathway of S. cerevisiae 
Homeoviscous adaption and maintenance of physiological membrane fluidity is essential 
for cell viability. One of the key factors that determines fluidity and phase behavior of 
membranes in living cellular systems is the proportion of saturated and unsaturated fatty 
acids that are incorporated in glycerophospholipids [35]. The mechanism and system that 
regulates the synthesis of unsaturated fatty acids in order to adapt the extent of membrane 
lipid unsaturation to environmental conditions (e.g. temperature, oxygen availability) was 
extensively studied in the model organism S. cerevisiae. This system was referred to as 
“OLE pathway” [54] and includes all components that are required to sense membrane lipid 
unsaturation as well as to synthesize unsaturated fatty acids de novo if required. Key 
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players of the system are Ole1p, a stearoyl-CoA desaturase which is the sole fatty acid 
desaturase found in yeast that is essential to synthesize ∆9 monounsaturated fatty acids 
[55]. Other components of the system are the transcription activators Spt23p and Mga2p, 
ER membrane-resident proteins that function as membrane fluidity sensors [56].  
Spt23p and Mga2p possess a transmembrane helix (TMH) that anchors both proteins, 
respectively, within the ER membrane. Both proteins form homo-dimers which is a 
prerequisite for sensing of membrane fluidity and lipid packing. Helix-helix interactions are 
facilitated by the high proportion of aromatic amino acids situated within the TMHs 
presumably forming intermolecular interactions by pi stacking [56]. The sensing mechanism 
of dimeric Mga2p is based on the structure of its TMHs and involves rotational TMH motions 
which leads to a continuum of alternative TMH-TMH interfaces [54]. A bulky tryptophan 
residue is atypically positioned deep within the membrane bilayer and important for sensing. 
Voluminous tryptophan residues are usually located close to the membrane-water interface 
[57]. In a loosely packed, fluid membrane, this bulky amino acid side chain can be easily 
accommodated in the lipid environment so that a high proportion a Mga2p dimers and their 
TMHs features a characteristic rotational orientation to each other with both tryptophan 
residues facing outwards. This relative orientation of both TMHs represents the off-state of 
the sensor and indicates physiological membrane fluidity. In contrast, increasing membrane 
packing and decreasing membrane fluidity favor an inward rotation of the bulky tryptophan 
residue, thus stabilizing an alternative relative TMH orientation that hides both residues in 
the dimer interface. This relative rotational orientation marks the on-state of the sensor. 
Importantly, the different rotational orientations seem not to be separated by high energy 
barriers so that even very little changes in membrane lipid unsaturation can be effectively 
sensed by the system [35, 56]. The on-conformation further allows Rsp5p-mediated 
ubiquitination of Mga2p at a position close to the ER membrane which is suggest to be the 
signal for subsequent proteolytic processing by the cytosolic 26S proteasome. Proteasome-
dependent activation involves the cleavage of the protein thereby releasing the N-terminal 
soluble p90 fragment. The activated p90 domains translocate to the nucleus and upregulate 
the expression of a number of genes involved in various cellular processes such as the 
central carbon and lipid metabolism, ribosome biogenesis, flocculation and mating [58, 59]. 
Although Mga2p90 and Spt23p90 do not contain any known DNA binding domain, they 
seem to control transcription by chromatin remodeling [58, 60]. Prominent targets of 
Mga2p90 are OLE1 and ERG1 that encodes for an essential enzyme involved in the 
biosynthesis of ergosterol. The upregulation of OLE1 leads to increased fatty acid 
unsaturation thus eventually fluidizing the ER membrane and closing the end-product 
feedback regulation loop to maintain physiological membrane fluidity.  
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Fig. I-4: Sensing of lipid packing and membrane fluidity by Spt23p and Mga2p. Homodimers of 
Spt23p or Mga2p use their transmembrane helices (TMH) to sense the lipid packing of the bilayer. 
A loosely packed bilayer stabilizes a relative rotational orientation of both TMHs that allows to bury 
their bulky tryptophan residue (red) deep within the lipid bilayer. This relative TMH orientation refers 
to the off-state of the sensor. In contrast, highly ordered lipid bilayers do not allow the tryptophan 
residue to be rotated outwards and favors a relative rotational orientation of the TMHs in which both 
tryptophan residues face towards the dimer interface. This orientation characterizes the on-state of 
the sensors and supports Rsp5p-mediated ubiquitination of both monomers. Ubiquitination serves 
as the signal for subsequent proteolytic processing by the cytosolic 26s proteasome which activates 
the sensor. Activation involves protein cleavage, thus releasing a soluble p90 fragment (orange) 
which translocates to the nucleus and serves as a transcription activator. Adopted from [54]. 
Other organisms have evolved different mechanisms to sense the composition of their 
membranes. The DesK/DesR system from B. subtilis measures the thickness of the 
membrane for deducing the unsaturation degree and viscosity of the bilayer. Increased 
bilayer thickness eventually leads to the activation of des, encoding for a lipid desaturase 
[61]. Another prominent example of transcriptional regulation of genes involved in lipid 
metabolism is mediated by the metazoan SREBPs (sterol response element binding 
proteins). These proteins measure the content of sterols in the membrane and get activated 
upon sterol depletion [62].  
1.6. Membrane sterols and the lipid raft concept 
According to the fluid mosaic model of biological membrane organization [9], all membrane 
lipids and membrane embedded proteins form a homogenous two-dimensional fluid in 
which its components can laterally diffuse without restriction. Although the general 
description of cell membrane organization has proven to be correct, findings from the last 
three decades strongly contradict the theory of biological membranes as homogenous 
phases. The mere fact that cellular membranes contain a high proportion of sphingolipids 
and sterols that tend to segregate into lipid clusters with a more ordered phase behavior 
within a fluid-disordered glycerophospholipid-rich phase is not in accordance with a uniform 
lipid bilayer. These sterol- and sphingolipid-enriched lipid clusters turned out to be more 
resistant against non-ionic detergents and seemed to provide an environment in which 
certain proteins preferably move into due to an intrinsic affinity [63]. These findings gave 
rise to a concept of lipid rafts which were defined as “small (10-200 nm), heterogeneous, 
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highly dynamic sterol- and sphingolipid-enriched domains that compartmentalize cellular 
processes” [64]. 
Specific association of proteins with lipid rafts was firstly reported for GPI-anchored proteins 
[63]. Besides that, some other membrane-anchoring protein modifications such as 
myristoylation and palmitoylation have been suggested to be associated with protein 
targeting to lipid rafts [65, 66]. However, also proteins without fatty acid conjugation were 
discovered in lipid rafts, indicating that proteinous elements must be responsible for raft 
localization. Both, transmembrane [67] as well as intra- [68] and extracellular domains [69] 
were identified to targeting signals, although no consensus protein-based raft targeting 
sequences could be determined. Additionally, protein domains with sphingolipid-binding 
activity were already discovered [70]. However, forces that drive proteins to segregate into 
different lipid environments are still poorly understood. Another mechanism that directs 
proteins to lipid rafts could be based on membrane thickness and the length of 
transmembrane domains of membrane proteins. Liquid-ordered, sterol containing bilayers 
are considerably thicker than liquid-disordered ones [71, 72] thereby making it energetically 
favorable for a protein to enter and stay within a membrane whose thickness matches the 
length of its membrane spanning part [73]. This way, membrane proteins with longer 
transmembrane domains would preferably segregate into lipid rafts in order to prevent 
hydrophobic mismatches [51]. In line with that theory, it could already be shown that the 
ratio of membrane thickness and length of transmembrane domains influences protein 
sorting to the plasma membrane. The concentration of sphingolipids and sterols increase 
along the way from the ER to the plasma membrane thus also increasing the membrane 
thickness [74] and proteins with longer TMHs (~20 aa) are preferably addressed to the 
plasma membrane whereas Golgi proteins feature usually shorter TMHs (~15 aa) [75]. It 
has also been hypothesized that so-called “lipid shells” can confer membrane proteins an 
affinity for lipid rafts. Lipid shells consist of ~80 sterol/sphingolipid molecules that surround 
the transmembrane domain of membrane proteins due to physical interactions and direct 
proteins to lipid rafts in a thermodynamically-driven lipid-mediated manner as sterols and 
sphingolipids themselves have an affinity for preexisting raft domains [76]. 
Similarly, it is not well understood how raft or non-raft localization of membrane proteins 
can affect their function. However, it is known that proteins can exist in different states 
depending on their lipid environment. For example, glutamate receptors were found to be 
in a low affinity state when embedded in a sterol-depleted membrane whereas the receptor 
changes its conformation in sterol-rich bilayers with liquid-ordered phase behavior and 
switches to a high-affinity state [77]. This way, it could be suggested that the lipid 
environment directly influences the conformation of proteins and the most functional 
conformation is only supported in raft domains. Following the previously mentioned theory, 
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an unfavorable ratio of membrane thickness and the length of transmembrane domains 
could force proteins into an unfavorable conformation in order to prevent hydrophobic 
mismatches, thus negatively affecting protein function [49]. Alternatively, protein function 
could be affected by the lipid environment in a similar way as shown for the lipid packing 
sensors Spt23p and Mga2p from S. cerevisiae [56]. Large bulky amino acid side chains of 
transmembrane domains could affect protein motion [75] (e.g. rotation) in different lipid 
environments as liquid-ordered and liquid-disordered membrane domains differ significantly 
in their order parameter and packing density. 
Proteomics on lipid raft-resident proteins was used to identified biological processes that 
might be closely associated with lipid rafts. These analyses identified raft localization of cell 
signaling proteins such as heterotrimeric G proteins, tyrosine kinases, phosphatases [78] 
and support the long-time evidence that lipid rafts are associated with cell signaling [79]. 
Additionally, cytoskeletal and adhesion proteins (e.g. actin, myosin, vinculin) [78, 80, 81] 
were found in lipid raft preparations thereby suggesting lipid rafts interact with the 
cytoskeleton. For S. cerevisiae, lipid rafts have been discussed to be involved in protein 
sorting, development of cell polarity [82, 83], cell growth, drug-mediated cell death [84] and 
membrane compartmentation [85]. 
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2. Chapter II: Lipid engineering reveals regulatory roles for membrane fluidity 
in yeast flocculation and oxygen-limited growth 
2.1. Abstract 
Cells modulate lipid metabolism in order to maintain membrane homeostasis. Here a 
metabolic engineering approach was used to manipulate the stoichiometry of fatty acid 
unsaturation, a regulator of cell membrane fluidity, in Saccharomyces cerevisiae. 
Unexpectedly, reduced lipid unsaturation triggered cell-cell adhesion (flocculation), a 
phenomenon characteristic of industrial yeast but uncommon in laboratory strains. It was 
found that ER lipid saturation sensors induce expression of FLO1 – encoding a cell wall 
polysaccharide binding protein – independently of its canonical regulator. In wild-type cells, 
Flo1p-dependent flocculation occurs under oxygen-limited growth, which reduces 
unsaturated lipid synthesis and thus serves as the environmental trigger for flocculation. 
Transcriptional analysis shows that FLO1 is one of the most highly induced genes in 
response to changes in lipid unsaturation, and that the set of membrane fluidity-sensitive 
genes is globally activated as part of the cell’s long-term response to hypoxia during 
fermentation. The results presented here show how the lipid homeostasis machinery of 
budding yeast is adapted to carry out a broad response to an environmental stimulus 
important in biotechnology.  
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2.2. Introduction 
The lipid composition of cellular compartments is thought to control the physicochemical 
properties of their membranes and thus could act as a broad regulator of membrane-
localized cellular machinery. Lipid composition can vary tremendously between cells, 
organelles, and tissues, potentially reflecting differing constraints that molecular processes 
hosted by these membranes place [1]. For example, in budding yeast (Saccharomyces 
cerevisiae), global lipid analysis by mass spectrometry has shown that the cellular lipidome 
changes during growth and is dependent on carbon source [2]. However, understanding 
functional roles for differences in lipid composition remains a challenge because a limited 
set of tools is available for studying lipid composition in vivo. Standard genetic approaches, 
e.g. gene knockouts, provide little functional information on essential lipid components, 
while chemical tools, such as media supplements [3] and lipid chelators [4], provide limited 
stoichiometric control over lipid composition.  
An alternative strategy to chemical manipulation of lipid composition is to engineer cells in 
which the expression of lipid synthesis pathways is placed under experimental control. It 
was sought to use this approach to investigate a central chemical parameter in determining 
the physical state of cell membranes: the proportion of fluidizing double bonds in 
phospholipid acyl chains (lipid unsaturation). Enzymatic desaturation generates cis-double 
bonds in acyl chains, whose geometry interferes with inter-lipid interactions, thereby 
reducing lipid packing and fluidizing the bilayer [5]. Membrane fluidity is thought to be 
maintained by cells in response to changes in temperature [6] or solvents [7] by modulating 
the fatty acid composition of membrane phospholipids. Changes in fatty acid unsaturation 
are also associated with human diseases, including the development of type-2 diabetes [8] 
and tumor proliferation in cancer [9]. However, the functional effects of these physical and 
chemical parameters on basic cellular physiology are still not fully understood. 
 
Fig. II-1: Reaction scheme of oxygen- and NADH-dependent desaturation of fatty acid acyl 
chains catalyzed by Ole1p. Ole1p uses coenzyme A (CoA) bound precursors of fully saturated fatty 
acids as substrate and introduces a double bond between C9 and C10 yielding the corresponding 
Δ9-cis monounsaturated fatty acid species. The reaction requires NADH as electron donor and 
molecular oxygen (O2) as final electron acceptor. 
O2 +
NADH+H+ NAD+
Ole1p
2 H2Opalmitoyl CoA
(C16:0) 
palmitoleoyl CoA
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Higher eukaryotes feature a repertoire of desaturases with varying substrates and products 
[10], including polyunsaturated species whose complex biophysical effects make identifying 
fluidity-regulated functions a challenge [11]. In contrast, budding yeast features only a single 
lipid desaturase (Ole1p), which converts a wide range of coenzyme A-bound fatty acids into 
their corresponding Δ9-cis monounsaturated species [12] (Fig. II-1). 
Because bilayer fluidity is an important parameter for membrane-associated cellular 
processes, yeast has evolved mechanisms for modulating the level of OLE1 in response to 
metabolic stages during growth [13] and to environmental stimuli, such as the supply of 
exogenous lipids. In budding yeast, a fatty acid regulatory (FAR) region in the OLE1 
promoter was first identified to be responsive to fatty acid metabolism genes [14]. Later it 
was found that a pair of ER membrane-bound transcriptional activators – Spt23p and 
Mga2p [15], which were first identified as regulators of TY retrotransposon elements [16] – 
mediate OLE1-specific lipid regulation. Biochemical and genetic experiments have led to a 
model in which membrane-anchored Spt23p and Mga2p are proteolytically processed in 
response to changes in fatty acid composition [17]. The resulting active fragments, termed 
p90 domains, induce OLE1 expression, though neither protein contains a recognizable DNA 
binding domain [16, 18, 19]. Recent work has proposed a model in which proteolysis is 
driven by conformational changes in the transmembrane helices of Spt23p/Mga2p 
homodimers mediated by the unsaturated lipid content of the ER membrane [20]. Several 
key aspects of this pathway are still under investigation, including the exact mechanism by 
which Spt23p/Mga2p or their interacting partners influence gene expression. 
In this study it was sought to systematically investigate the physiological effects of changes 
to lipid unsaturation by bypassing the cell’s native lipid regulation pathway. A surprising 
phenotype was observed resulting from repression of the lipid desaturase-encoding OLE1: 
cell-cell adhesion, termed flocculation, which was found to be a transcriptional response to 
low membrane fluidity. Flocculation is induced when oxygen availability for lipid 
desaturation reactions is restricted and is part of a wide-ranging transcriptional response to 
low membrane fluidity that is activated during microaerobic fermentation. 
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2.3. Materials and Methods 
2.3.1. Yeast strains 
Tab. II-1: Yeast strains used in this study. The table lists all strains with corresponding genotypes. 
Plasmids harbored by respective strains are named as indicated in Tab. II-S2. 
strain genotype reference 
BY4742 MATa; his3D1; leu2D0; lys2D0; ura3D0 [21] 
SII-1 BY4742; ole1:: PMET3-OLE1 This study 
SII-2 BY4742; spt23::kanMX (Dspt23) This study 
SII-3 BY4742; mga2::URA3 (Dmga2) This study 
SII-4 BY4742; flo1::yECitrine-URA3 (Dflo1) This study 
SII-5 SII-1; flo1::yECitrine-URA3 (Dflo1) This study 
SII-6 SII-1; FLO1hd::TCYC1-kanMX (FLO1Dhd) This study 
SII-7 SII-1; flo8::yECitrine-URA3 (Dflo8) This study 
SII-8 SII-1; flo9::kanMX (Dflo9) This study 
SII-9 SII-1; spt23::kanMX (Dspt23) This study 
SII-10 SII-1; mga2::URA3 (Dmga2) This study 
SII-11 SII-2; pCM188-SPT23p90 This study 
SII-12 SII-4; pCM188(LEU2)-SPT23p90 This study 
SII-13 SII-3; pCM188(LEU2)-MGA2p90 This study 
SII-14 SII-1; pCM188-OLE1 This study 
SII-15 SII-1; pGREG523-PSPT23-mycSPT23 This study 
SII-16 SII-9; pGREG523-PSPT23-mycSPT23 This study 
SII-17 SII-9; pGREG523-PSPT23-mycSPT23W1042L This study 
SII-18 SII-9; pGREG523(2µ)-PSPT23-mycSPT23 This study 
SII-19 SII-9; pGREG523-PTEF1-mycSPT23 This study 
SII-20 SII-9; pGREG523(2µ)-PTEF1-mycSPT23 This study 
SII-21 SII-1; pGREG523-PMGA2-mycMGA2 This study 
SII-22 BY4742; ura3::HAC1-GFP This study 
SII-23 SII-1; ura3::HAC1-GFP This study 
SII-24 SII-1; hac1::kanMX (Dhac1) This study 
SII-25 SII-1; ire1::kanMX (Dire1) This study 
SII-26 SII-1; pRS416-ER-sfGFP-HDEL This study 
2.3.2. Yeast transformation and strain construction 
Genetically modified S. cerevisiae strains generated in this study are derived from BY4742 
(MATa; his3D1; leu2D0; lys2D0; ura3D0) obtained from EUROSCARF (Frankfurt, 
Germany). BY4742 cells were routinely cultured in YPD media (2% glucose; 2% peptone; 
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1% yeast extract). BY4742 derived strains harboring selectable markers (URA3; LEU2; 
HIS3) were grown in appropriate synthetic defined (SD) drop-out media (2% glucose; yeast 
nitrogen base (YNB); drop-out amino acid supplement). KanMX cassette harboring cells 
were selected at 200 mg/L G418. Cells were propagated at 30°C. All strains are listed in 
Tab. II-1. 
Transformation of S. cerevisiae with previously generated plasmids was routinely 
performed by using the Frozen-EZ Yeast Transformation II kit (Zymo Research) according 
to manufacturer’s instructions. 
S. cerevisiae transformation for genomic integration of integration cassettes (promoter 
replacement cassette; knockout cassettes) via homologous recombination and plasmid 
uptake was routinely performed by the standard lithium acetate method [22]. Replacement 
of endogenous OLE1 promoter was performed by genomic integration of a PMET3 containing 
promoter replacement cassette (loxP-LEU2-loxP-PMET3) amplified by PCR from plasmid 
p416-LEU2-PMET3-yECitrine (OneTaq DNA polymerase; primers P5 & P6). FLO1 and FLO8 
were knocked-out by replacing the entire ORF, respectively, with the yECitrine-URA3 
cassette from plasmid p416-LEU2-PTEF1-yECitrine. SPT23, FLO9, HAC1 and IRE1 were 
knocked-out by replacing the ORF with the kanMX cassette from plasmid pCM224. MGA2 
was knocked-out by replacing the ORF with the URA3 cassette from plasmid p416-LEU2-
PTEF1-yECitrine. The sequence encoding the Flo1p hydrophobic domain (FLO1hd) was 
knocked out by genomically integrating the TCYC1-kanMX cassette from plasmid pGREG506 
thereby introducing a premature stop-codon and a terminator sequence to the 3’-end of the 
FLO1 ORF. The so modified FLO1 ORF encodes for a C-terminal shortened protein variant 
lacking the hydrophobic domain (S1510 – I1537) thus preventing proper Flo1p anchoring 
at the cell surface. Knockout cassettes (KOCs) were routinely amplified by PCR (OneTaq 
DNA polymerase) using primers P15 & P16 (FLO1 KOC); P17 & P18 (FLO1hd KOC); P19 
& P20 (FLO8 KOC); P21 & P22 (FLO9 KOC); P23 & P24 (SPT23 KOC); P25 & P26 (MGA2 
KOC); P27 & P28 (HAC1 KOC); P29 & P30 (IRE1 KOC). A yeast integrative plasmid 
containing the HAC1 splicing reporter (pCD256-hac1-gfp; not published; kindly provided by 
Dr. Itay Budin) was cleaved with PmeI & PacI to generate a linear DNA fragment carrying 
sequences (718 bp & 586 bp) homologous to the genomic URA3 ORF flanking regions. The 
linearized plasmid (1 µg) was applied for transformation to integrate the HAC1 splicing 
reporter at the URA3 locus. Genomic integrations were verified by colony PCR using a 
respective pair of primers that amplify a DNA fragment containing the artificial integration 
border resulting from the homologous recombination event. 
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Confirmation of flo8-1 allele in the background strain was done by sequencing a portion of 
the FLO8 ORF after amplification by PCR (primers P45 & P46) from position -24 to +659 
using BY4742 genomic DNA as template. 
2.3.3. Plasmid construction 
Introduction of selectable loxP-LEU2-loxP cassette from plasmid pUG73 [23] in plasmid 
p416-PTEF1-yECitrine [24] was performed as previously described by Nevoigt et al. [25]. The 
resulting plasmid can be used as a template for amplifying a TEF1 promoter (PTEF1) 
containing promoter replacement cassette and was named p416-LEU2-PTEF1-yECitrine. To 
replace the TEF1 promoter of plasmid p416-LEU2-PTEF1-yECitrine with the MET3 promoter 
(PMET3), the plasmid was cleaved with SpeI and the amplified PMET3-loxP sequence was 
inserted via recombination-based cloning. The PMET3-loxP sequence was amplified by PCR 
(OneTaq DNA polymerase, NEB) from plasmid pUG72-PMET3 using primers P3 and P4. 
pUG72-PMET3 was generated by inserting the MET3 promoter sequence [26] amplified from 
S288C genomic DNA (OneTaq DNA polymerase; primers P1 & P2) in SpeI cleaved plasmid 
pUG72 via recombination-based cloning. 
The integration of yeast endogenous genes (OLE1; SPT23p90; MGA2p90) in plasmid 
pCM188 (doxycycline repressible expression, CEN/ARS; URA3 marker, [27]) was 
performed by recombination-based cloning. For this, pCM188 was digested with BamHI 
and NotI and the ORFs were amplified by PCR (Q5 DNA polymerase, NEB) using S228C 
genomic DNA as template. Plasmids pCM188(LEU2)-SPT23p90 and pCM188(LEU2)-
MGA2p90 were generated by inserting an additional loxP-LEU2-loxP cassette amplified 
from plasmid pUG73 [23] (OneTaq DNA polymerase) in HindIII cleaved plasmids pCM188-
SPT23p90 and pCM188-MGA2p90. Flanking of PCR products with sequences homologous 
to the restricted plasmid backbone was achieved by using corresponding overhang primers 
(primers P7 & P8 (OLE1); P9 & P10 (SPT23p90); P11 & P12 (MGA2p90); P13 & P14 (loxP-
LEU2-loxP)). 
Plasmids pGREG523-PSPT23-mycSPT23 and pGREG523-PMGA2-mycMGA2 (CEN/ARS; HIS3 
marker) for expressing 13xmyc-tagged versions of full length Spt23p or Mga2p from their 
native promoters PSPT23 or PMGA2 were generated by replacing the HIS3 stuffer and GAL1 
promoter (PGAL1) from plasmid pGREG523 [28] with SPT23 ORF and PSPT23 or MGA2 ORF 
and PMGA2, respectively. The ORFs and the native promoters (1kb upstream of ORF) were 
amplified from S288C genomic DNA by using corresponding overhang primers (primers 
P31 & P32 (SPT23); P33 & P34 (PSPT23); P41 & P42 (MGA2); P43 & P44 (PMGA2)). The PCR 
amplified ORFs were inserted in the SalI cleaved plasmid pGREG523 by recombination-
based cloning, generating plasmids pGREG523-SPT23 or pGREG523-MGA2. PGAL1 from 
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plasmids pGREG523-SPT23 or pGREG523-MGA2 were cut out using restriction enzymes 
AscI and NotI and replaced by PCR amplified PSPT23 or PMGA2 via in vivo recombination 
cloning. The same way PGAL1 was replaced by the TEF1 promoter (PTEF1) from plasmid 
p416-PTEF1-yECitrine [24] for generating plasmid pGREG523-PTEF1-mycSPT23 (primers P39 
& P40 (PTEF1)). For generating a high-copy plasmid variants, the CEN/ARS sequence of the 
pGREG523 backbone was replaced by the 2µ ORI. For that the 2µ ORI of plasmid pRS425 
was amplified with overhang primers (P37 & P38) and inserted in PmlI cut plasmids 
pGREG523-PSPT23-mycSPT23 and pGREG523-PTEF1-mycSPT23 via recombination-based 
cloning resulting in plasmids pGREG523(2µ)-PSPT23-mycSPT23 and pGREG523(2µ)-PTEF1-
mycSPT23. 
Plasmid pGREG523-PSPT23-mycSPT23W1042 for expressing a W1042L mutant variant of 
Spt23p was generated by modifying plasmid pGREG523-PSPT23-mycSPT23. For that 
pGREG523-PSPT23-mycSPT23 was cut with SpeI and BamHI and the removed sequence part 
was replaced via recombination-based cloning by the respective PCR amplified sequence 
part harboring the indicated W1042L mutation. The PCR fragment was amplified from 
S288C genomic DNA using respective overhang primers (P35 & P36) introducing the new 
L-Leucine (L) encoding codon (CAA) at the 3’ terminal end.  
The ER-sfGFP-HDEL encoding cassette of the plasmid pRS415-ER-sfGFP-HDEL (LEU2 
marker; kindly provided by Dr. Eric Snapp; [29]) was  amplified with PCR (Q5 DNA 
polymerase; primers P47 & P48) and cloned into KpnI and SacI cleaved plasmid pRS416 
(URA3 marker). 
Co-transformation of linearized plasmid backbone and PCR product for recombination-
based cloning in vivo were routinely carried out by using the Frozen-EZ Yeast 
Transformation II kit (Zymo Research) according to manufacturer’s instructions. PCR 
conditions were chosen according to manufacturer’s instructions. 
Plasmids and primers used in this study are listed in the supporting information (Tab. II-S2 
& Tab. II-S3). 
2.3.4. Growth and flocculation tests 
Aerobic growth of OLE1-repressible strains was carried out in 24 well plates (Falcon) with 
1 mL media at 30°C using a microplate reader (BioTek Synergy 4; BioTek Instruments) with 
integrated temperature control and under continuous orbital shaking (slow shaking mode). 
The plates were sealed with a gas permeable adhesive seal (Thermo Fisher Scientific) to 
avoid evaporative losses of culture medium. These conditions were chosen to maintain 
consistent oxygenation of the cultures. Absorbance readings at 600 nm were used to 
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characterize cell growth and detect flocculation via fluctuations in readings. Flocculation 
was also detected after 24 hours of growth via 24 well plate imaging (UVP BioSpectrum 
Multispectral Imaging System) and confocal microscopy of cells in growth media stained 
with Calcofluor White at 23 °C. Micrographs were acquired on a LSM 710 (Zeiss) scanning 
confocal microscope with an oil immersion lens (100x magnification, 1.4 numerical 
aperture) using ZEN 2009 software (Zeiss).  
Growth media for flocculation assays without Ca2+ were prepared identically to standard 
synthetic defined (SD) drop-out media but using YNB without calcium (Formedium). 
Oxygen-limited fermentation growth of cells was carried out in a home-built apparatus 
based on 250 mL culture flasks fitted with rubber stopper. Caps were connected with tubing 
to a water bath, which allowed gas ex-flow via bubbling but restricted gas inflow. Flasks 
also featured syringe-fitted tubing for culture sampling at time points during growth. Cultures 
(50 mL) were briefly flushed with nitrogen before sealed after inoculation. Comparative 
aerobic growth was performed in 250 mL shake flasks with loose-fitting gas-permeable 
caps. Acute hypoxia was induced by thoroughly flushing aerobically growing cultures with 
argon and sealing their flasks with a tightly fitting rubber stopper connected to an argon-
filled balloon to provide positive pressure. 
2.3.5. Fatty acid analysis 
Total lipids were routinely extracted from yeast cells harvested from 1 mL liquid culture 
using a modified Bligh Dyer method [30]. Prior to lipid extraction, yeast cells were pelleted, 
resuspended in 400 µL 0.9 M Sorbitol/ 0.1 M EDTA (pH 7.0), and treated with 15 units 
zymolyase (Zymo Research) for 1 h at 35°C. This incubation step had no influence on the 
lipid composition as confirmed by comparison with the specific lipid composition from cells 
disrupted by bead beating (Fig. II–S1). Lipids were extracted from the organic phase of a 
mixture of 1:1:1 chloroform:methanol:water and dried under nitrogen. Lipid incorporated 
fatty acids were derivatized to their corresponding fatty acid methyl esters (FAMEs) by 
transesterification using 2% (v/v) sulfuric acid in methanol (90°C; 2 h). FAMEs were 
subsequently extracted in 400 µL hexane, of which 1 µL was analyzed on an Agilent 5973 
– HP6890 GC-MS using a 30 meter DB-5ms capillary column. The oven was held at 40°C 
for 3 min, followed by a ramp to 300°C at 20°C/min. The MS was operated in selected ion 
monitoring (SIM) mode using ions of m/z 55 and 74, which represent abundant and 
diagnostic fragment ions of saturated fatty acids (SFAs) and mono-unsaturated fatty acids 
(MUFAs), respectively. Abundance of fragment ions with m/z 55 was used for relative 
quantification of corresponding fatty acid species. 
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Analysis of abundance of different lipid classes (GPL; DAG; TAG; EE) were done by 
Lipotype GmbH, Dresden, Germany. Sample preparation was done according to the 
instructions provided by the service company. All analyses were done in biological triplicate. 
2.3.6. Spectroscopy 
Fluorescence anisotropy analysis of membrane fluidity was carried out on 1 mL of cells in 
stationary phase that were pelleted, resuspended in 400 µL 0.9 M Sorbitol/ 0.1 M EDTA 
(pH 7.0), and treated with 15 units zymolyase (Zymo Research) for 1 h at 35°C. 1% of a 
concentrated stock (5 mM) of di-phenyl-hexatriene (Sigma) in ethanol was added and the 
samples were incubated at room temperature for 30 min. Steady-state anisotropy 
measurements were made on a Fluorolog spectrofluorometer (Horiba), equipped with 
automatic polarizers and a temperature controller. Fluorescent protein expression driven by 
the FLO1 promoter or the HAC1 mRNA splicing reporter construct was monitored on a 
FACSAria II flow cytometer (BD Biosciences). 
2.3.7. Spt23p processing 
For western blotting, total protein extracts were obtained from strains cultured at specified 
methionine concentrations using a urea/SDS protein extraction method [31]. Protein 
extracts were separated by SDS-PAGE (7.5% Mini-PROTEAN-TGX gels; BioRad), blotted 
onto a PVDF membrane and probed with 9E10 primary antibodies (mouse anti c-MYC; 
Developmental Studies Hybridoma Bank) and mAbGEa primary antibodies (mouse anti 
actin; Thermo Fisher Scientific) in 1XPBST. Primary antibodies were detected with a goat 
anti-mouse IgG secondary antibody conjugated with horseradish peroxidase (Santa Cruz 
Biotechnology). Horseradish peroxidase activity was detected with SuperSignal™ West 
Pico Chemiluminescent Substrate (Thermo Fisher Scientific). 
2.3.8. Gene expression analysis 
To determine the relative expression levels of individual genes (OLE1, FLO1, FLO5, FLO8, 
FLO9, FLO11, SPT23, MGA2), total RNA was extracted from cells in stationary phase 
cultured for flocculation assays using a commercial kit (YeaStarTM; Zymo Research) 
according to manufacturer’s instructions. RNA samples were treated with DNaseI 
(RapidOut DNA Removal Kit; ThermoFisher Scientific) to remove genomic DNA 
contaminations. One-step qRT-PCR was carried out using a SYBR Green-based kit 
(Invitrogen) on a StepOnePlus Real-Time PCR System (Applied Biosystems). Primers were 
previously described by Van Mulders et al. [32] and Verbelen et al. [33]. Melting curve 
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analysis was performed according to thermocycler specifications. Relative expression 
levels were analyzed with the ∆∆ct method and normalized to ACT1 expression. 
For global expression analysis, RNA-Seq libraries were prepared from cells at OD600 ~ 1 
grown in either SD (BY4742, aerobic or hypoxic), SD – uracil (BY4742 expressing plasmid-
based p90 constructs), or SD – methionine (PMET3-OLE1, with or without addition of 250 μM 
methionine). In the case of PMET3-OLE1 strains, growth was carried out in 24 well plates (as 
described above), with 24x1 mL cultures pooled together per sample. BY4742 cells were 
grown in 250 mL flasks as described above. After growth, cells were briefly spun down 
(5000 rpm, 1 minute) and immediately frozen in liquid nitrogen. Total RNA was extracted 
from frozen pellets via the hot phenol method [34], and mRNA was isolated via poly-A beads 
(NEB). From these, Illumina RNA-Seq libraries were prepared with the adapter ligation 
method (NEBNext Ultra RNA Library Prep Kit for Illumina, New England Bio Labs) and 
barcoded with index oligonucleotides (NEBNext Multiplex Oligos for Illumina, NEB). 
Samples were pooled, and sequencing was performed on either an Illumina HiSeq 2000 
(PMET3-OLE1 samples, ~2M reads per sample) or MiSeq (p90s and hypoxia samples, ~ 1M 
reads per sample). HiSeq runs were performed at the Vincent J. Coates Genomics 
Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants 
S10RR029668 and S10RR027303, while MiSeq runs were performed in-house at the Joint 
BioEnergy Institute. Sequencing reads were aligned to the S288C R64-1-1 reference 
genome with TopHat 2 (version 2.0.13) with a max intron length of 2500 and differential 
analysis was performed with Cuffdiff (version 2.2.1) with the –frag-bias-correct and the –
multi-read-correct flags. Infinite values for differential expression resulting from assigned 
reads in one condition were assigned a log2 value of 10. Statistical analysis and plotting 
was done in R and GraphPad Prism. Gene Ontology (GO) term mapping was done with 
PANTHER (version 10.0; http://www.pantherdb.org) according to PANTHER Classification 
System in terms of “biological processes” in which respective gene products are involved. 
A processed data file containing all differential expression values and the raw sequencing 
data are publicly available at the Gene Expression Omnibus 
(https://www.ncbi.nlm.nih.gov/geo) using the GEO accession number GSE94345. 
2.3.9. HAC1 mRNA splicing 
Splicing of HAC1 mRNA in dependence of lipid unsaturation was investigated by RT-PCR. 
For that total RNA was extracted from cells in stationary phase cultured for flocculation 
assays using a commercial kit (YeaStarTM; Zymo Research) according to manufacturer’s 
instructions. RNA samples were treated with DNaseI (RapidOut DNA Removal Kit; 
ThermoFisher Scientific) to remove genomic DNA contaminations. RT-PCR was performed 
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using a commercial kit (OneTaq® One-Step RT-PCR kit, NEB) according to manufacturer’s 
instructions (primers P49 & P50 (HAC1 mRNA)). Reverse transcriptase negative controls 
(-RT) were performed by using Taq DNA polymerase (OneTaq® 2X Master Mix with 
Standard Buffer, NEB). PCR samples were analyzed by standard agarose gel 
electrophoresis (1% agarose in TAE).  
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2.4. Results 
2.4.1. Construction and characterization of a strain featuring a titratable unsaturated 
lipid content 
Different constitutive and repressible promoters were screened (Fig. II-2A) to effectively 
replace the native OLE1 promoter, aiming to generate a system that can sample a wide 
range of phospholipid unsaturation stoichiometry (% of acyl chains with double bonds). One 
of these was the MET3 promoter (PMET3), which has previously been characterized as being 
tightly controlled (repression) by methionine concentrations in the media [26] and has been 
used to regulate expression of an essential ergosterol synthesis gene in yeast [35, 36]. 
Substitution of the endogenous OLE1 promoter with the MET3 promoter yielded an 
unsaturated fatty acid auxotroph on agar plates supplemented with methionine (Fig. II-3A). 
In liquid media, lipid composition of growing cells was dependent on the concentration of 
methionine in the media, with the proportion of lipid acyl chains with double bonds ranging 
from 25% to greater than 80% (Fig. II-2C), as measured by gas chromatography – mass 
spectrometry (GC-MS) of derivatized fatty acids extracted from cell lipids (Fig. II-2B). 
Variations in lipid unsaturation for the PTEF1-mut mutant strains (e.g. PTEF1-mut2 vs. PTEF1-mut11) 
were not large enough to result in wide range of phospholipid unsaturation (Fig. II-2A) as 
well as in an observable effect on the growth phenotype (data not shown), while the weak 
expression from the tetO7-PCYC1 strain resulted in a substantial drop of fatty acid 
unsaturation (Fig. II-2A) as well as in a severe growth defect (data not shown) even in the 
absence of repressor  and was therefore also not considered as suitable cellular system. In 
contrast, the PMET3-OLE1 system allowed for rapid growth in the absence of the repressor 
and inhibited growth with increasing methionine concentrations (Fig. II-3B). The effects of 
methionine on the PMET3-OLE1 system was further analyzed on the OLE1 mRNA level. 
Since PMET3 is repressed by methionine, increasing methionine concentrations should result 
in a decrease of OLE1 mRNA. OLE1 mRNA levels were strongly influenced by external 
methionine and high methionine concentrations (5 mM) caused a substantial decrease of 
OLE1 mRNA (Fig. II-2D). Surprisingly, methionine levels of 100 µM to 150 µM resulted in 
at least an intermediate (at the time point of sample collection) increase of OLE1 mRNA 
compared to unmodified BY4741 cells. These results do not entirely match the methionine 
effects on the level of lipid unsaturation and might be an artifact caused by a direct 
methionine effect on the cell’s overall metabolic state.  
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Fig. II-2: Engineering of OLE1 expression modulates lipid unsaturation. (A) The endogenous 
OLE1 promoter (POLE1) was replaced by 1) a library of TEF1 promoter mutants (PTEF1-mut) by the 
strategy described in Nevoigt et al. [25], 2) a doxycycline repressible promoter, tetO7-PCYC1, as 
described by Belli et al. [37], or 3) the methionine-repressible MET3 promoter (PMET3), as described 
in the text. Fatty acid composition of resulting strains was analyzed as described in Materials and 
methods. The range of acyl chain unsaturation of PMET3-OLE1 provided the widest range of 
manipulation both above and below the level of wild-type cells (BY4742, included for comparison) in 
these conditions. Promoter replacement of POLE1 was performed with methods analogous to the 
those described for PMET3 insertion. (B) GC-MS chromatograms of fatty acid profiles from PMET3-
OLE1 cells at representative external methionine concentrations. (C) Percentage of total 
monounsaturated fatty acid species (% acyl chains unsaturated) at a given methionine concentration 
was determined from GC-MS data. A sigmoid function (y = a + (b – a)/(1 + 10^((log IC50 – x) * m)) 
was fitted to data points. (D) Changes in OLE1 expression in response to varying external methionine 
concentrations, as tested by comparing expression in PMET3-OLE1 vs. unmodified BY4742 cells (wt) 
grown at respective exogenous methionine. Gene expression was measured by qRT-PCR and 
shows significant changes of OLE1 expression. Error bars, SEM (n = 3). (E) Spectroscopic 
measurements of membrane fluidity taken of PMET3-OLE1 spheroplasts prepared from cells that were 
grown at different external methionine concentrations. Fluidity was measured at varying temperature 
by steady state fluorescence anisotropy of di-phenyl-hexatriene (DPH), which was added externally. 
Anisotropy values are presented as a unit-less ratio: R = (I|| − I⊥) / (I|| + 2 I⊥), where I|| and I⊥ are the 
emission (430 nm) intensities parallel and perpendicular, respectively, to the polarization of the 
excitation (360 nm). Higher anisotropy values reflect restricted mobility of the DPH probe and thus 
lower whole-cell membrane fluidity. Membrane fluidity was found to depend on the level of lipid 
unsaturation content, the presence of the membrane fluidizer n-octanol (0.02% w/v), as well as on 
the temperature. Values in the presence of n-octanol are shown as an average of two biological 
replicates. Error bars, SEM (n = 3). 
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Moderate methionine concentrations might have slightly positive effects on the general 
fitness of PMET3-OLE1, as cells take up methionine from the medium and do not have to 
synthesize it by themselves, before negative effects resulting from reduced fatty acid 
unsaturation get eventually dominant. Similar effects were also observed especially for the 
growth phenotype as intermediate methionine concentrations increased the occurring 
maximal growth rate (µmax) for PMET3-OLE1 cells (Fig. II-3D). Nevertheless, methionine 
effects on total lipid unsaturation were clear and consistent.  
 
Fig. II-3: Effect of OLE1 repression on exponential growth and cell-cell adhesion. (A) 
Replacement of the endogenous OLE1 promoter (POLE1) by the methionine repressible MET3 
promoter (PMET3) results in a yeast strain (PMET3-OLE1) whose OLE1 expression is under 
experimental control. Growth phenotype of PMET3-OLE1 cells is shown via spotting of a 10-fold 
dilution series on methionine containing media (5 mM) in the presence and absence of oleic acid. 
(B) Growth curves of PMET3-OLE1 grown at increasing methionine concentrations show a decrease 
in growth rate and visible flocculation (C). Flocculation can be prevented by exogenous unsaturated 
fatty acids. Wild-type cells (BY4742) do not flocculate regardless of external methionine 
concentrations, in contrast to PMET3-OLE1 cells grown in the absence of externally supplied oleic acid 
(C18:1; 0.01% w/v). Top rows, schematic growth curves; bottom rows, photographic documentation 
of final flocculation phenotype. (D) Exponential growth rates as a function of methionine 
concentrations (Error bars, SEM, n = 3). The relationship between measured unsaturated lipid 
composition at the end of growth and the max. exponential growth rates of individual cultures grown 
at varying methionine concentrations. Cells displayed a gradually decreasing growth rate between 
30 and 80% unsaturated lipids with a sharp drop below 30%. 
To further investigate changes in lipid unsaturation with respect to different lipid classes as 
well as to verify that specifically the fatty acid unsaturation of membrane-forming 
glycerophospholipids is altered upon OLE1 repression, additional GC-MS analyses were 
performed. The degree of fatty acid unsaturation for glycerophospholipids (GPL) as well as 
energy storing triacylglycerols (TAG) and diacylglycerols (DAG) (Fig. II-4A) often involved 
in lipid signaling were all similarly influenced in PMET3-OLE1 cells when grown at 250 µM 
methionine compared to when grown in the absence of methionine. The percentage of lipid 
molecules containing exclusively MUFAs (CXX:2; CXX:3 for TAG) sharply dropped from 50 
– 60% down to 10 – 20% for all prominent lipid classes (Fig. II-4B). Accordingly, the 
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proportion of lipid molecules featuring heterogeneous fatty acid composition (CXX:1; CXX:2 
for TAG) or including exclusively fully saturated fatty acids (CXX:0) increased in the same 
order. Fully saturated lipids were basically not existent in cells with physiological OLE1 
expression and rose up to more than 20% upon OLE1 repression (Fig. II-4C). The relative 
abundance of TAG significantly decreased from greater than 50% down to 20% when PMET3-
OLE1 cells were propagated at 250 µM compared to when cells were cultured in 
corresponding methionine-free medium for an identical time span (Fig. II-4D). A substantial 
accumulation of TAG is generally observed for yeast in stationary phase [2]. 
 
Fig. II-4: Effects of OLE1 repression on fatty acid unsaturation and relative abundance of 
different lipid classes. (A) Analyzed lipid classes were membrane-forming glycerophospholipids 
(GPL), diacylglycerides (DAG), often involved in lipid signaling, as well as energy storing 
triacylglyerides (TAG) including 3 fatty acid molecules (Rx). (B) The percentage (mol%) of molecules 
including exclusively fully saturated (CXX:0) or monounsaturated fatty acids (CXX:2; CXX:3 for TAG) 
as well as of molecules featuring heterogeneous fatty acid composition (CXX:1; CXX:1 & CXX:2 for 
TAG) were determined for indicated lipid classes from PMET3-OLE1 cells either grown at 250 µM met 
or in the absence of methionine (0 µM met). (C) Compilation of data from (B) showing the average 
fatty acid composition regardless of lipid classes. (D) Changes of relative abundance (mol%) of 
indicated lipid classes upon OLE1 repression in PMET3-OLE1 cells. EE: ergosterol esters; PA: 
phosphatidic acid; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PG: 
phosphatidylglycerol; PI: phosphatidylinositol; PS: phosphatidylserine. Error bars, SEM (n = 3). 
• Chapter II:  Lipid engineering reveals regulatory roles for membrane fluidity in yeast flocculation and oxygen-
limited growth 
 35 
The accumulation of TAG observed here is therefore not necessarily a direct primary effect 
of OLE1 repression but rather a secondary effect that results from a general growth defect 
upon unnatural fatty acid unsaturation (Fig. II-3B). Absence of methionine benefits growth 
and thus promotes an earlier transition to stationary phase behavior which is amongst 
others characterized by the synthesis of energy storing lipids.  
Since OLE1 repression strongly effects fatty unsaturation of membrane-forming GPL, 
central membrane characteristics such as membrane fluidity should be strongly affected 
when cells are grown at high methionine concentrations. Fluorescence anisotropy of di-
phenyl-hexatriene (DPH) was used to test the effects of lipid unsaturation on membrane 
fluidity. The emission anisotropy of this probe reflects its thermal motion in the host 
membrane [38]. Anisotropy measurements on yeast PMET3-OLE1 spheroplasts incubated 
with DPH yielded an increasing ordering parameter (R), reflecting lower membrane fluidity, 
when grown at increasing methionine concentrations (Fig. II-5C). This effect could be 
partially relieved by the addition of the established membrane fluidizer n-octanol [39] to the 
spheroplasts (Fig. II-2E). The PMET3-OLE1 strain characterized here therefore has proven 
to serve as a suitable cellular model to monitor effects of decreasing membrane fluidity 
when grown under varying concentrations of methionine. 
 
Fig. II-5: Reduced levels of lipid unsaturation and membrane fluidity induce flocculation. (A) 
Effect of plasmid-based (pCM188-OLE1), doxycycline repressible OLE1 expression on growth and 
cell aggregation of PMET3-OLE1 at non-repressed (0 µM met) and repressed (250 µM met) OLE1 
expression. Top rows, schematic growth curves identical to growth curves; bottom rows, 
photographic documentation of final flocculation phenotype. (B) Effect of membrane fluidizers, n-
octanol (oct, 0.02% w/v) and benzyl alcohol (BnOH, 10 mM), on flocculation of strain PMET3-OLE1 
when added either during growth or post-growth. For post-growth assays, cells were grown at 150 µM 
methionine to develop flocculation. Cells were then washed with water, deflocculated by pipetting 
and tested for reflocculation in the presence of membrane fluidizers. 
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2.4.2. Membrane fluidity regulates yeast flocculation through Spt23p-mediated 
activation of FLO1 
While characterizing the effect of lipid unsaturation on exponential growth rates (Fig. II-3D), 
an unexpected phenotype was observed: cells with low lipid unsaturation visibly clumped 
together, forming macroscopic aggregates that precipitated from the medium (Fig. II-3C).  
Cell aggregation was blocked when D-mannose was added to the culture medium post-
growth, consistent with a role for a class of mannose-binding proteins, termed flocculins, 
that cause adhesion between the polysaccharide-coated cell walls of neighboring yeast 
cells [40]. Other monosaccharidic hexoses as well as disaccharidic maltose had no effect 
on flocculation (Fig. II-6A). Reduced flocculation was also observed when cells were grown 
in the presence of the established membrane fluidizers n-octanol (oct; 0.02% w/v) and 
benzyl alcohol [41, 42] (BnOH; 10 mM) (Fig. II-5B), though these did not affect lipid 
unsaturation (Fig. II-S4B). This indicated that low membrane fluidity, and not lipid 
composition per se, were responsible for flocculation. Flocculation was unaffected when 
these additives were introduced post-growth (Fig. II-5B), as was the case for oleic acid (Fig. 
II-3C), suggesting that flocculation resulted from a transcriptional response to low 
membrane fluidity. 
Expression changes upon OLE1 repression were screened for a set of flocculation (FLO) 
genes and a significant increase in expression of a single flocculation gene, FLO1 was 
identified (Fig. II-S3). Flo1p is a GPI-anchored cell wall mannose binding protein, and thus 
is functionally consistent with the dispersion of flocs in high concentrations of D-mannose 
(Fig. II-6A). Deletion of FLO9, which was also slightly activated upon OLE1 repression (Fig. 
II-S3), had no effect on lipid induced flocculation (Fig. II-6F). In contrast, a partial deletion 
of the Flo1p hydrophobic domain which impairs the anchorage of the protein to the cell wall 
[43] resulted in a loss of flocculation (Fig. II-6F) indicating that proper localization and 
function of FLO1 and not just the presence of the carbohydrate binding domain is crucial 
for lipid induced flocculation. 
Micrographs (Fig. II–S2) showed that clumping was not due to any sort of defects in cell 
division (e.g. chain formation [44] or agglomeration [45], but rather resulted from binding of 
neighboring yeast cells through cell wall interactions. It was possible to restore non-
adhesive growth by the addition of exogenous oleic acid to the culture during growth (Fig. 
II-3C), as well as by plasmid-based expression of OLE1 (Fig. II-5A, Fig. II-S4A), 
demonstrating that the flocculation is induced by modified OLE1 expression levels and 
altered lipid composition. 
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Fig. II-6: Lipid induced flocculation is mediated by Flo1p. (A) The effect of the indicated 
compounds (sugars & oleic acid) on restoring non-adhesive growth was tested by resuspending 
adhesive cells (PMET3-OLE1 grown at 250 µM met) in medium containing D-mannose (Man, 0.5 M), 
D-glucose (Glc, 0.5 M), D-galactose, (Gal, 0.5 M) D-maltose (Mal, 0.5 M), oleic acid (C18:1, 0.01% 
w/v). For these post-growth assays, cells were grown at 250 µM methionine to develop flocculation. 
Cells were then washed with water, deflocculated by pipetting and tested for reflocculation in the 
presence of indicated compounds. (B) The function of flocculins such as FLO1 strongly depends on 
the availability of Ca2+ which takes part in the binding of the carbohydrate to the protein. In the 
absence of free Ca2+ in the medium, cells do not develop a lipid induced flocculation phenotype. (C) 
To knockout FLO1 in the PMET3-OLE1 background, the entire FLO1 ORF was replaced by a cassette 
containing the yECitrine ORF as well as an URA3 selection marker. The resulting genomic construct 
mediates FLO1 promoter (PFLO1) driven yECitrine expression. (D) Lipid-induced flocculation with 
FLO1 (abolishes flocculation) or FLO8 (no effect) knockouts grown at various external methionine 
concentrations. (E) Fluorescence emission of PMET3-OLE1 cells with PFLO1 driving yECitrine 
expression grown at different methionine concentrations. Fluorescence emission, measuring PFLO1 
activity, was correlated with unsaturated lipid stoichiometry. (F) Deletion of FLO9 does not abolish 
lipid induced flocculation. In contrast, deletion of the hydrophobic domain (∆tm) of FLO1 strongly 
impairs flocculation, probably by preventing proper anchorage of Flo1 to the cell surface. 
However, the activation of FLO1 expression was surprising in the S288C strain background, 
which features an in-frame stop codon in FLO8, encoding the major transcription factor 
activating flocculation. This allele (flo8-1, 425 G → A) has been proposed to have been 
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selected for during strain cultivation due to the difficulty of working with flocculent strains in 
the lab [46]. It was confirmed that lipid-triggered flocculation was independent of the 
canonical pathway by knockout of FLO8, which did not affect flocculation (Fig. II-6D) nor 
lipid composition (Fig. II-S4C). In contrast, deletion of FLO1 completely abolished 
flocculation (Fig. II-6D) and did not affect lipid unsaturation (Fig. II-S4C). In this deletion 
strain, FLO1 was replaced with a fluorescent reporter gene (yECitrine) (Fig. II-6C), which 
allowed to monitor the increase in PFLO1 activity as lipid unsaturation dropped from 80% to 
45% (Fig. II-6E). 
Induction of the unfolded protein response (UPR) is a known phenotype that is triggered by 
low lipid unsaturation and thereby increased membrane thickness and lipid packing density 
[47]. The UPR is a conserved cellular program that is activated by the accumulation of 
misfolded proteins in the ER lumen and provides multiple strategies to deal with ER stress 
in order to maintain ER integrity and the proper function of the secretory pathway. Strategies 
that are provided by the UPR to respond to the accumulation of misfolded proteins include 
haltering of further protein translation, the synthesis of molecular chaperons that support 
protein folding and the degradation of harmful protein aggregates [48]. 
Unfolded proteins are directly sensed by the N-terminal domain of the ER-membrane 
embedded endoribonuclease Ire1p. Binding of unfolded proteins in the ER lumen to Ire1p 
induce its oligomerization, thus eventually activating the Ire1p C-terminal RNase domain 
which is located in the cytosol. Activated Ire1p catalyzes a nonconventional splicing reaction 
of HAC1 mRNA that removes an intronic sequence from the HAC1 mRNA which usually 
prevents proper mRNA translation due to a physical interaction with the mRNA’s 3’UTR, 
thus producing a translatable HAC1 mRNA (Fig. II-7A). The Hac1p transcription factor binds 
the unfolded protein response elements (UPREs) that are found in the promoter of 
approximately 5% of all genes in yeast [49]. Among them, a large number of ER-resident 
chaperones were identified as a response to accumulated misfolded proteins [50] as well 
as genes that are involved in all stages of the secretory pathway [49]. However, in addition 
to them, components of the phospholipid biosynthetic pathway are targets of Hac1p and 
the UPR, suggesting a regulatory function of the UPR in the biogenesis of the ER 
membrane. Indeed, recent work could show that aberrant lipid compositions, or more 
precisely increased lipid packing within the ER membrane can also directly activate Ire1p 
and thereby finally inducing UPR [51]. These results suggest two completely distinct types 
of Ire1p activating stimuli – unfolded proteins and non-physiological lipid bilayer 
characteristics – although ER membrane-based processes like (co-translational) protein 
translocation would provide mechanistic explanations how intrinsic membrane properties 
could influence proper protein folding [52].  
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Fig. II-7: Reduced levels of unsaturated lipids induce unfolded protein response (UPR) in 
budding yeast. (A) HAC1 mRNA encodes for a transcription activator which serves as a key player 
of the UPR induction pathway. Natural HAC1 mRNA owns an intron which prevents its proper 
translation. Upon ER stress, native HAC1 mRNA gets processed in a nonconventional splicing 
reaction catalyzed by the endoribonuclease Ire1p. Splicing removes the 252 bp intron, thus 
producing a translatable HAC1 mRNA yielding Hac1p that upregulates UPR genes. A HAC1 mRNA 
splicing reporter was used to monitor induction of UPR. The splicing reporter contains the GFP ORF 
instead of the natural HAC1 ORF. ER stress-induced mRNA splicing allows for GFP reporter 
expression. HAC1 mRNA (splicing reporter) schematics were adopted from Aragon et al. [53]. (B) 
GFP expression from the HAC1 mRNA splicing reporter is induced upon decreased lipid unsaturation 
in PMET3-OLE1. Mean fluorescence emission of cell cultures was measured by flow cytometry. Dotted 
lines indicate mean fluorescence emission values of untreated wild-type cells (BY4742) and those 
that were treated with the strong reducing reagent DTT (0.5 mM). (C) RT-PCR analysis reveals direct 
HAC1 mRNA splicing. Spliced HAC1 mRNA (397 bp PCR product) can be additionally detected in 
PMET3-OLE1 cells grown in 250 µM met whereas cells grown in the absence of methionine yield only 
unspliced HAC1 mRNA (649 bp PCR product). Primer binding sites for HAC1 cDNA are 
schematically indicated. Note that the length of RT-PCR products does not reflect the length of HAC1 
mRNA.  –RT: RT-PCR negative control w/o reverse transcriptase (RT); Ladder: 2-Log DNA ladder 
(NEB). (D) An artificial ER-sfGFP-HDEL fusion protein serves as ER-lumenal marker. PMET3-OLE1 
grown in 250 µM met (+met) show no aberrant ER morphology as compared to cells grown in the 
absence of methionine (-met). Thus, ER lipid stress is not necessarily accompanied by changes in 
ER morphology. (E) Induction of lipid induced flocculation does not involve the UPR induction 
pathway. Knockout of either HAC1 (∆hac1) or IRE1 (∆ire1) does not abolish methionine-induced 
development of flocculation in PMET3-OLE1. 
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Since UPR can be directly activated by an unnaturally saturated lipidome and Hac1p 
activates a large variety of different genes as well as due to the fact that FLO gene 
expression in wild yeasts is inherently induced by various, partially contrary stress stimuli, 
it should be checked and ruled out that activation of FLO1 expression is an unspecific result 
of lipid-mediated UPR induction. 
A previously published HAC1 mRNA splicing reporter [53] was used to monitor UPR 
induction as the lipidome more and more saturates. Ire1p activation induces HAC1 mRNA 
splicing reporter processing, thus leading to induced GFP expression (Fig. II-7A). The 
PMET3-OLE1 cellular system proved to functionally activate UPR upon reduction of 
unsaturated fatty acids. The strongest activation of UPR (measured as GFP fluorescence 
emission) was detected at unsaturation levels of 55% to 45% (~2.6-fold increase of GFP 
fluorescence emission) which even exceed the level of induction by the strong reducing 
reagent DTT (0.5 mM) that breaks disulfide bonds thereby disrupting proper protein folding 
(Fig. II-7B). Strong UPR induction appeared interestingly exactly in the range of lipid 
unsaturation which also leads to strong activation of flocculation (Fig. II-2C; Fig. II-3C), thus 
raising the possibility of an involvement of the UPR in FLO1 activation. HAC1 mRNA could 
be also directly detected by RT-PCR. Only PMET3-OLE1 cells that were propagated at 
250 µM met yielded an additional RT-PCR product that represents a shortened species of 
the full length HAC1 mRNA that was in contrast observed for cells either cultured in the 
presence or absence of external methionine (Fig. II-7C). The lipid composition of the ER 
membrane is relatively different from that of other membranes such as the plasma 
membrane – it features almost exclusively glycerophospholipids as well as a high proportion 
of phosphatidylcholine (PC) [1] which usually contains a high extent of unsaturated fatty 
acids [54]. Furthermore, the ergosterol content is exceptionally low in that organelle [1], so 
that taken together, ER membranes feature very high membrane fluidity that might be 
essential for ER-specialized processes such as protein translocation or even the proper 
structural organization of the compartment [47]. Therefore, a severe reduction of the overall 
cellular Ole1p activity might particularly affect ER membranes and strongly disturb organelle 
morphology, thus, indirectly induce UPR. To check for aberrant ER morphology, a HDEL-
sequence tagged GFP variant (sfGFP; superfold) [29] that is targeted to and retained in the 
ER lumen, was expressed in PMET3-OLE1 cells with or without altered membrane lipid 
composition. However, ER morphology was not affected by an overly saturated lipidome, 
thus indicating that ER lipid stress is not necessarily accompanied by changes in structural 
ER organization (Fig. II-7D). Knocking out Ire1p and Hac1p eliminates the two key players 
of UPR induction in budding yeast so that UPR is fully suppressed. Lipid-induced 
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flocculation was unaffected by both knockouts, definitively ruling out a direct involvement of 
UPR into the cellular pathway for activating FLO1 expression (Fig. II-7E). 
The observations that membrane-fluidizing additives inhibit flocculation led to the 
hypothesis that activated forms (cleaved off p90 domains) of known membrane fluidity 
sensors (Spt23p and Mga2p) can directly initiate FLO1 transcription, as is the case for OLE1 
in the native feedback loop to maintain physiological membrane fluidity. Previous studies 
could observe reductions in Spt23p/Mga2p proteolytic processing by the supplementation 
of the growth media with highly-fluidizing polyunsaturated fatty acids, which are not naturally 
found in S. cerevisiae [15, 55]. Instead it should be tested here, if genetic titration of OLE1 
would modulate Spt23p/Mga2p processing in response to varying levels of unsaturated 
lipids that are natively found in yeast and thus give stronger evidence of a physiological role 
for lipid environment-mediated Spt23p/Mga2p proteolytic processing. For that, an N-
terminally 13xmyc-tagged Spt23p variant (mycSpt23p) was constructed, whose proteolysis 
can be monitored by Western blotting (Fig. II-8A) and was expressed from a centromeric 
plasmid. Spt23p processing and release of p90 domains was induced when OLE1 was 
repressed in the presence of methionine, as indicated by a relative enrichment of 
mycSpt23p90 over mycSpt23p (Fig. II-8B). Importantly, mycSPT23 was expressed using its 
endogenous promoter (PSPT23), as overexpression of mycSpt23p using a strong promoter or 
a high copy plasmid led to constitutive FLO1 induction (Fig. II-8E). This was the case not 
due to an increase of processed mycSpt23p90 over full-length mycSpt23p caused by elevated 
total protein levels (Fig. II-8D) but rather because of an increase in total mycSpt23p90, which 
seems to be sufficient to activate FLO1 expression under wild-type lipid composition (Fig. 
II-8E). Similar mycSpt23p processing behavior was observed in an Dspt23 background (Fig. 
II-S5) indicating that additional expression from the endogenous genomic SPT23 locus as 
well as potential mycSpt23p/Spt23p heterodimer formation do not influence protein 
activation.  
In the Dspt23 background, proteolytic processing could be completely abolished using a 
W1042L variant of mycSpt23p (Fig. II-8B), supporting the importance of this residue in a 
rotation-based activation mechanism of Spt23p [20].  
Lipid dependent processing of the Spt23p paralogue Mga2p was investigated using an 
equivalent approach. Repression of OLE1 expression also induced mycMga2p proteolytic 
processing as indicated by a relative enrichment of mycMga2p90 over mycMga2p. Moreover, 
MGA2 expression seems to underlie an additional lipid-dependent control mechanism as 
increasing protein levels could be observed with a decreasing extent of lipid unsaturation. 
Even almost no MGA2 expression was detected at physiological membrane characteristics 
(0 µM met) which was already slightly increased at 50 µM external methionine (Fig. II-8C).  
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Fig. II-8: Reducing unsaturation of yeast endogenous lipids triggers proteolytic processing 
of Spt23p and Mga2p. (A) Model of Spt23/Mga2p90 processing upon lowering ER membrane 
fluidity. Spt23p dimers are proteolytically processed by the 26S proteasome, which releases soluble 
portions of Spt23p termed Spt23p90 (p90). Shown is a labeled system in which N-terminally 13xmyc-
tagged protein variants (mycSpt23p) that can be both detected by Western Blot analysis functionally 
replaces native proteins. The W1042 residue is indicated in red. (B) Western blot analysis showing 
proteolytic processing of 13xmyc-tagged fluidity sensor Spt23p (mycSpt23p) upon addition of 
methionine to PMET3-OLE1 cells. A W1042L mycSpt23p (mycSpt23pW1042L) mutant variant remains 
largely unprocessed, regardless of methionine addition. Act1p (Actin) was probed as a loading 
control. (C) Western blot analysis showing proteolytic processing of 13xmyc-tagged fluidity sensor 
Mga2p (mycMga2p) upon addition of methionine to PMET3-OLE1 cells. mycMga2p was expressed from 
a centromeric plasmid (pGREG523) under control of its endogenous promoter (PMGA2). The absence 
of a mycMga2p band in the absence of methionine can be explained by transcriptional repression of 
MGA2 expression in high lipid unsaturation. (D) Different dilutions of total protein extracts form 
indicated expression variants (from PSPT23 or PTEF1; from CEN/ARS ORI or 2µ OR) that contain 
comparable Spt23p amounts and therefore allow for a comparison of p90 to p120 ratios were 
analyzed. High Spt23p protein levels do not promote Spt23p proteolytic processing per se. (E) High 
intracellular protein levels of mycSpt23p caused by expression from a high-copy plasmid variant (2µ 
ORI) or a strong promoter (PTEF1) led to constitutive induction of FLO1 expression. This is not a 
consequence of increased enrichment of mycSpt23p90 over full-length mycSpt23p but rather is likely 
due to an increase in total mycSpt23p90, which is sufficient to activate FLO1 expression under wild-
type lipid composition. 
The Western blot data is supported by MGA2 expression analysis (RNAseq) showing a 
strong upregulation of MGA2 transcription upon OLE1 repression with a log2 differential 
expression value (log2 DE) of 4.3. FPKM values (fragments of kilobase of transcript per 
million mapped reads) for MGA2 in PMET3-OLE1 grown at 0 µM met of 8.2 (vs. 166.3 when 
grown at 250 µM met) indicate a generally weak MGA2 expression level at high lipid 
unsaturation that might explain low protein levels under these conditions. Gene expression 
analysis in an SPT23 knockout strain also suggests a role for Spt23p in the regulation of 
MGA2 transcription since upregulation of MGA2 in the absence of Spt23p was considerably 
lower (log2 DE of 4.3 vs. 3.0), however, could not be responsible for the whole effect. Spt23p 
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might serve only a part of a complex response that acts on MGA2 expression. Nevertheless, 
these data provide further evidence that Spt23p and Mga2p act as membrane fluidity 
sensors that respond to changes in native lipid composition [15, 56]. 
A following assay addressed genetic roles for SPT23 and its paralogue, MGA2, in OLE1-
mediated FLO1 expression and flocculation. Because OLE1 is freed from its endogenous 
promoter in the PMET3-OLE1 background, it was able to delete SPT23 while maintaining the 
engineered strain’s control of lipid unsaturation with supplemented methionine (Fig. II-S4D). 
Deletion of SPT23 strongly reduced flocculation (Fig. II-9A) and FLO1 expression (Fig. II-
9B); flocculation could be fully restored by plasmid-based expression of a SPT23 variant 
(mycSpt23p, Fig. II-S5). 
 
Fig. II-9: Lipid-dependent flocculation is mediated by activated forms of membrane fluidity 
sensors Spt23p and Mga2p. (A) Effect of SPT23 or MGA2 knockout on flocculation phenotype of 
strain PMET3-OLE1 grown at various external methionine concentrations. Top rows, schematic growth 
curves; bottom rows, photographic documentation of final flocculation phenotype. (B) Changes in 
FLO1 expression upon methionine addition (250 µM vs. 0 µM met) in PMET3-OLE1. FLO1 expression 
is significantly increased (p = 0.046) with functional SPT23 and MGA2, but not in the absence of 
SPT23 (p = 0.99) or MGA2 (p = 0.31). (C) FLO1-dependent flocculation can be induced in the wild-
type background (BY4742) using repressible (+dox), plasmid-based expression of SPT23p90 or 
MGA2p90 active domains. Flocculation is stronger during expression of SPT23p90, indicating the 
dominant role of this fluidity sensor. Flocculation upon SPT23p90 expression is abolished in a ∆flo1 
background strain. (D) Comparison of fatty acid composition for BY474; ∆spt23 + tetO2-PCYC1-
SPT23p90 either in the presence (+dox) or absence (-dox) of the repressor of plasmid-based 
SPT23p90 expression. Exemplary GC-MS chromatograms show that plasmid-based SPT23p90 
expression slightly increases the content of unsaturated fatty acid species (C14:1, C16:1, C18:1; 
90.9%) compared to non-inducing conditions (80.2%). (E) Changes in FLO1 expression upon 
plasmid-based expression of active variants of membrane fluidity sensors Spt23p90 and Mga2p90, 
as measured by qRT-PCR. Asterisks designate significant changes in gene expression (*, p ≤ 0.05). 
Error bars, SEM (n = 3). 
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MGA2 deletion prevented flocculation as well, but also strongly inhibited cell growth in the 
presence of external methionine (Fig. II-9A,B), and thus its effects on flocculation could not 
be fully characterized. This null phenotype could be a result of a potential additional, post-
transcriptional role for Mga2p in stabilizing OLE1 transcripts [57], which would act 
independently of the applied OLE1 promoter replacement strategy. To compare the effects 
of Spt23p and Mga2p on FLO1 expression, truncated gene products containing only active 
p90 domains, simulating the proteolysis that activates them endogenously [58], were 
expressed instead. When these domains were expressed from a repressible promoter 
(tetO2-PCYC1), flocculation in wild-type cells that was abolished by addition of the repressor 
(doxycycline) was observed. Flocculation was induced more strongly by Spt23p90 in 
comparison to Mga2p90, and was abolished completely by deletion of FLO1 (Fig. II-9C). 
GC-MS clearly indicated that p90 induced flocculation was no effect of an overly saturated 
lipidome since plasmid-based p90 expression even increased lipid unsaturation compared 
to non-inducing conditions (Fig. II-9D). Observed flocculation strengths corresponded to 
differences in FLO1 expression upon induction of Spt23p90 and Mga2p90 (Fig. II-9E). 
Spt23p and Mga2p therefore act upon FLO1 expression during low lipid unsaturation, with 
Spt23p serving as the dominant activator. 
2.4.3. Lipid-mediated flocculation is triggered by oxygen limitation during 
fermentation 
Next, potential physiological roles for reduced lipid desaturation activating FLO1 should be 
identified. For S. cerevisiae strains used in brewing, flocculation allows for industrial-scale 
clarification of the culture (wort) without the use of filtration or centrifugation. Fermentation 
vessels, unlike laboratory flasks, feature restricted architecture meant to reduce oxygen 
availability in the culture. While yeast grown anaerobically are strict unsaturated fatty acid 
auxotrophs [59], it was hypothesized that also a microaerobic environment could restrict 
Ole1p activity through reduced oxygen binding and availability for the desaturase reaction. 
To test whether oxygen limitation could drive flocculation, wild-type cells (BY4742) were 
grown in fermenter like vessels that allow for outflow of gas (e.g. carbon dioxide), but not 
oxygen uptake (Fig. II-10A).  
Growth of cells under these conditions resulted in the increased accumulation of ethanol, 
i.e. fermentation, compared to well-aerated growth in standard shake flasks (Fig. II-10B and 
Fig. II-10C) at the expense of biomass (OD600 of 2.3 ± 0.06  vs. 2.9 ± 0.06 after 48 hours). 
As fermentation progressed, triggering of visible flocculation was induced similar to that 
observed during OLE1 repression. This did not occur when the culture was well aerated in 
a standard shake flask, nor in the absence of FLO1 or SPT23 (Fig. II-10A). 
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Fig. II-10: Growth under hypoxia 
induces changes in lipid 
unsaturation and FLO1- 
dependent flocculation. (A) 
Wild-type cells (BY4742) were 
grown either under standard, 
aerated conditions or in flasks 
where gas inflow is restricted (see 
Materials and methods). As 
growth progresses, visible 
flocculation occurs only in the 
oxygen-starved environment. 
Deletion of either FLO1 or SPT23 
abolishes hypoxia-induced 
flocculation, whereas deletion of 
MGA2 does not impair flocculation 
upon growth under limited oxygen 
availability. (B) Oxygen limited 
conditions correspond to 
fermentation-style growth, where 
ethanol accumulates due to the 
limitation of oxygen for respiration. 
In contrast, ethanol accumulation 
is limited during aerated growth 
(C), where respiration can be 
active. (D) Oxygen restriction 
leads to a progressive reduction in 
lipid unsaturation as fermentation 
progresses, which corresponds to 
an increase in FLO1 expression 
(E), explaining the flocculation 
phenotype in this environment. 
Error bars, SEM (n = 3). 
The increase in FLO1 expression under hypoxic growth (Fig. II-10E) mirrored the reduction 
in lipid unsaturation as fermentation progressed (Fig. II-10D), as monitored by the shift from 
glucose to ethanol in the culture. Under these conditions, unsaturated lipid stoichiometry 
was reduced to 45% of all acyl chains, corresponding to the levels where full PFLO1 induction 
and Spt23p processing in PMET3-OLE1 cells was observed. In contrast to this long-term 
hypoxia experiment, growth of cells under short-term, strict oxygen starvation, achieved by 
incubation under argon for 90 minutes, did not lead to increased FLO1 expression (Fig. II-
11A). Because Ole1p acts during de novo lipid synthesis, it was hypothesized that only 
long-term exposure to hypoxic conditions would lead to significant changes in cell lipid 
composition (Fig. II-11B), and therefore serves as a trigger for flocculation. 
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Fig. II-11: Acute hypoxia is not sufficient for changes in lipid unsaturation and FLO1 
expression. (A) Comparison of changes in FLO1 expression, as compared to aerated growth, for 
BY4742 either under acute hypoxia (90 minutes under argon) or long-term hypoxia (hypoxic growth; 
18 hours in a microaerobic fermenter). Error bars, SEM (n = 3) (B) Comparison of fatty acid 
composition for BY4742 either under acute hypoxia or long-term hypoxic growth. GC-MS 
chromatograms show that long-term hypoxia leads to a reduction in the major unsaturated species 
(oleic acid, C18:1) and an increase in major saturated species (palmitic acid, C16:0). 
2.4.4. Membrane fluidity-regulated genes are globally activated during microaerobic 
fermentation 
The central and surprising role of lipid composition in regulating a non-membrane process 
(which is true for flocculation as a cell wall adhesion process) motivated to ask if this was 
indicative of a larger long-term hypoxic response regulated by membrane fluidity. Deep 
sequencing of mRNA-derived cDNA (RNA-seq) was used to characterize changes in global 
gene expression upon OLE1 repression. Cells (PMET3-OLE1) grown in the presence of 
250 μM methionine (38.4 ± 2.5 % unsaturated lipids) were sampled after 24 hours of growth 
and were compared to those with no added methionine (88.3 ± 2.3 % unsaturated lipids). 
OLE1 repression led to large-scale gene expression changes, with 1012 genes significantly 
(q-value ≤ 0.05) upregulated and 882 downregulated (Fig. II-12A).  
Systematic GO term mapping of upregulated genes upon OLE1 repression showed 
significant enrichment of those involved in lipid and fatty acid metabolism, glycolysis and 
carbohydrate metabolism, and response to stress stimuli (Fig. II-14A). FLO1 was one of the 
strongest overexpressed genes upon OLE1 repression, with a log2 differential expression 
value (log2 DE) of 5.0. In contrast, downregulated genes include those involved in protein 
(amino acid) and ribosome synthesis (Fig. II-14B), consistent with non-specific effects of 
OLE1 repression in slowing growth and the primary metabolism. 
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Fig. II-12: Global analysis of membrane 
fluidity-mediated gene expression. (A) A 
Bland-Altman plot showing the differential 
expression (DE) for genes in the PMET3-
OLE1 background grown in the presence of 
250 µM (low lipid unsaturation) vs. 0 µM 
(high lipid unsaturation) methionine, as 
compared to their mean average normalized 
expression (FPKM) under these conditions. 
Genes with significant (q-value ≤ 0.05) 
differential expression are highlighted in 
black. Of these 1872 genes, 1012 are 
upregulated; expression of FLO1 (in red, 
arrow) increased more than 30-fold upon 
OLE1 repression. (B) The effect of ∆spt23 
on the overexpression of OLE1-sensitive 
genes: DE values for PMET3-OLE1 in 250 µM 
vs. 0 µM methionine are compared to those 
for PMET3-OLE1 ∆spt23 in 250 µM vs. 0 µM. 
Of the 1012 upregulated upon OLE1 
repression, 200 feature an at least 2-fold 
reduction of DE (RDE) in the ∆spt23 
samples. A set of 12 genes including FLO1 
(in red) shows a reduction of gene 
expression of more than 8-fold upon 
knocking out SPT23. Dashed lines 
(x – y = 1; 2; 3) visually separate sets of 
genes with significantly reduced expression 
and are added for clarity. (C) The effect of 
plasmid-based expression of Spt23p90 and 
Mga2p90 on the 1012 genes upregulated 
upon OLE1 repression (includes gray). Of 
these, 341 were also significantly induced 
by either Spt23p90 or Mga2p90 domains 
(black). This set includes genes involved in 
a diverse range of cell functions, including 
metabolism (TDH1), lipid synthesis (HES1), 
membrane organization (SRO77), metal 
homoeostasis (IZH2), and cell wall structure 
(DAN4). Other examples are listed in Tab. 
II-S1 by their functional classes. DE values 
were taken for wild-type cells (BY4742) 
harboring a plasmid expressing p90 
domains of either SPT23 or MGA2 grown in 
either the absence (induced) or presence 
(repressed) of doxycycline. The vertical line 
(x – y = 0) separates genes whose 
expression is dominantly influenced by 
either Spt23p (below) or Mga2p (above). 
Dots following the line represent genes that 
are equally regulated by both transcription 
activators. 
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However, these conclusions are based on the assumption that transcriptional changes 
triggered by OLE1 repression were largely a result of physiological responses to changes 
in membrane homeostasis, as opposed to specific activation by lipid-activated 
transcriptional elements, and could also contain artifacts from reduced growth rates and 
methionine supplementation. Therefore, expression effects to the induction of active 
Spt23p90 and Mga2p90 domains were also characterized by RNA-seq. With this approach 
it should be possible to separate gene regulation effects resulting from specific lipid 
activation from those that caused by non-specific or secondary effects. These might directly 
origin from the expose of cells to high external methionine concentrations (e.g. the 
endogenous MET3 gene), generally reduced growth rates or cell aggregation and 
flocculation. 
Of the 1012 OLE1-sensitive genes (Fig. II-12A), 341 were also significantly activated by 
either Spt23p90 or Mga2p90 (Fig. II-12C). For FLO1, expression was increased by both 
activators, though more strongly by Spt23p90 (log2 DE of 3.7 vs. 2.4). Among all genes 
significantly overexpressed by either p90 domains, there was only a weak correlation 
between the increase in expression in response to the individual domains (e.g. Mga2p90 
vs. Spt23p90, Pearson r = 0.19). Along with the paucity of genes activated by both Mga2p90 
and Spt23p90 domains (~15% of the genes activated by either), this indicates a divergent 
set of targets for these paralogues, despite their presumably similar modes of activation. 
Changes in lipid unsaturation have a role in activation of FLO1 during oxygen limitation (Fig. 
II-10E; Fig. II-11A). The following experiments should address the question whether and if 
yes to what extent does this pathway play a role in activation of other Spt23p/Mga2p targets 
during extended hypoxic growth. 
To generate a comparative data set, global expression profiles for wild-type cells (BY4742) 
grown aerobically compared to those grown under long-term hypoxic conditions (e.g., 18h 
hours, conditions described above) or under acute hypoxia (90 minutes under argon) were 
analyzed; first-mentioned conditions mimicked those for FLO1 expression whereas the 
latter did not (Fig. II-11). Long-term hypoxia caused widespread changes in gene 
expression: 1373 upregulated genes with Gene Ontology (GO) terms significantly enriched 
in the metabolism of coenzymes, vitamins, as well as interestingly fatty acids and lipids (Fig. 
II-14C), including OLE1 (log2 DE of 3.2). In contrast, acute hypoxia induced a significantly 
smaller transcriptional response (266 upregulated genes), yet still included several 
canonical hypoxic response elements (e.g. TIR1 and ANB1). These profiles are consistent 
with previous characterizations of gene-dependent timescales for hypoxia response 
induction upon oxygen starvation responses in S. cerevisiae, which was interpreted as 
suggesting the activity of multiple oxygen sensors [60]. Of the set of genes identified as 
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being sensitive to OLE1 repression and induced by Spt23p90 or Mga2p90 domains (341 
genes; Fig. II-12C), 70% were significantly upregulated during long-term hypoxic growth 
(Fig. II-13A). Differential expression values for long-term hypoxic growth were significantly 
correlated with differential expression upon OLE1 repression (Figure S7A, r = 0.38, p = 
2x10-13) and for the additive effects of Spt23p90 and Mga2p90 induction (Fig. II-13B, r = 
0.49, p < 10-15), which is consistent with a model in which the two activators have 
independent effects on transcription (Herschlag and Johnson 1993). 
 
Fig. II-13: Membrane fluidity sensors globally activate gene expression during long-term 
hypoxic growth. (A) Comparison of differential expression (DE) values upon long-term hypoxia (18 
hours) and acute hypoxia (90 minutes) for all genes (gray) and those regulated by membrane fluidity 
identified in panel B (341 genes; black). Fluidity-regulated genes are induced under long-term 
hypoxic growth, which correspond to fermentation, but not acute hypoxia. (B) Differential expression 
upon long-term hypoxia is correlated with the combined differential expression due to SPT23p90 and 
MGA2p90 induction (log2DE SPT23p90 + log2DE MGA2p90), assuming a model in which the effect 
of the activators is additive (multiplicative differential expression). Line shows x – y = 0 and is added 
for clarity. (C) Model for the long-term hypoxic response during fermentation. Low oxygen during cell 
growth reduces lipid unsaturation, activating membrane fluidity sensors (Spt23p and Mga2p), which 
then induce a wide range of physiological responses to long-term hypoxia (gray box). This pathway 
acts in parallel with the activity of molecular sensors for sterols and heme, whose synthesis is also 
oxygen dependent. 
These correlations are medium in strength, which likely reflects additional roles for other 
hypoxic response pathways. In contrast, differential expression values for short-term (90-
minute) oxygen starvation were not significantly correlated with either differential expression 
upon OLE1 repression (p = 0.07) (Figure S7B) or upon p90 induction (p = 0.5) (Figure S7C). 
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The ER membrane fluidity regulon is therefore induced by long-term hypoxia in yeast and 
plays an extensive role in the transcriptional response to fermentation conditions. 
 
Fig. II-14: Gene Ontology (GO) term 
mapping of genes overexpressed or 
downregulated upon stimuli that have 
proven to alter lipid unsaturation . The 
analyzed gene sets contain genes that 
were significantly (q ≤ 0.05) (A) 
overexpressed upon OLE1 repression, 
(B) that were significantly downregulated 
upon OLE1 repression or (C) that were 
significantly overexpressed upon growth 
under long-term hypoxic conditions.  
Input gene lists include genes that were 
identified by RNA-seq analysis and 
already shown in Fig. II-12A or Fig. II-
13A, respectively. GO term mapping was 
done according to PANTHER 
Classification System in terms of 
“biological processes” in which 
respective gene products are involved. 
Shown are only those “biological 
processes” that contain a significant 
overrepresentation of genes (*, p ≤ 0.05; 
**, p ≤ 0.01; ***, p ≤ 0.001; ****, 
p ≤ 0.001). P-values were determined by 
binomial statistics that were adjusted by 
Bonferroni correction for multiple testing. 
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2.5. Discussion 
The experiments presented here use rational genetic manipulation of lipid desaturase 
expression in order to allow for causal study of the roles for lipid unsaturation and 
membrane fluidity in the physiology of budding yeast. Modulation of OLE1 promoter activity 
allowed us to characterize the dependence of yeast physiology on lipid unsaturation. Most 
strikingly, a role for lipid unsaturation in regulating yeast cell-cell adhesion or flocculation 
was identified. Flocculation is a well-known aggregation phenotype among different yeast 
species with a large set of diverse stress conditions, including nutrient limitation and 
starvation [61-63], temperature and pH stress [62, 64], and cell aging [65-67]. Because 
native flocculation pathways have generally been studied in yeast species and strains with 
heterogeneous genetic backgrounds, there has been an assumption that flocculation 
behavior is a highly strain-specific phenomenon [68]. Due to a nonsense mutation in the 
FLO8 gene [46], previous studies showing flocculation in the S288C background relied on 
restoring Flo8p activity [46, 69], direct expression of different flocculins [32, 70], or 
overexpression of related factors Gts1p [71] or Mss11p [69]. The work presented here 
introduces a novel, FLO8-independent pathway for inducing flocculation, in which reduction 
in unsaturated lipid content causes the activation of ER-bound membrane fluidity sensors, 
primarily Spt23p, that induce FLO1 expression. This pathway is triggered by genetic 
repression of OLE1, but also by hypoxia (Figure 4), as desaturase activity requires 
molecular oxygen. It is likely that other stimuli that are expected to reduce membrane fluidity 
or lipid desaturase activity, e.g. low temperature [56], iron depletion [72], and transition 
metals [73], can also induce flocculation by increasing Spt23p processing. 
It is proposed that the regulation of FLO1 by lipid composition can account for many of the 
aggregation features utilized for separating cells from the fermentation broth (or wort) in 
industrial fermentation. For example, in brewing, initial culture aeration is a long-recognized 
factor that modulates the extent and timing of flocculation [61] and studies with both beer 
and wine producing yeast have reported that supplementation of the growth medium with 
ergosterol and fatty acids counteracts the consequences of anaerobic conditions [61, 74, 
75]. This study presents a molecular mechanism that connects oxygen availability and 
flocculation mediated by the physical state of the ER membrane. In poorly aerated 
fermenters, oxygen levels are reduced as the culture grows, thereby reducing lipid 
desaturation reactions and increasing FLO1 expression. In this context, the late stage 
switch from glycolytic to respiratory metabolism would especially starve cells and their lipid 
desaturases from oxygen, thereby providing the trigger for flocculation to increase at the 
end of fermentation. This work therefore provides a mechanistic understanding of the 
activation of flocculation due to oxygen restriction and its timing during fermentation - an 
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important parameter for industrial yeast, as pre-mature flocculation causes incomplete or 
‘hanging’ fermentation and, in the context of brewing, severe off-flavors [64, 68]. Future 
work will utilize the genetic components and lipid-mediated pathway characterized here to 
introduce and tailor flocculation behavior in industrial strains.  
What physiological benefits for cell aggregation under unsaturated lipid restriction, 
potentially initiated by oxygen limitation, could lead the evolution of this flocculation 
pathway? Experiments on laboratory yeast overexpressing FLO1 show that flocculating 
cells are physically shielded from harmful effects of the external milieu by diffusion barriers 
built up within flocs [76]. Flocculation, which is routinely triggered by nutritional starvation in 
FLO8 cells, is widely thought of as an adaptive stress response. In the case of oxygen 
starvation, however, floc formation would appear to be disadvantageous, as aggregates 
minimize surface area for diffusive uptake of oxygen. On the other hand, such diffusion 
barriers could generate microenvironments with high local concentrations of limiting 
nutrients, such as unsaturated fatty acids and sterols, which are released by lysing cells 
inside of flocs [77, 78]. Alternatively, flocculation could present a strategy for increasing the 
efficiency of mating, which is itself induced by stress conditions e.g. nitrogen limitation. In 
this model, flocculation is a prelude to mating by increasing the proximity of neighboring 
haploid yeast cells [79]. The observations that Spt23p90 and Mga2p90 also activate 
transcription of a number of meiotic cell cycle and sporulation genes (Tab. II-S1) support 
such an interplay between unsaturated lipid composition and mating in yeast, which is 
potentially related to their originally proposed role in mating silencing [19]. In light of the 
possible commercial origins of laboratory yeast strains [80], the role of saturated lipid and 
hypoxia-induced flocculation during industrial fermentation is also considered. In brewing, 
ale strains (S. cerevisiae) are known as top-fermenters, as flocs rise to the surface of wort 
due to association with carbon dioxide bubbles arising from alcohol fermentation. In this 
context, flocculation could assist in oxygen uptake by bringing the yeast closer to the 
aerated surface. This would suggest the pathway presented here is a highly strain specific 
phenomenon. However, a mention that OLE1 repression also results in cell aggregation in 
the distantly related, pathogenic fungus Candida albicans was noted [81]. Lipid-regulated 
flocculation pathway could therefore be conserved among non-brewing yeast species, 
which are similarly equipped with all required components involved in the signal pathway 
[82].  
The central role of Spt23p in regulating FLO1 expression is in line with a model in which 
membrane fluidity sensors act not only to maintain unsaturated lipid homeostasis but also 
as general regulators of cell physiology in response to environmental factors. Several lines 
of previous evidence support this proposal, including the discovery of SPT23 and MGA2 as 
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silencers of mating genes [19], the finding that Mga2p activates a minimal Low Oxygen 
Response Element (LORE) promoter [83], and the detection of potentially hundreds of 
physical interaction sites for active Spt23p/Mga2p fragments using chromatin 
immunoprecipation DNA microarray (ChIP-chip) [58]. The strains made to analyze OLE1-
dependent flocculation were used to carry out a genome-wide characterization of genes 
regulated by membrane fluidity. This effort yielded a large set of genes (~15% of genome) 
induced by low lipid unsaturation, as well as a subset that are also activated by heterologous 
expression of pre-processed Spt23p/Mga2p active domains (341 genes). Manual curation 
of the expression data reveals several functional categories for genes activated by low 
membrane fluidity, which are summarized in Tab. II-S1. Common targets include synthesis 
and regulatory genes (involved in the synthesis of fatty acids, phospholipids, sterols, 
sphingolipids, and lipid droplets) and genes involved in metal homeostasis and tolerance, 
consistent with the catalytic roles for iron and the inhibitory roles of other metals on lipid 
metabolism [84, 85]. Repression of OLE1 or expression of Spt23/Mga2 p90 also induced a 
number of stress response genes involved in osmotic shock, cold shock, heat stress, and 
oxidative stress, as well as members of well-characterized cell protein homeostasis 
pathways: the Heat Shock Response, the Unfolded Protein Response, and ER Associated 
Degradation. Finally, a prominence of fluidity-regulated genes that encode for catalytic and 
structural proteins involved in mitochondrial structure and respiratory metabolism was 
noted, which motivate future experiments on the role of unsaturated lipids in the dynamics 
and inheritance of these organelles [86]. 
The global expression analysis supports the hypothesis that the level of unsaturated lipids 
serves as broad regulator of gene expression during oxygen-limited fermentation. The 
membrane fluidity regulon (Fig. VI-1) is globally induced upon hypoxic growth (Fig. II-13A, 
B), and includes classic hypoxia genes (DAN4, TIR genes), those associated with the 
diauxic shift (ISC1, SUF1), and components of both respiratory (FMPs) and glycolytic 
metabolism (TDH1, PCK1). Specific roles for these proteins in low oxygen responses has 
long been recognized – OLE1, for example, is a canonical hypoxia response gene – but 
these data confirm that they are a widespread source of transcriptional regulation by 
oxygen. It is proposed that yeast has evolved lipid homeostasis machinery to adjust enzyme 
expression levels in accordance to environmental conditions, but has then adapted these 
sensors to act upon a wide range of molecular functions that are associated with these 
conditions. For several genes, including FLO1, sensing of unsaturated lipids is the dominant 
pathway for oxygen-induced activation, as transcript levels upon OLE1 repression or p90 
induction closely mimic those upon hypoxia. However, for most targets it is likely that 
SPT23/MGA2 serve only a part of a complex response from several oxygen sensors in the 
• Chapter II:  Lipid engineering reveals regulatory roles for membrane fluidity in yeast flocculation and oxygen-
limited growth 
 54 
cell. Ergosterol synthesis is also oxygen dependent, and Sterol Regulatory Element Binding 
Proteins (SREBP) have been identified as regulating hypoxia adaptation in fission yeast 
[87] as well as two families (DAN and TIR) of hypoxic response genes in S. cerevisiae [88]. 
The emerging roles for different lipid sensors in the yeast hypoxic response can therefore 
explain the varying timescales and oxygen concentration regimes noted for the induction of 
different hypoxic response genes, which cannot be explained by the classic yeast oxygen 
response regulators, Hap1p and Rox1p, as they are singularly activated by heme 
biosynthesis [60]. In metazoans, hypoxia-inducible factor (HIF-1) acts as a master regulator 
of hypoxic genes, and along with and its associated hydroxylases is thought to act as a 
direct sensor to changes in oxygen concentration (Semenza, 2004). In contrast, yeast relies 
on secondary messengers such as unsaturated fatty acids whose synthesis is intrinsically 
regulated by environmental oxygen concentration. One limitation of such a sensing 
mechanism is its temporal response: activation remains until membrane composition is 
diluted by new lipid synthesis, and is therefore unaffected by acute or short-term changes 
in the environment. Such kinetics could also be beneficial, however, by allowing the cell to 
integrate long-term environmental stimuli before committing on major changes to its 
physiology, such as rewiring basic metabolism or engagement in primitive collective 
behaviors like flocculation.  
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2.6. Conclusions 
This study introduced a metabolic engineering approach for investigating endogenous lipid 
synthesis pathways. Transcriptional modulation of the lipid desaturase gene OLE1 
generated a budding yeast strain in which lipid unsaturation and membrane fluidity is under 
experimental control. Work with this strain led to the unexpected discovery of a non-
canonical flocculation pathway, in which ER-localized membrane ordering sensors trigger 
expression of FLO1. This pathway is triggered by low-oxygen conditions in wild-type cells, 
and provides a mechanistic explanation for sedimentation phenotypes important in 
industrial yeast. It is shown that the FLO1 pathway is part of a larger transcriptional 
response to low oxygen that is mediated by lipid unsaturation and is activated during 
anaerobic fermentation.  
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2.8. Supporting information 
 
Fig. II–S1: Control measurements of lipid compositions. (A) Lipid extracts from cells either 
disrupted by enzymatic digestion with zymolyase or mechanical bead beating were analyzed by GC-
MS to check for differences in lipid composition in dependence of the method of cell disruption. Fatty 
acid unsaturation was uninfluenced by the pretreatment of cells. Concerns regarding differences in 
lipid unsaturation arose due the incubation step (1h, 35°C) involved in the zymolyase treatment of 
cells for enzymatic disruption of the cell wall since temperature is a critical parameter influencing 
membrane lipid composition. Left: exemplary GC-MS traces; right: bar diagrams for biological 
triplicates. Error bars, SEM (n = 3). 
 
Fig. II–S2: PMET3-OLE1 cells flocculate in methionine, but show no defect in cell division. 
Confocal fluorescence micrographs of flocculating PMET3-OLE1 cells cultured at 250 µM methionine 
and freely suspended PMET3-OLE1 cells cultured in methionine-free synthetic dextrose medium. 
Yeast cell walls were stained with calcofluor white. 
 
Fig. II-S3: The flocculation gene FLO1 is uniquely activated upon OLE1 repression. Changes 
in expression of different FLO genes in response to growth at low lipid unsaturation, as tested by 
comparing expression in PMET3-OLE1 grown in 5 mM vs. 0 mM exogenous methionine. Gene 
expression was measured by qRT-PCR and shows significant upregulation only of FLO1. Error bars, 
SEM (n = 3). 
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Fig. II-S4:  Control measurements of membrane lipid composition upon indicated gene 
expression, media supplementation and gene knockouts. (A) Lipid unsaturation (% acyl chains 
unsaturated) of PMET3-OLE1 cells grown at 250 µM met with (-dox) and without (+dox) additional 
plasmid-based OLE1 expression from a tetO2-PCYC1 promoter construct. The dependence of lipid 
unsaturation on methionine without an additional plasmid – from Figure 1D – is included for 
comparison. (B) Lipid unsaturation (% acyl chains unsaturated) of PMET3-OLE1 cells grown in the 
presence of membrane fluidizers, n-octanol (0.02% w/v) and benzyl alcohol (10 mM) and various 
external methionine concentrations (50 µM; 100 µM; 150 µM; 200 µM; 250 µM). The dependence of 
lipid unsaturation on methionine in the absence of additives – from Figure 1D – is included for 
comparison. (C) Prevention of flocculation in PMET3-OLE1;Δflo1 does not result from restored lipid 
unsaturation. Lipid unsaturation upon OLE1 repression (PMET3-OLE1 + met) in a Δflo1 or Δflo8 
background when grown at various methionine concentrations. The dependence of lipid unsaturation 
on methionine with unaltered FLO1/FLO8 – from Figure 1D – is included for comparison. (D) Lipid 
unsaturation in PMET3-OLE1 is largely unaffected by SPT23 and MGA2. Lipid unsaturation upon 
OLE1 repression (PMET3-OLE1 + met) in a Δspt23 or Δmga2 background when grown at various 
methionine concentrations. The dependence of lipid unsaturation on methionine with unaltered 
SPT23/MGA2 – from Figure 1D – is included for comparison. 
 
Fig. II-S5: Lipid unsaturation induced proteolytic processing of mycSpt23p in a SPT23 
knockout background. Expression of mycSpt23p under control of its endogenous promoter (PSPT23) 
from a centromeric (CEN) plasmid (pGREG523) in a SPT23 knockout background (PMET3-OLE1; 
∆spt23) shows a comparable profile of mycSpt23p proteolytic processing as the background harboring 
endogenous SPT23 (Fig. II-8B). 
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Fig. II-S6: Global expression of membrane 
fluidity genes under long- and short-term 
(acute) hypoxia. (A) Differential expression 
values upon long-term hypoxia are correlated 
with those upon OLE1 repression for 
membrane fluidity genes. Comparison of the 
changes in differential expression (DE) 
resulting from low lipid unsaturation (PMET3-
OLE1 in 250 µM vs. 0 µM methionine) with 
those resulting from long-term hypoxic growth 
in the background strain (BY4742) for the 341 
genes found to be regulated by 
OLE1/SPT23/MGA2 in Figure 5B. These 
genes feature a medium strength correlation 
(r = 0.38) between differential expression 
upon long-term hypoxia and OLE1 
repression. Line shows x – y = 0 and is added 
for clarity. (B) Membrane fluidity-regulated 
genes are not globally induced under short-
term hypoxia. Comparison of the differential 
expression (DE) resulting from low lipid 
unsaturation (log2 DE for PMET3-OLE1 in 250 
µM vs. 0 µM methionine) or (C) combined p90 
induction (sum of log2 DE for SPT23p90 
induction and MGA2p90 induction) with those 
resulting from acute hypoxia (90 min under 
argon) in the background strain (BY4742) for 
the 341 genes found to be regulated by 
OLE1/SPT23/MGA2 in Figure 5B. Differential 
expression upon acute hypoxia, with few 
exceptions, is not correlated with activation 
due to low membrane fluidity, in contrast to 
long-term hypoxic growth (Figure 5D, S12). 
Lines show x – y = 0 and are added for clarity. 
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Tab. II-S1: Functional groups of genes regulated by SPT23p90 and MGA2p90. Genes 
significantly upregulated (q ≤ 0.05) by OLE1 repression and significantly upregulated (q ≤ 0.05) by 
SPT23p90 or MGA2p90 expression are listed with their log2 differential expression values. 
 
  
OLE1 
repression
SPT23 
activation 
MGA2 
activation
OLE1 
repression
SPT23 
activation 
MGA2 
activation
metal homeostasis hypoxic response
ARN1 1,16 0,76 1,48 DAN4 1,98 1,03 2,19
ARN2 1,05 0,75 0,84 RIM8 0,91 0,07 1,84
DAP1 1,72 0,63 1,48 TIR1 0,96 2,20 -0,74
FET4 0,76 0,55 1,45 TIR2 1,00 0,41 1,88
FRE8 1,39 0,45 0,78 oxidative stress
HMX1 0,99 0,92 1,46 ALD6 2,97 0,49 0,80
IZH1 2,03 0,38 1,48 GRE3 1,03 -0,49 0,59
IZH2 3,93 2,02 3,30 HMX1 0,99 0,92 1,46
IZH4 7,23 0,11 3,12 PST2 0,63 0,77 1,05
SIT1 2,60 1,00 0,77 TSA1 1,36 -0,15 0,90
fatty acid synthesis TSA2 1,56 0,73 1,09
ACC1 3,96 0,84 0,98 protein folding
ELO1 1,35 0,25 1,10 ADD37 1,74 0,27 1,25
FAS1 3,47 0,55 0,73 EMC10 0,51 -0,33 -0,32
FAS2 3,61 0,67 0,94 ERO1 0,76 -0,20 0,77
phospholipid synthesis GET3 1,23 -0,17 1,05
ALE1 2,39 0,51 1,64 HRD1 1,69 0,36 0,71
APP1 0,84 0,20 0,74 HSP26 2,27 3,29 1,90
CDS1 0,67 0,20 0,70 JEM1 0,64 0,27 0,81
CKI1 1,35 -0,26 1,54 KAR2 1,66 0,07 1,11
CST26 1,05 -0,48 0,67 LHS1 1,31 -0,20 0,54
EKI1 0,69 0,22 0,99 MIA40 0,65 -0,58 0,57
ICT1 3,03 0,14 2,41 PDI1 1,73 0,13 0,89
INO2 1,30 0,42 1,50 SSA4 1,43 -0,24 0,92
INO4 0,85 -0,10 1,14 SSE2 1,05 0,49 0,75
OPI3 0,88 0,92 1,77 TSA1 1,36 -0,15 0,90
PGS1 0,98 -0,05 1,13 UBX2 1,05 0,02 0,93
sterol synthesis thermal stress response
ARE2 1,99 1,57 0,89 FUN19 1,44 0,11 0,70
ERG10 1,66 0,15 1,67 TIP1 2,10 1,18 1,97
ERG13 1,48 -0,27 0,74 TIR1 0,96 2,20 -0,74
MVD1 1,75 -0,26 2,10 osmotic shock response
SCY1 1,02 -0,67 0,69 ALD6 2,97 0,49 0,80
SLC1 1,15 -0,47 0,63 GRE3 1,03 -0,49 0,59
sphingolipid synthesis HSP12 1,81 1,31 -0,26
LAC1 0,71 0,61 0,60 RVS161 0,52 0,52 0,43
ORM2 0,92 0,03 1,24 SMP1 0,64 1,40 0,09
PAH1 1,04 -0,09 1,20 meiotic cell cycle
PHS1 0,97 0,38 0,88 CDC4 1,38 -0,42 0,76
PLB2 3,27 0,92 1,68 DMC1 2,81 2,16 2,17
SUR1 0,62 0,75 0,31 GAC1 1,83 0,91 1,89
lipid droplet synthesis IML3 0,85 0,63 1,76
ATG15 1,37 0,56 1,76 IML3 0,85 0,63 1,76
OSH6 1,20 -0,35 1,76 ZIP1 1,84 -1,29 1,63
UPC2 1,73 0,22 0,91 diauxic shift
YSR3 2,49 0,71 0,51 CAT8 0,74 0,74 -0,53
peroxisomal ICL1 1,06 0,50 1,07
ECI1 1,05 0,24 1,25 ISC1 1,34 0,05 1,33
FOX2 1,29 -0,01 0,67 NQM1 1,92 0,17 2,48
LPX1 0,75 0,61 -0,01 SUF1 1,07 -0,30 1,84
LPX1 0,75 0,61 -0,01 glycolytic metabolism
PEX31 2,01 0,72 1,53 ENO1 2,96 0,97 0,53
POT1 2,64 1,36 -2,32 PCK1 3,97 1,19 0,76
POX1 1,46 1,12 0,95 TDH1 2,81 1,83 2,47
SPS19 2,69 1,48 1,33 mitochondrial
cell wall AIM2 0,57 -0,32 0,58
FIT2 2,18 1,05 0,47 FMP25 1,26 -0,11 1,44
FIT3 2,07 0,73 0,77 FMP40 1,22 1,41 1,69
FLO1 4,98 3,72 2,40 FMP46 1,61 0,69 1,26
FLO9 0,92 2,07 0,81 FUN14 1,67 0,69 0,99
sporulation MDM10 0,95 1,11 1,35
GSC2 1,17 0,66 0,89 OM45 1,34 0,08 0,75
OSW2 3,33 0,94 2,42 TIM23 1,77 -0,20 0,63
SPO1 1,61 1,11 0,58
SPO73 0,67 0,48 2,02
SPS100 3,65 0,21 4,24
SPS19 2,69 1,48 1,33
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Tab. II-S2: Plasmids used in this study. The table summarizes basic characteristics and properties 
of indicated plasmids. 
Plasmid description reference 
p416-PTEF1-yECitrine - [24] 
p416-LEU2-PTEF1-yECitrine - [25] 
p416-LEU2-PMET3-yECitrine 
CEN/ARS; URA3; LEU2; ampR; 
methionine repressible expression of 
yECitrine 
This study 
pCM188 - [27] 
pCM224 - [37] 
pCM188-OLE1 CEN/ARS; URA3; amp
R; doxycycline 
repressible expression of Ole1p 
This study 
pCM188-SPT23p90 CEN/ARS; URA3; amp
R; doxycycline 
repressible expression of Spt23p90 
This study 
pCM188(LEU2)-SPT23p90 
CEN/ARS; URA3; LEU2; ampR; 
doxycycline repressible expression of 
Spt23p90 
This study 
pCM188(LEU2)-MGA2p90 
CEN/ARS; URA3; LEU2; ampR; 
doxycycline repressible expression of 
Mga2p90 
This study 
pUG72 - [23] 
pUG72-PMET3 PCR template for PMET3-loxP This study 
pUG73 - [23] 
pGREG506 - [28] 
pGREG523 - [28] 
pGREG523-PSPT23-mycSPT23 
CEN/ARS; HIS3; kanMX; ampR; 
expression of an N-terminally 13xmyc-
tagged Spt23p variant (mycSpt23p) from 
native SPT23 promoter 
This study 
pGREG523-PSPT23-mycSPT23W1042L 
CEN/ARS; HIS3; kanMX; ampR; 
expression of an N-terminally 13xmyc-
tagged Spt23p W1042L mutant variant 
(mycSpt23pW1042L) from native SPT23 
promoter 
This study 
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plasmid description reference 
pGREG523(2µ) –PSPT23-mycSPT23 
2µ ORI; HIS3; kanMX; ampR; expression 
of an N-terminally 13xmyc-tagged 
Spt23p variant (mycSpt23p) from native 
SPT23 promoter 
This study 
pGREG523–PTEF1-mycSPT23 
CEN/ARS; HIS3; kanMX; ampR; 
expression of an N-terminally 13xmyc-
tagged Spt23p variant (mycSpt23p) from 
strong TEF1 promoter 
This study 
pGREG523(2µ) –PTEF1-mycSPT23 
2µ ORI; HIS3; kanMX; ampR; expression 
of an N-terminally 13xmyc-tagged 
Spt23p variant (mycSpt23p) from strong 
TEF1 promoter 
This study 
pGREG523-PMGA2-mycMGA2 
CEN/ARS; HIS3; kanMX; ampR; 
expression of an N-terminally 13xmyc-
tagged Mga2p variant (mycMga2p) from 
native MGA2 promoter 
This study 
pRS415-ER-sfGFP-HDEL - [29] 
pRS416-ER-sfGFP-HDEL 
CEN/ARS; URA3; ampR; expression of 
an ER guided GFP variant (sfGFP, 
superfold) that retains in the ER lumen 
because of an C-terminally attached 
HDEL sequence 
This study 
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Tab. II-S3: Primers used in this study. Underlined sequence parts represent homology regions of 
overhang primers used recombination-based cloning approaches. 
primer sequence (5’ → 3’) amplicon 
P1 (fw) GCTATACGAAGTTATTAGGTGATATCAGATCCACTAGTATCGTTTAATTTAGTACTAACAGAGACTTTTGTCACAAC PMET3 
P2 (rv) GGGAGACCGGCAGATCCGCGGCCGCATAGGCCACTAGTGTTAATTATACTTTATTCTTGTTATTATTATACTTTCTTAGTTCCTTTTC  PMET3 
P3 (fw) GATAACACTTTGTAAGCCTTTGCTGGGATCTTCACAGCGAGCTCTCGAGAACCCTTAAT  PMET3-loxP 
P4 (rv) TACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGCCAGCTGAAGCTTCGTACGC  PMET3-loxP 
P5 (fw) GGCGCTTATCTGGTGGGCTTCCGTAGAAGAAAAAAAGCTGTTGACAGCTGAAGCTTCGTACGC PMET3-PRC 
P6 (rv) ATTGGTCGTCAATCAATTCAATAGTAGTTCCAGAAGTTGGCATGTTAATTATACTTTATTCTTG PMET3-PRC 
P7 (fw) CACAAATACACACACTAAATTACCGGATCAATTCGGGGGATCCATGCCAACTTCTGGAACTACTATTGAATTG OLE1 
P8 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTAAAAGAACTTACCAGTTTCGTAGATTTCACC OLE1 
P9 (fw) ACTAAATTACCGGATCAATTCGGGGGATCCATGATGAGTGGCACAGGAAAC SPT23p90 
P10 (rv) TGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTAACCCCTAACGTCACACATGG SPT23p90 
P11 (fw) ACTAAATTACCGGATCAATTCGGGGGATCCATGCAGCAGAACAGTGAG MGA2p90 
P12 (rv) TGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTCTATTCATCCCCGTCTTCTTC MGA2p90 
P13 (fw) GGTTTTGGGACGCTCGAAGGCTTTAATTTGCGGCCCTGAAGCTTCGTACGCTGCAG 
loxP-LEU2-
loxP 
P14 (rv) TTCACACAGGAAACAGCTATGACCATGATTACGCCCGCATAGGCCACTAGTGGATCTG 
loxP-LEU2-
loxP 
P15 (fw) TAAGCTCTCTTCCGGGTTCTTATTTTTAATTCTTGTCACCAGTAAACAGAACATCCAAAAATGTCTAAAGGTGAAGAATTATTCACTGG FLO1 KOC 
P16 (rv) CATGTCAGCGTATAATTAGCAAAGAAAAGATACACAGATACGTAAAAAGAACGCGAATTTTAGCAGATTGTACTGAGAGTGCAC FLO1 KOC 
P17 (fw) CAGCCTCGTAGCACACCAGCAAGCAGCATGGTAGGATATAGTACAGCTTCTTTAGAAATTTAACACCGATTATTTAAAGCTGCAGG FLO1hd KOC 
P 18(rv) TGTCAGCGTATAATTAGCAAAGAAAAGATACACAGATACGTAAAAAGAACGCGAATTTTAGGGTACCCTTAATTAAGACAACCC FLO1hd KOC 
P19 (fw) AAAAATAAACACGAAGACGTTTATAGACATAAATAAAGAGGAAACGCATTCCGTGGTAGAATGTCTAAAGGTGAAGAATTATTCACTGG FLO8 KOC 
P20 (rv) GCTTTTTATTATGTTTCCTGTCATTAAGAGTTTTTATTTTTTATTATAATACTCAACACGTGACTGCAGATTGTACTGAGAGTGCAC FLO8 KOC 
P21 (fw) ACAGGTACGCTCTTTAAATTGCAATTTAAAAAGAACAATTGTACAATAAAAGCCCCAAAACGTACGCTGCAGGTCGAC FLO9 KOC 
P22 (rv) TGTCAGCGTATATTTAGCAAAGAAAAGATACACAGATACGTAAAAAGAACGCGAATTTTAGCGGCGTTAGTATCGAATCG FLO9 KOC 
P23 (fw) TTATACTCTAGATATCCTCTAAACGACTAATCACAACAGTAGTACACCACTGAAACGTACGCTGCAGGTCGAC SPT23 KOC 
P24 (rv) GCAAAATAATAAAAAATGAATCTATATAGTGTAAGGATTATGTAGCTAGAAAAATGTCTGCGGCGTTAGTATCGAATCG SPT23 KOC 
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primer sequence (5’ → 3’) amplicon 
P25 (fw) CCTTATTGTGCATTTAAAGGCACTTATTGAAGGTCATTTTGGCGAACAGAACATTTCGTTGGTATTTCACACCGCATAGGG MGA2 KOC 
P26 (rv) TAAGTGTACTGTCTTTTCATTATACACACATATATATATATATATACGTAAAAAAGCAGAGCAGATTGTACTGAGAGTGCAC MGA2 KOC 
P27 (fw) TTAACTCAGTGTCAAACATAACAACCTCCTCCTCCCCCACCTACGACAACAACCGCCACTCGTACGCTGCAGGTCGAC HAC1 KOC 
P28 (rv) AAAACCCACCAACAGCGATAATAACGAGAAAAAAAAAATTATACCCTCTTGCGATTGTCTGCGGCGTTAGTATCGAATCG HAC1 KOC 
P29 (fw) CCTTCATACACATTAAAAAAACAGCATATCTGAGGAATTAATATTTTAGCACTTTGAAAACGTACGCTGCAGGTCGAC IRE1 KOC 
P30 (rv) ATGATCAAAGTAACATTAATGCAATAATCAACCAAGAAGAAGCAGAGGGGCATGAACATGGCGGCGTTAGTATCGAATCG IRE1 KOC 
P31 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGAGTGGCACAGGAAACGT SPT23 ORF 
P32 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTTAATTGACTCGCATGTCGTTTAGAAT SPT23 ORF 
P33 (fw) AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCCGATGAGGTCGCTGGCGTAG PSPT23 
P34 (rv) GCTTTTGTTCACCGTTAATTAACCCGGGGATCATTTTCAGTGGTGTACTACTGTTGTG PSPT23 
P35 (fw) TGGTCGTCCACAGGTTTTAATAG SPT23W1042L 
P36 (rv) CAAATTCGATAATGTGAAACATAATAAGAGTACTAAAGTTAAGGGGATCAAAAAGAATAGGAGCATCTTATCA SPT23W1042L 
P37 (fw) GGTTAATGTCATGATAATAATGGTTTCTTAGGACGCCTGAACGAAGCATCTGTG 2µ ORI 
P38 (rv) GCACATTTCCCCGAAAAGTGCCACCTGGGTCCTTTTCATGATCCAATATCAAAGGAAATGATAGC 2µ ORI 
P39 (fw) AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCCATAGCTTCAAAATGTTTCTACTCCTT PTEF1 
P40 (rv) GCTTTTGTTCACCGTTAATTAACCCGGGGATCATAAACTTAGATTAGATTGCTATGCTTTCT PTEF1 
P41 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGCAGCAGAACAGTGAGTTC MGA2 ORF 
P42 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACCTAACTGACAATTAAATCGTTCAACATTC MGA2 ORF 
P43 (fw) AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCCGAAAAATCCAAATGTTCTTCCTTGC PMGA2 
P44 (rv) GCTTTTGTTCACCGTTAATTAACCCGGGGATCATAACGAAATGTTCTGTTCGCC PMGA2 
P45 (fw) AGAGGAAACGCATTCCGTG FLO8 ORF (-24 to +659) 
P46 (rv) GCAGGTGCCATAGGATTTCC FLO8 ORF (-24 to +659) 
P47 (fw) GCGCGCGTAATACGACTCACTATAGGGCGAATTGCTGCAGCCCGGGGGATC ER-sfGFP-HDEL 
P48 (rv) GCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGCAAAAGCTGGAGCTCAGTTTATCA 
ER-sfGFP-
HDEL 
P49 (fw) CAGGGATTTCCAGAGCACG HAC1 mRNA 
P50 (rv) TCATGAAGTGATGAAGAAATCATTC HAC1 mRNA 
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3. Chapter III: Heterologous expression of stearoyl-CoA desaturases from 
trypanosomes 
3.1. Abstract 
A yeast strain in which expression of OLE1, encoding for the sole fatty acid desaturase 
found in S. cerevisiae, is under experimental control serves as a cellular platform to assay 
the activity of heterologously expressed stearoyl-CoA desaturases (SCDs). Functional 
expression of SCDs complements for repressed endogenous OLE1, thus providing for an 
easy, fast and affordable assay read-out that is based on simply restoring growth or 
preventing a prominent flocculation phenotype. Based on this assay, putative SCDs from 
human pathogens T. brucei and T. cruzi were functionally expressed in S. cerevisiae, 
thereby confirming their SCD activity. The assay presented here might also provide a tool 
to screen for inhibitors of SCDs, which are interesting drug targets in the treatment of a 
variety of disease states as well as bacterial and parasitic infections in humans. 
  
• Chapter III: Heterologous expression of stearoyl-CoA desaturases from trypanosomes 
 70 
3.2. Introduction 
Members of the genus Trypanosoma such as Trypanosoma brucei and Trypanosoma cruzi 
belong to the world’s most prevalent human pathogens with millions of people infected, 
even more being at risk of infection, causing thousands of fatalities per year [1, 2]. T. brucei 
is the infective agent of the sleeping sickness (African Trypanosomiasis) whereas T. cruzi 
is endemic to South Africa and causes the so-called Chargas’ disease (American 
Trypanosomiasis). Persons affected suffer from serious health problems without good 
chances of recovery due to a limited number of drugs for chemotherapy that also feature 
little efficiency, severe side effects and high costs [1]. Moreover, available drugs lose 
efficiency as parasites can acquire drug resistances [3]. These facts emphasize that the 
development of more efficient drugs with higher potency and specificity is highly urgent. 
Screenings to identify new anti-trypanosomal drugs can either test natural substances, 
synthetic compounds or novel agents that were rationally designed. Even the screening of 
compounds already used for treating other human diseases can identify potent anti-
trypanosomal drugs, also taking advantage that these agents have passed a multitude of 
clinical trials and are already approved [4]. Independent from the agent source, reliable drug 
screens are required to evaluate the efficiency of promising candidates. The yeast 
Saccharomyces cerevisiae has been successfully used as a heterologous expression 
system to study the effect of drugs on defined protein targets [5]. Several protein encoding 
sequences of trypanosomal origin were already successfully expressed in S. cerevisiae and 
complemented for the loss-of-function of homologous endogenous genes [6-12]. Thus, 
yeast as heterologous expression system provides a well-characterized platform that can 
be exploited to identify novel anti-parasitic drugs [13]. The power of yeast cell-based assays 
are founded on the easy and versatile genetic accessibility of yeast and the high degree of 
conservation of cellular processes among eukaryotic cells in combination with technical 
advantages of yeast cell cultures. Moreover, in vivo drug screens in a suitable eukaryotic 
environment provide advantages over classical biochemical in vitro assays as they already 
select for essential drug intrinsic properties such as the ability to permeate biological 
membranes as well as intracellular stability [14]. This way, yeast cell-based assays are also 
attractive for anti-cancer drug research [15] or the identification of potential drugs to treat 
other diseases that rely on human endogenous gene products [16]. High-throughput drug 
screens for anti-parasitic agents against heterologously expressed drug target proteins 
were also successfully developed and pioneered in yeast [13, 17]. 
Fatty acid desaturases were identified as promising drug targets in the human pathogen 
trypanosomes T. brucei and T. cruzi.  These pathogens feature a normal set of lipids 
common to eukaryotic organisms including phospholipids [18], sphingolipids [19, 20], 
sterols [21] and tri- and diacylglycerols [22] containing saturated as well as mono- and 
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polyunsaturated fatty acids [4]. However, the ratio of saturated to mono- and 
polyunsaturated fatty acids can vary tremendously between the different life cycles of the 
pathogens: Trypanosomes as insect-resident epimastigotes are exposed to environmental 
temperatures of 28°C and feature are high degree of (poly)unsaturated fatty acids that can 
make up to 60% of total fatty acids whereas fatty acid unsaturation of metacyclic 
trypomastigotes in the human/mammalian host at 37°C is significantly reduced [23]. These 
findings suggest that the ability to modify membrane fluidity is a critical parameter of 
trypanosomes to adapt to dramatic changes in their environmental temperature exposed to 
during their typical life cycles and imply homeoviscous adaption as a prominent virulence 
factor. In the recent years, biosynthesis pathways of unsaturated fatty acids in 
trypanosomes have been studied and principle mechanisms and key players were identified 
[24-26]. Desaturases for the synthesis of highly prevalent polyunsaturated fatty acids use 
monounsaturated fatty acids as substrate which are synthesized by a ∆9 stearoyl-CoA 
desaturase (SCD) [25, 27]. This relationship emphasizes SCDs as key determinants in the 
synthesis of polyunsaturated fatty acids and homeoviscous adaption of trypanosomes, thus 
indicating that fatty acid desaturases might be good targets for anti-trypanosomal drugs. 
The T. brucei and T. cruzi SCDs were shown to be specifically inhibited by the thiourea drug 
isoxyl which is already used to treat infections with Mycobacterium tuberculosis [28, 29]. 
Experiments that showed an inhibitory effect of isoxyl on trypanosomal SCD were principally 
based on the exposure of trypanosomes to the active agent in combination with GC-MS 
analysis of the lipid composition [4, 30] and did not use heterologous expression systems, 
thus rendering the analysis time consuming, little affordable and complex in application. 
The study presented here, was aimed to provide the basis for investigating the potency of 
fatty acid desaturase inhibitors towards trypanosomal SCDs using the power of a cost-
effective yeast-based assay that is easy in use and does not require large technical efforts. 
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3.3. Materials and Methods 
3.3.1. Yeast strains 
Tab. III-1: Yeast strains used in this study. The table lists all strains with corresponding genotypes. 
Plasmids harbored by respective strains are named as indicated in Tab. III-S1. 
strain genotype reference 
BY4742 MATa; his3D1; leu2D0; lys2D0; ura3D0 [31] 
SII-1 BY4742; ole1:: PMET3-OLE1 This study; section 2.3.1 
SIII-1 SII-1; pCM188 This study 
SIII-2 SIII-1; pGREG523-PSPT23-mycSPT23 This study 
SII-14 SII-1; pCM188-OLE1 This study; section 2.3.1 
SIII-3 SII-14; pGREG523-PSPT23-mycSPT23 This study 
SIII-4 SII-1; pCM188-OLE1-yEGFP This study 
SIII-5 SII-1; pCM188-K.l.OLE1 This study 
SIII-6 SIII-5; pGREG523-PSPT23-mycSPT23 This study 
SIII-7 SII-1; pCM188-K.l.OLE1-yEGFP This study 
SIII-8 SII-1; pCM188-T.b.SCD This study 
SIII-9 SIII-8; pGREG523-PSPT23-mycSPT23 This study 
SIII-10 SII-1; pCM188-T.b.SCD-yEGFP This study 
SIII-11 SII-1; pCM188-T.c.SCD This study 
SIII-12 SIII-11; pGREG523-PSPT23-mycSPT23 This study 
SIII-13 SII-1; pCM188-T.c.SCD-yEGFP This study 
3.3.2. Yeast transformation and strain construction 
Genetically modified S. cerevisiae strains generated in this study are derived from BY4742 
(MATa; his3D1; leu2D0; lys2D0; ura3D0) obtained from EUROSCARF (Frankfurt, 
Germany). BY4742 cells were routinely cultured in YPD media (2% glucose; 2% peptone; 
1% yeast extract). BY4742 derived strains harboring selectable markers (URA3; HIS3) were 
grown in appropriate synthetic defined (SD) drop-out media (2% glucose; yeast nitrogen 
base (YNB); drop-out amino acid supplement). Cells were propagated at 30°C. All strains 
are listed in Tab. III-1. 
Transformation of S. cerevisiae with previously generated plasmids was routinely 
performed by using the Frozen-EZ Yeast Transformation II kit (Zymo Research) according 
to manufacturer’s instructions. 
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3.3.3. Plasmid construction 
The introduction of stearoyl-CoA desaturase (SCD) encoding sequences (OLE1; K.l.OLE1; 
T.b.SCD; T.c.SCD) into plasmid pCM188 was done by recombination-based cloning in vivo. 
For that, plasmid pCM188 [32] was cleaved with BamHI and NotI and the respective ORFs 
were amplified by PCR (Q5 DNA polymerase, NEB). OLE1 was amplified from S288C 
genomic DNA. K.l.OLE1 was amplified from K. lactis genomic DNA isolated by a modified 
alkaline lysis from zymolyase treated K. lactis MWL9S1 cells (kind gift of Prof. Dr. Michele 
M. Bianchi; Sapienza University of Rome) and subsequent column purification of DNA by 
using a commercial kit (ZR Plasmid Miniprep – Classic Kit, Zymo Research). Trypanosoma 
brucei (T.b.) and Trypanosoma cruzi (T.c.) genomic DNA (kind gift of Prof. Dr. Nestor Luis 
Uzcategui Araujo; Universidad Central de Venezuela) served as a template for amplifying 
the respective ORFs (T.b.: Tb427.08.6000-t26; T.c.: Tc00.1047053509239.10). Flanking of 
PCR products with sequences homologous to the restricted plasmid backbone was 
achieved by using corresponding overhang primers (primers P1 & P2 (OLE1), P3 & P4 
(K.l.OLE1); P5 & P6 (T.b.SCD); P7 & P8 (T.c.SCD)).  
For C-terminal GFP-tagging of SCDs, the yEGFP encoding sequence was inserted 
downstream of the respective SCD ORF that were cloned into plasmid pCM188 beforehand 
via homologous recombination-based cloning in vivo. The yEGFP sequence was amplified 
from plasmid pKT103 [33] with primers P13 and P9 (for OLE1), P10 (for K.l.OLE1), P11 (for 
T.b.SCD) or P12 (for T.c.SCD).  
Co-transformation of linearized plasmid backbone and PCR product for recombination-
based in vivo cloning was routinely carried out by using Frozen-EZ Yeast Transformation II 
kit (Zymo Research) according to manufacturer’s instructions. PCR conditions were chosen 
according to manufacturer’s instructions. 
Plasmids and primers used in this study are listed in the supporting information (Tab. III-S1 
& Tab. III-S2). 
3.3.4. Sequence analysis 
Alignment of protein sequences and determination of protein identity was performed online 
with the Clustal Omega Multiple Sequence Alignment Program (EMBL-EBI). 
3.3.5. Microscopy 
Cells expressing C-terminally GFP-tagged SCDs were analyzed using a microscopy setup 
consisting of a Leica TCS SP5 II spectral confocal laser scanning microscope (Leica 
Microsystems, CLSM) equipped with a 100-x oil objective (HCX PL APO CS 100x/1.44). 
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GFP was excited at 488 nm and emission was detected between 510 – 585 nm. Prior to 
microscopy analysis, cells were grown to exponential phase (OD600 = 1.0) in appropriate 
synthetic defined drop out medium.  
For DNA staining with DAPI, 1 mL of a cell culture grown to exponential phase was mixed 
with 2.5 µL of a DAPI (Sigma Aldrich) stock solution (1 mg·mL-1) to a final concentration of 
2.5 µg·mL-1. Cells were then incubated for 30 min at 30°C, harvested by centrifugation, 
washed 2 times with 1XPBS und used for microscopy analysis. DAPI was excited at 405 nm 
and emission was detected between 435 – 485 nm. 
3.3.6. Growth assays on agar medium 
Growth assays were performed for characterizing the growth phenotype of (genetically 
modified) strains under defined growth conditions. Cells used for growth assays were grown 
overnight in appropriate synthetic defined media or YPD (where applicable) at 30°C in a 
rotary shaker at 200 rpm. Cells from overnight cultures were harvested by centrifugation 
and washed 2 times with sterile water (ddH2O) to remove any remaining residuals from the 
culture medium. For each preparation, fresh suspensions were adjusted to 
OD600 = 1.0 ± 0.05 using H2O and from these 10-fold serial dilutions were set up (1:10 - 
OD600 = 0.1; 1:100 - OD600 = 0.01; 1:1000 - OD600 = 0.001). 7 µL from each dilution and all 
strains to be compared were spotted in a row on indicated agar medium. Plates were 
incubated at 30°C for 3 days. The growth phenotype was evaluated by comparing the size 
of colonies from sample strains and positive/negative controls by eye. 
These growth assays were applied to evaluate the growth phenotype and cell viability upon 
doxycycline-mediated repression of plasmid-based heterologous SCD expression in the 
genomic PMET3-OLE1 background. 
3.3.7. Growth and flocculation tests 
Growth assays in liquid media and flocculation tests were performed as previously 
described (section 2.3.4). 
3.3.8. Fatty acid analysis 
The GC-MS analysis of fatty acids was performed as previously described (section 2.3.5). 
3.3.9. Spt23p processing 
Proteolytic processing of myc-tagged Spt23p was monitored as previously described 
(section 2.3.7).  
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3.4. Results and Discussion 
3.4.1. Assay design 
A lipid engineering approach revealed physiological roles of membrane fluidity and packing 
of glycerophospholipids in cellular membranes for yeast flocculation (section 2.4.2) [34]. 
Flocculation is induced upon decreased membrane fluidity resulting either from repression 
of genomic OLE1, encoding for the sole fatty acid desaturase in yeast, or from growth under 
hypoxic conditions which reduces the overall cellular Ole1p activity due to limited dissolved 
oxygen (serves as a co-factor of the Ole1p catalyzed desaturation reaction) availability. 
Membrane fluidity and flocculation inducing Flo1p expression are linked by ER membrane-
resident membrane fluidity sensors, Spt23p and Mga2p, which are activated upon 
decreased membrane rigidity and lipid packing by proteasome-mediated proteolytic 
processing. The resulting soluble activated fragments (p90 domains) translocate to the 
nucleus where they induce gene expression. Prominent targets of p90 transcription 
activators are OLE1, thereby constituting a feedback loop to maintain physiological 
membrane fluidity, and, among others, FLO1 encoding for a cell wall protein that binds 
sugar moieties of adjacent cells, thus mediating cell-cell interactions termed flocculation. 
Upon formation of flocs consisting of thousands of cells, these flocs rapidly separate from 
the medium by sedimentation [35], thereby leading to a clear, prominent and easily 
detectable phenotype. Such strong phenotypes are e.g. required for phenotypic drug 
screening approaches and can serve as assay readouts for screenings, aimed to identifying 
particular enzyme functions. 
The OLE1-mediated flocculation phenotype can be exploited to assay for e.g. stearoyl-CoA 
desaturase (SCD) activity of enzymes that complement for repressed Ole1p activity, thus 
inhibiting flocculation as well as for drugs or conditions that negatively affect SCD activity, 
thus leading to flocculation. A potential assay construct to screen for enzymatic SCD activity 
was already introduced in Fig. II-5A.  
This assay system (Fig. III-1) consists of a yeast strain background that allows for 
methionine-mediated repression of genomically encoded OLE1 (induces flocculation) and 
a vector (pCM188-OLE1) allowing for orthogonally controlled expression of OLE1 
(orthogonal control of gene expression by using the MET3 promoter and an artificial tetO2-
CYC1 promoter construct is also demonstrated in Fig. IV-3). Plasmid-based expression of 
a functional stearoyl-CoA desaturase prevents flocculation (positive result), whereas 
repressed plasmid-based expression (control) or non-functional enzymes do not prevent 
flocculation (negative result) (Fig. III-1). 
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Fig. III-1: Schematic representation of the assay system. Cells of the PMET3-OLE1 strain harbor 
a plasmid that allows for doxycycline-repressible expression of SCD candidates. Methionine-
repressed (250 µM met) OLE1 expression from the genome induces flocculation, which can be 
prevented by plasmid-based expression of a functional SCD that complements for repressed Ole1p 
expression (positive result). 
3.4.2. Defining protein targets 
The described assay should be suitable to identify putative stearoyl-CoA desaturase activity 
of two uncharacterized proteins of Trypanosoma brucei (T.b) and Trypanosoma cruzi (T.c.) 
that share intermediate identity (T.b.: 39.4% and T.c.: 38.7%) to S. cerevisiae Ole1p and 
feature a homologous protein architecture, therefore identifying these proteins as potential 
SCD candidates (Fig. III-2). Unlike mammalian ∆9 fatty acid desaturases, yeast Ole1p is a 
chimeric protein, consisting of a N-terminal fatty acid desaturase domain that is linked to a 
C-terminal cytochrome b5-like domain [36]. This protein intrinsic cytochrome b5 is reduced 
by a NADH cytochrome b5 reductase and provides reducing equivalents required for the 
desaturation reaction [37]. In contrast, mammalian fatty acid desaturases interact with free 
cytochrome b5 that is anchored in the ER membrane by a hydrophobic 19 residues long C-
terminal region [38]. The desaturase domain of yeast Ole1p harbors two ~50 amino acids 
long hydrophobic sequences, which are divided into one 9 residues long cluster of charged, 
helix-breaking amino acids and two (20 – 23 amino acid) hydrophobic clusters that might 
span the ER membrane and anchor the protein within the bilayer as well as positioning the 
active site of the desaturase domain on the cytosolic surface of the ER [39]. Furthermore, 
the protein contains three histidine clusters (HX4H and HX2HH) that are highly conserved 
among fatty acid desaturases as they coordinate elemental iron and are therefore essential 
for the catalytic activity of the enzymes [40]. Putative SCDs from T. brucei and T. cruzi share 
all described features of S.c.Ole1p (Fig. III-2), rendering these promising SCD candidates 
to exhibit enzymatic function when expressed in yeast. 
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Fig. III-2: Multiple protein sequence alignment of stearoyl-CoA desaturases from yeasts and 
from trypanosomes. Sequences from verified stearoyl-CoA desaturases (SCDs) from the yeast 
S. cerevisiae and K. lactis, as well as putative SCDs from T. brucei and T. cruzi were aligned. 
Consensus symbols denote the degree of conservation observed in each column: (*) residues in the 
column are identical in all sequences; (:) conserved substitutions with residues having highly similar 
properties; (.) semi-conserved substitutions with residues having weakly similar properties. Yellow 
sequence parts of S.c.Ole1p mark predicted alpha-helical transmembrane domains. Conserved 
histidine clusters (HX4H; HX2HH) required to coordinate catalytic iron ions are shown in red. A 
conserved NX3H cluster that is required to coordinate a water molecule is shown in green. Conserved 
amino acids of the cytochrome b5 domain corresponding to a heme binding pocket are highlighted 
in blue. 
Furthermore, both enzymes meet criteria that propose them as useful targets for anti-
parasitic drugs [11]: (i) stearoyl-CoA desaturases were found to be essential enzymes for 
the parasites T. brucei and T. cruzi as assessed by gene knock-down experiments [30] and 
chemical evaluation [4]. The latter was performed by the treatment of T. cruzi infected mice 
with the thiourea drug isoxyl (thiocarlide; 4,4’-diisoamyloxydi-phenylthiourea) which is 
known to be an effective anti-tuberculosis drug and was identified as an inhibitor of the ∆9-
stearoyl desaturase of Mycobacterium tuberculosis [29]. (ii) Moreover, the putative T.c.SCD 
S. cerevisiae     MPTSGTTIELIDDQFPKDDSASSGIVDEVDLTEANILATGLNKKAPRIVNGFGSLMGSKEM 
K. lactis         -------------------------MEQVDLVNANVLAAGANKKSVRVVNGLGSLMGSKQM 
T. brucei         ------------------------------------------------------------- 
T. cruzi          ------------------------------------------------------------- 
                                                                                
 
VSVEFDKKGNEKKSNLDRLLEKDNQEKEEAKTKIHISEQPWTLNNWHQHLNWLNMVLVCGMPMIGWYFALSGKVPLHLN 
ADVDFEN-----DSNMDYLLEQDKKEKEKYKNKRHISELPWTLNNWHLHLNWLNLILVVAIPLYGVYMALSGRVPLRHE 
---------------MSEAMESK-VCDAPAVKKTEYDIPQWSKGNY--EINWVAVAVLALPPLM-GIGALMAGVPLQTN 
---------------MTSLNKSETQNISAAEEKVPSNLPQWTKGNY--EINWVAVAVLALPPTM-VFAAILAGIPLLPK 
xxxxxxxxxxxxxxx:    :..         *   .   *: .*:  .:**: : ::xxx*      *: . :**  : 
 
VFLFSVFYYAV-GGVSITAGYHRLWSHRSYSAHWPLRLFYAIFGCASVEGSAKWWGHSHRIHHRYTDTLRDPYDARRGL 
ILIFSMIYYCI-GGISITGGYHRLWAHRAYSAHWPLRLFFAVFGAASVEGSIKWWSHSHRIHHRYTDTVRDPYDARRGL 
TLIVGVLFYIFNGMIGITVGYHRLFSHRSFTAHPILQWICAFAGAGAFEGSAKWWCRNHRIHHRYVDTFKDPYDATRGF 
TFAVAAFFYVFNGMIGITLGYHRLFSHRSFVAHPILQWICVFAGAGAFEGSAKWWGRNHRIHHRYVDTPKDPYDATRGF 
 : .. ::* . * :.** *****::**:: **  *: :x.. *..:.*** *** :.*******.** :***** **: 
 
WYSHMGWMLLKPNPKYKARADITDMTDDWTIRFQHRHYILLMLLTAFVIPTLICGYFFNDYMGGLIYAGFIRVFVIQQA 
WYSHMGWMLLQPNPKHRARADIADLTDDWIVRWQHRNYIPLMLFSAFILPALFCHYMWNDFWGGLIYGGVLRVCAIQQA 
FFSHIGWMIMKQNYAIPARVDVSDFKYNNIIQFQHRHFFKMAIASGIILPTLVCGLGWGDWLGGYFYAAILKIVFVHHC 
FFSHMGWMVMKQNYGLLGKVDVSDFKYNIIIQFQHRYFFRIAMLSGIILPTLICGLGWGDWLGGYFYAGLAKVVFVHHC 
::**:***::: *    .:.*::*:. :  :::*** :: : : :.:::*:*.*   :.*: ** :*... ::  :::. 
 
TFCINSLAHY---IGTQPFDDRRTPRDNWITAIVTFGEGYHNFHHEFPTDYRNAIKWYQYDPTKVIIYLTSLVGLAYDL 
TFCINSLAHY---LGDQPFDDRRTPRDNWITALVTFGEGYHNFHHEFPTDYRNAIKWYQYDPTKVLIYLTSLFGLSYDL 
TFFINSLAHTDLFGAVQTYSDRHTPHDSVVCALLTFGEGYHNFHHEFSQDYRNGIKWYHYDPTKWVIRLCEFVGLASRL 
TFFINSLAHTSFFGAVQNYSDRNTSHDSMVCALLTFGEGYHNFHHEFAQDYRNGIKWYHFDPTKWTIRLCEWLRMASHL 
**x******     . * :.**.* :*. : *::*************  ****.****::****  * * . . ::  * 
 
KKFSQNAIEEALIQQEQKKINKKKAKI-----NWGPVLTDLPMWDKQTFLAKSKENKGLVIISGIVHDV---------- 
KKFSQNAIQQGLVQQQQKKLDRTRSKL-----NWGSPLSKLPVWDKDEFMEKLKSNNGLVVISGIVHDV---------- 
VRTPNDIIKLNVNKLKYKRLLKQAAILEREMDECEPAETKMYTWEDIHS--LVEKGRKLIVVSNRVIDLDKPLNTGTSY 
MRTPNEVIERNVKNLQYKGVRRQMELLEKRLGELELPTTVEYTWEDVAK--YVQQGQKLIVIGDNVIDLEKSVPTGSGY 
 :  :: *:  : : : * : :    :     :     :xxxx*:.       :... *:::.. * *:           
 
------SGYISEHPGGETLIKTALGKDATKAFNGGVYLHSNAAQNVLADMRVAVIKESKNSAIRMASKRGEIYETGKFF 
------SGYITEHPGGETLIQASLGKDATKEFGSGMHKHSNAAHNILATMRIAVVKDNVDQAAKFAARRGEVYEKK--- 
THDNETFQWYEVHPGGRQVLDLYIGKDATEAFQGGIYKHSAGAESLLHHLQVGYLNE---------------------- 
THSNEKIVWYEAHPGGKKMLDIYVGKDATEAFQGGIYKHSLGAESLIPHLRVAKLKRK--------------------- 
        :   ****. ::.  :*****: * .*:: ** .*..::  :::. :: 
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was suggested by the TDR targets database (http://tdrtargets.org) as potential drug target 
against major tropical disease pathogens. (iii) The protein targets have homologues in 
human, sharing low similarity (T.b.: 29.6% and T.c.: 27.6%) and feature a significantly 
different architecture especially regarding the missing cytochrome b5 domain. (iv) The 
heterologously expressed proteins are essential for the used expression strain (BY472; 
PMET3-OLE1 grown in 5 mM met) or cause a prominent (flocculation) phenotype. 
3.4.3. Functional SCD expression 
A series of pCM188-based plasmids containing the stearoyl-CoA desaturase (SCD) ORFs 
of (i) S. cerevisiae, S.c.OLE1; (ii) of the closely related yeast Kluyveromyces lactis, K.l.OLE1 
or the ORFs of the putative SCDs from (iii) T. brucei, T.b.SCD or (iv) T. cruzi, T.c.SCD were 
constructed. The plasmid contains the constitutive tetO2-PCYC1 promoter driving the SCD 
expression, which can be repressed by the addition of e.g. the tetracycline analogue 
doxycycline. The yeast strain BY4742-PMET3-OLE1 having its endogenous OLE1 under 
control of the methionine repressible MET3 promoter was transformed with these plasmids 
and resulting strains were used for initial growth assays, testing for functional 
complementation of repressed genomic S.c.OLE1. For that, serial dilutions of the respective 
strains were dropped on methionine-containing (5 mM) and methionine-free agar either 
supplemented with doxycycline (40 µg·mL-1) or free of doxycycline. All strains grew 
unimpaired on methionine-free (-met; -dox) medium as genomic OLE1 was fully expressed 
and addition of doxycycline (-met; +dox) did also not affect growth. In contrast, growth was 
almost fully repressed in methionine and doxycycline containing medium (+met; +dox) since 
both, plasmid-based SCD expression as well as genomic OLE1 expression was fully 
repressed. However, growth was restored in the absence of doxycycline (+met; -dox), thus 
verifying that the putative SCDs from T. brucei and T. cruzi possess the predicted enzymatic 
activity and can complement for the loss of OLE1 function (Fig. III-3). T.c.SCD expression 
was found to rescue growth more effectively, as compared to T.b.SCD expression which 
might suggest slightly higher stearoyl-CoA activity of T.c.SCD when expressed in yeast. 
This conclusion was also consistent with GC-MS control measurements of total fatty acid 
unsaturation (Fig. III-S2). Growth of liquid cultures was similarly rescued upon heterologous 
expression of both SCD from T. brucei and T. cruzi (Fig. III-S1). The SCD from K. lactis 
complemented reduced OLE1 activity very effectively as one could predict from the high 
identity (70.4%) of both primary protein structures. K.l.Ole1p was therefore considered as 
the heterologous positive control since proteins from K. lactis are known to complement 
well for S. cerevisiae endogenous proteins and are therefore often used as selection 
markers, e.g. K.l.URA3 [41]. 
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To test for the development of the flocculation phenotype upon heterologous expression of 
SCDs, growth assays in 1 mL liquid cultures were performed. Previous experiments 
revealed a reliable development of flocculation of strain SII-1 in 250 µM external methionine 
(Fig. II-3). Respective strains harboring SCD plasmids as well as empty vector control (e.v.) 
were grown in the presence or absence of methionine and doxycycline in all 4 possible 
permutations as illustrated in Fig. III-1. The predicted characteristic flocculation profile at 
the indicated conditions clearly illustrates enzymatic SCD activity. SCD expression from 
plasmids (-dox) resulted in suppression of the flocculation behavior when cells were grown 
in the presence of methionine. Repression of plasmid-based expression traced restoration 
of flocculation unambiguously to enzymatic SCD activity. In the negative control with an 
empty vector, flocculation was not suppressed in the presence of methionine, independent 
external doxycycline. Thus, the flocculation-based assay has proven to clearly indicate 
enzymatic SCD activity. 
 
Fig. III-3: Putative stearoyl-CoA desaturases from T. brucei and T. cruzi functionally 
complement for the yeast endogenous Ole1p. (A) Growth assay on agar plates to test for 
functional complementation of repressed genomic S.c.OLE1. The growth phenotype of PMET3-OLE1 
cells is shown via spotting a 10-fold dilution series on methionine containing medium (+met; 5 mM) 
in the presence or absence of doxycycline (+dox; 40 µg·mL-1). The growth defect upon repression 
(+met; +dox) of genomically encoded S.c.OLE1 is rescued by plasmid-based expression (+met; -
dox) of SCDs from K. lactis, T. brucei and T. cruzi as well as by the endogenous enzyme from 
S. cerevisiae (S.c.OLE1, positive control). Growth on methionine free medium (-met) was unimpaired 
as expected and was tested to verify the functionality of the genomically encoded Ole1p. (B) 
Suppression of flocculation upon plasmid-based SCD expression tested in 1 mL liquid cultures. Cells 
strongly flocculated in the presence of methionine (250 µM) when plasmid-based SCD expression 
was repressed (+dox; 40 µg·mL-1). SCD expression (-dox) prevented flocculation and clearly 
demonstrated stearoyl-CoA desaturase activity of heterologously expressed enzymes. The empty 
vector (e.v.) did not prevent flocculation.  
3.4.4. Control experiments to verify SCD activity  
Ole1p is anchored to the ER membrane where it interacts with cytochrome b5 reductases 
and fatty acid CoA substrates deriving from fatty acid synthase reaction to generate CoA-
bound precursors of monounsaturated fatty acids (MUFA). These are further utilized by e.g. 
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ER localized Gat1p, Gat2p and Slc1p to generate diacylglycerols (DAGs) by stepwise 
acylation of glycerol-3-phosphate [42, 43]. DAGs are further converted to 
glycerophospholipids or triacylglycerols. The ER localization of the glycerophospholipid 
biosynthesis machinery emphasizes the requirement of correct ER residency of SCD to 
allow for MUFA delivery in the place of demand. The check whether heterologously 
expressed SCDs from K. lactis and trypanosomes behave like the yeast endogenous SCD 
and are correctly localized to the ER membranes, SCDs were C-terminally tagged with GFP 
and subcellular localization was determined by confocal fluorescence microscopy (Fig. III-
4A). GFP-fused yeast endogenous Ole1p was localized in the cortical ER membranes 
tethered to the plasma membrane as well as in the ER membranes attached to the nuclear 
envelop as visualized by DAPI co-staining of nuclear DNA [44]. GFP-fusions of 
heterologously expressed SCDs exhibited the same subcellular distribution pattern. Thus, 
previously detected SCD activity is supported by the closely interlinked localization-function 
relationship.  
 
Fig. III-4: Foreign SCDs are correctly localized in ER membranes and influence proteolytic 
processing of Spt23p similar to Ole1p. (A) Yeast endogenous SCD, Ole1p, as well as foreign 
SCDs from K. lactis (K.l.), T. brucei (T.b.) and T. cruzi (T.c.) were fused to yEGFP (green) and 
subcellular localization was determined by confocal fluorescence microscopy. Co-straining of DNA 
with DAPI (blue) revealed that foreign SCDs localized to the ER membranes attached to the nuclear 
membrane as well as to the cortical ER membranes tethered to the plasma membrane, also true for 
native S.c.Ole1p. (B) Western Blot analysis to monitor proteolytic processing of Stp23p in 
dependence of heterologous SCD expression. The ratio of acitivated Spt23p (p90) over the full length 
protein (p120) increased upon repression of OLE1 in the empty vector control (e.v.). Spt23p90 
accumulation could be abolished by plasmid-based expression of foreign SCDs from K. lactis, 
T. brucei and T. cruzi.  
3 µm
Ole1p-yEGFP
DAPI
T.b.SCD-yEGFP
DAPI
3 µm
K.l.Ole1p-yEGFP
DAPI
T.b.SCD-yEGFP
DAPI
3 µm
3 µm
e.v. K.l.OLE1S.c.OLE1 T.b.SCDT.c.SCD
+ + + +
- + - +
+ + + +
- + - +
- + - +
- - + +
- p120
- p90
- Act1p
met
dox
A
B
• Chapter III: Heterologous expression of stearoyl-CoA desaturases from trypanosomes 
 81 
Spt23p proteolytic processing upon S.c.OLE1 repression and simultaneous heterologous 
SCD expression was monitored by Western blot analyses to link FLO1 upregulation to 
Spt23p activation triggered by changes in membrane fluidity. In the empty vector control 
(e.v.), a characteristic accumulation of the activated Spt23p fragment (p90) was observed 
upon methionine-mediated S.c.OLE1 repression and this was independent of external 
doxycycline. Accumulation of Spt23p90 was strongly reduced upon plasmid-based 
heterologous SCD expression (+met; -dox) in comparison to the empty vector control at 
equivalent conditions (+met; -dox) as well as to repressed plasmid-based SCD expression 
(+met; +dox) (Fig. III-4B). Thus, enzymatic activity of foreign SCDs from T. brucei, T. cruzi 
but also from K. lactis is able to reduce yeast ER membrane fluidity below the threshold 
level that prevents sufficient Spt23p proteolytic processing to induce flocculation. 
Furthermore, it is shown that foreign SCDs interact with the OLE pathway [45] in an identical 
manner as the native yeast stearoyl-CoA desaturase, Ole1p. GC-MS analyses also 
demonstrated that foreign SCDs effectively reduced the amount of fully saturated fatty acid 
species, although, K. lactis Ole1p and yeast endogenous S.c.Ole1p (Fig. II-S4A) had a 
stronger effect on lipid unsaturation. Expression of trypanosomal SCDs had a major effect 
on C18 fatty acid unsaturation and caused a slight decrease of C16 (~76% to ~63%) and a 
shift towards C18 fatty acid species (Fig. III-S2). 
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3.5. Conclusions 
Yeast has proven to be a suitable host for the heterologous expression of stearoyl-CoA 
desaturases (SCDs) from T. brucei and T. cruzi. These enzymes were previously identified 
as putative SCDs based on sequence homology to enzymes with verified SCD activity. 
Gene knockdown experiments in the donor organism [30] and chemical evaluation [4] 
suggested that both enzymes indeed possess enzymatic SCD activity. The study presented 
here, describes for the first time the heterologous expression of putative T.b.SCD and 
T.c.SCD in budding yeast and clearly verified their stearoyl-CoA activity using different 
approaches (e.g. OLE1 complementation, GC-MS analysis). By using a strain background 
that has its endogenous stearoyl-CoA desaturase gene under control the repressible MET3 
promoter as expression system, it was possible to set up a simple and affordable SCD 
activity screen. Growth or flocculation served as assay read-out that can even be easily 
detected by eye. This assay might be useful for in vivo drug screenings as Trypanosoma 
SCDs have proven to be promising drug targets for the treatment of parasitic infections in 
humans [30]. Growth and flocculation assays were performed in 24-well plates but could be 
easily transferred to 384-well microtiter trays thereby allowing for a higher throughput, 
maybe also in combination with robotic assistance. Moreover, yeast-based assays allow to 
screen for drugs against enzymes of human infecting parasites without necessarily coming 
in contact with the pathogen itself, which would require special laboratory equipment. 
However, the functionality of this assay for successful identification of SCD inhibitors has 
not been confirmed, yet. Yeast cells might be resistant against actually potent SCD 
inhibitors due to their thick cell wall or due to the presence of effective drug efflux pumps in 
their plasma membrane [46]. These factors might decrease the sensibility of the assay to 
an unfavorably low level. However, the assay system offers multiple ways to adjust and 
fine-tune the sensibility of a potential screen. Growth of the platform strain as well as 
development of flocculation is determined by the ratio of OLE1 to heterologous SCD 
expression. Since expression of both genes can be orthogonally controlled, expression of 
Trypanosoma SCDs could be downregulated to an absolute minimum that just supports 
growth. The decreased amount of target protein as well as the fine-tuned critical ratio of 
OLE1 to SCD expression might increase the sensitivity of the screen as it was previously 
demonstrated [11]. Furthermore, yeast is readily accessible to genetic modifications by e.g. 
using the straightforward CRISPR/Cas9 technology (chapter V) thereby easily allowing for 
knocking-out genes that encode for drug efflux pumps or other genes that impair the 
sensitivity of the system. Deletion of PDR5 that encodes for the yeast major ABC multidrug 
transporter [47] was previously shown to increase the sensitivity of a similar drug screen 
[11].  
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3.7. Supporting information 
 
Fig. III-S1: Effect of heterologous SCD expression on growth in liquid media. Growth curves of 
PMET3-OLE1 cells harboring plasmids that encode for indicated SCDs from S. cerevisiae (S.c.), 
K. lactis (K.l.), T. brucei (T.b.) and T. cruzi (T.c.) in the presence (40 µg·mL-1) or absence of 
doxycycline (repressor). Experiments were performed in a repressed PMET3-OLE1 background 
(150 µM met). Heterologous expression of SCDs rescued the growth defect upon repressed 
genomically encoded OLE1. A strain harboring an empty vector served as negative control. 
 
Fig. III-S2: Fatty acid composition of PMET3-OLE1 cells expressing indicated foreign SCDs as 
measured by GC-MS analysis. Chromatograms of GC-MS analysis show an increasing level of 
monounsaturated fatty acid (MUFA) species upon heterologous expression (-dox) of SCDs from 
K. lactis, T. brucei and T. cruzi compared to repressed expression (+dox). GC-MS analyses were 
performed in a repressed PMET3-OLE1 background (250 µM met). Indicated percentage values focus 
on major fatty acid classes (C16 and C18), C14 species are not indicated.   
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Tab. III-S1: Plasmids used in this study. The table summarizes basic characteristics and 
properties of indicated plasmids. 
Plasmid description reference 
pCM188 - [32] 
pKT103 - [33] 
pCM188-OLE1 CEN/ARS; URA3; amp
R; doxycycline 
repressible expression of Ole1p 
This study; 
section 2.3.1 
pCM188-OLE1-yEGFP 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of C-terminally 
yEGFP-tagged Ole1p 
This study 
pCM188-K.l.OLE1 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of  
Kluyveromyces lactis Ole1p 
This study 
pCM188-K.l.OLE1-yEGFP 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of C-terminally 
yEGFP-tagged                   
Kluyveromyces lactis Ole1p 
This study 
pCM188-T.b.SCD 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of    
Trypanosoma brucei SCD 
This study 
pCM188-T.b.SCD-yEGFP 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of C-terminally 
yEGFP-tagged                       
Trypanosoma brucei SCD 
This study 
pCM188-T.c.SCD 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of       
Trypanosoma cruzi Ole1p 
This study 
pCM188-T.c.SCD-yEGFP 
CEN/ARS; URA3; ampR; doxycycline 
repressible expression of C-terminally 
yEGFP-tagged                       
Trypanosoma cruzi Ole1p 
This study 
pGREG523-PSPT23-mycSPT23 
CEN/ARS; HIS3; kanMX; ampR; 
expression of an N-terminally 13xmyc-
tagged Spt23p variant (mycSpt23p) from 
native SPT23 promoter 
This study;  
section 2.3.1 
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Tab. III-S2: Primers used in this study. Underlined sequence parts represent homology regions of 
overhang primers used recombination-based cloning approaches. 
Primer sequence (5’ → 3’) amplicon 
P1 (fw) CACAAATACACACACTAAATTACCGGATCAATTCGGGGGATCCATGCCAACTTCTGGAACTACTATTGAATTG OLE1 
P2 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTAAAAGAACTTACCAGTTTCGTAGATTTCACC OLE1 
P3 (fw) CACAAATACACACACTAAATTACCGGATCAATTCGGGGGATCCATGGAGCAAGTGGATTTAGTGA K.l.OLE1 
P4 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTCTACTTCTTTTCGTAAACTTCACCTC K.l.OLE1 
P5 (fw) CACAAATACACACACTAAATTACCGGATCAATTCGGGGGATCCATGAGCGAAGCAATGGAAAG T.b.SCD 
P6 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTCACTCATTCAAGTAGCCCAC T.b.SCD 
P7 (fw) CACAAATACACACACTAAATTACCGGATCAATTCGGGGGATCCATGACGAGTTTAAACAAAAGCGAG T.c.SCD 
P8 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTCACTTACGCTTCAATTTGGC T.c.SCD 
P9 (fw) TAGTAAGAGAGGTGAAATCTACGAAACTGGTAAGTTCTTTATGTCTAAAGGTGAAGAATTATTCACT 
yEGFP 
(OLE1) 
P10 (fw) CTAAGTTCGCCGCAAGAAGAGGTGAAGTTTACGAAAAGAAGATGTCTAAAGGTGAAGAATTATTCACT 
yEGFP 
(K.l.OLE1) 
P11 (fw) GAGCCTTCTCCATCACCTACAAGTGGGCTACTTGAATGAGATGTCTAAAGGTGAAGAATTATTCACT 
yEGFP 
(T.b.SCD) 
P12 (fw) CCTGATTCCTCACCTGCGTGTCGCCAAATTGAAGCGTAAGATGTCTAAAGGTGAAGAATTATTCACT 
yEGFP 
(T.c.SCD) 
P13 (rv) TTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTATTTGTACAATTCATCCATACCATGG yEGFP 
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4. Chapter IV: Ergosterol is essential for protein sorting, endocytosis and 
protein compartmentation within the plasma membrane of yeast cells 
4.1. Abstract 
Ergosterol and sphingolipids form spatially discrete membrane patches with liquid-ordered 
phase behavior within the plasma membrane of yeast that feature a special protein 
equipment. These membrane areas referred to as lipid rafts are suggested to be implicated 
in lateral compartmentation of the plasma membrane as well as in fundamental biological 
processes such as endo- and exocytosis. Ergosterol was furthermore shown to be essential 
for proper protein sorting and intracellular protein delivery. Studies on the physiological roles 
of ergosterol for yeast and on the physiological effects of ergosterol depletion used viable 
yeast knock-out strains that are defective in late steps of the ergosterol biosynthetic 
pathway thereby accumulating different sterol species without necessarily altering the cell’s 
total sterol content. The study presented here addresses ERG9, an essential gene involved 
in the ergosterol biosynthetic pathway and uses a metabolic engineering approach to 
achieve control over the total sterol biosynthetic activity of the cell. Cells that allow for 
manipulating the native sterol homeostasis were employed to unveil physiological effects of 
ergosterol and total sterol depletion on fundamental membrane associated processes such 
as protein sorting and endo- and exocytosis as well as on the cell’s general viability. 
Furthermore, it is shown that ergosterol and sterols in general are essential for native lateral 
compartmentation of the plasma membrane of yeast. 
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4.2. Introduction 
Sterols are essential membrane components of organisms from various domains and 
kingdoms. Although the chemical structures of the respectively prevalent sterol classes 
differ from each other in detail, all of them share identical physicochemical properties being 
responsible for a conserved function of sterols for the organization of biological membranes. 
The major sterol of higher eukaryotes and vertebrates is cholesterol, while ergosterol is 
dominant in fungi. Plants feature a diverse and complex set of sterols with stigmasterol and 
sitosterol as major components of plant sterol profiles (reviewed in [1]). Membranes of some 
extremophilic bacteria feature a sterol-like class of membrane molecules, hopanoids, 
suggested to be required for stress tolerance under extreme conditions [2]. Other bacterial 
representatives such as proteobacteria and mycoplasma species even contain eukaryotic 
sterols instead of hopanoids, although they are not synthesized by these organisms 
themselves but taken up from the environment [3]. In contrast to that, archaea are not 
known to synthesize sterols, however, these organisms have evolved other strategies and 
use different membrane molecules such as glycerol-ether lipids to ensure the stability and 
robustness of their plasma membrane [4]. 
Plasma membranes feature the highest fraction of sterols and sphingolipids (besides 
glycerophospholipids) from all eukaryotic membranes, which is about 30 to 40% for sterols 
and 10 to 20% for sphingolipids [5]. Because of their chemical structures, sterols and fully 
saturated sphingolipids interact in a special manner, thereby clustering into spatially 
discrete membrane patches with liquid-ordered phase behavior instead of homogenously 
mixing with glycerophospholipids which, in turn, form liquid-crystalline (liquid-disordered) 
membrane areas [6]. According to the umbrella model [7], sterols are shielded by head-
groups of sphingolipids from the aqueous phase on both side of the bilayer, thereby forming 
tightly packed and stable sterol-lipid complexes [8]. The typical yeast sterol, ergosterol, was 
shown to form the most stable microdomains of all sterol derivatives tested [9].  
The first notion of lipid-determined plasma membrane compartmentation is related of the 
observation that mammalian plasma membrane proteins show different abilities to 
accumulate in or associate with detergent-resistant membrane (DRM) areas [10]. 
Subsequently it was shown that DRMs of the yeast plasma membrane feature a high 
content of ergosterol and sphingolipids [11, 12]. This observation joined the concepts of 
liquid-ordered membrane areas and DRM-mediated lateral plasma membrane 
compartmentation and gave rise to the concept of protein-lipid domains forming lipid rafts 
in the plasma membrane [13] although these termini should not be seen as being fully 
equivalent [14]. Besides the partitioning effect of sterols in eukaryotic membranes, it was 
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shown that lipid rafts are implicated in protein sorting [12], protein secretion, endocytosis 
[15] and establishing cell polarity [16], although little is known about how ergosterol and 
sphingolipids are involved in detail [17].  
The biosynthesis of sterols takes place in the ER. From there, sterols are subsequently 
transported to the plasma membrane using the conventional secretory pathway [18] but is 
not restricted to this as yeast sec mutants that are defective in exocytosis also feature a 
natural ergosterol content in the plasma membrane [19]. Sterols are also internalized by 
endocytosis and are therefore present in endocytic vesicles but are subsequently recycled 
back to the plasma membrane [20]. Assembly of lipid rafts and DRMs in yeast as well as 
corresponding protein-lipid interactions seems to begin already in the ER and progresses 
along the secretory pathway [11, 21] whereas in mammalian cells lipid raft formation seems 
to take place in the Golgi [10, 22]. Sterols and fungal ergosterol are chemical derivatives of 
isoprene which is synthesized from acetyl-CoA [23]. The conversion of acetyl-CoA to 
ergosterol represents a multistep biosynthetic pathway that shares intermediates with 
overlapping pathways, finally leading to ubiquinone, heme A, dolichols and others [24]. The 
first step of the, from then on, linear sterol biosynthetic pathway is carried out by Erg9p, the 
squalene synthase, that catalyzes the condensation of two farnesyl pyrophosphate 
molecules to form squalene [25] (Fig. IV-1).  
 
Fig. IV-1: Reaction scheme of Erg9p catalyzed condensation of farnesyl pyrophosphate 
yielding squalene. Erg9p joins two farnesyl pyrophosphate moieties to form squalene in an NADPH-
requiring reaction. The squalene synthase regulates the flux of intermediates through the FPP branch 
point towards the linear biosynthetic pathway thus regulating the total sterol biosynthetic activity of 
the cell. 
Erg9p is considered a gate keeper enzyme as it determines the flux of intermediates 
through the FPP branch point towards the ergosterol biosynthetic pathway. Thus, by 
regulating the expression of ERG9 it is possible to achieve control over the total sterol 
NADPH+H+ NADP+
Erg9p
2 PPi
O-(PO3)2
3-
OH
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conversion
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squalenefarnesyl pyrophosphate
2x
• Chapter IV: Ergosterol is essential for protein sorting, endocytosis and protein compartmentation within the 
plasma membrane of yeast cells 
 93 
biosynthetic activity of the cell [24]. The study presented here uses this approach to 
genetically control the total ergosterol/ sterol content of yeast cells thus generating a cellular 
model to unveil physiological roles of ergosterol for yeast and to explore physiological 
effects of ergosterol/ sterol depletion. It is shown that depletion of ergosterol and sterols in 
total affect fundamental membrane associated processes suggested to be closely affiliated 
with biological functions such as endo- and exocytosis, intracellular protein sorting and 
trafficking as well as plasma membrane compartmentation. 
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4.3. Materials and Methods 
4.3.1. Yeast strains 
Tab. IV-1: Yeast strains used in this study. The table lists all strains with corresponding genotypes. 
Plasmids harbored by the respective strains are named as indicated in Tab. IV-S1. * The doxycycline 
repressible promoter construct contains a CYC1 minimal promoter mediating no/ strongly reduced 
transcription in the absence of a functional tetracycline transactivator (tTA). 
strain genotype reference 
BY4742 MATa; his3D1; leu2D0; lys2D0; ura3D0 [26] 
BMA64-1A MATa; his3-11,15; leu2-3,112; ura3-1; trp1D2; 
ade2-1; can1-100 [27] 
SIV-1 BY4742; erg9::tetO2-PCYC1-ERG9 * This study 
SIV-2 SIV-1; ole1::PMET3-OLE1 This study 
SIV-3 SIV-1; pGREG576-UPC2 This study 
SIV-4 SIV-1; pGREG600-UPC2 This study 
SIV-5 BY4742; trp1::loxP-URA3-loxP (∆trp1) This study 
SIV-6 SIV-1; trp1::loxP-URA3-loxP (∆trp1) This study 
SIV-7 SIV-5; pGREG503 This study 
SIV-8 SIV-6; pGREG503 This study 
SIV-9 SIV-5; pGREG503-TAT2 This study 
SIV-10 SIV-6; pGREG503-TAT2 This study 
SIV-11 BY4742; ole1::PMET3-OLE1; pCM188-OLE1 This study 
SIV-12 SIV-1; pGREG600-TAT2 This study 
SIV-13 SIV-1; pGREG600-PTAT2-TAT2 This study 
SIV-14 BY4742; pGREG600-CAN1 This study 
SIV-15 SIV-14; pGREG505-PIL1-RedStar This study 
SIV-16 BY4742; can1::CAN1-yEGFP This study 
SIV-17 SIV-1; can1::CAN1-yEGFP This study 
SIV-18 SIV-16; erg6::loxP-LEU2-loxP (∆erg6) This study 
SIV-19 BY4742; pma1::PMA1-yEGFP This study 
SIV-20 SIV-1; pma1::PMA1-yEGFP This study 
SIV-21 SIV-19; erg6::loxP-LEU2-loxP (∆erg6) This study 
SIV-22 BY4742; pGREG600-TOK1 This study 
4.3.2. Yeast transformation and strain construction 
Genetically modified S. cerevisiae strains generated in this study are derived from BY4742 
(MATa; his3D1; leu2D0; lys2D0; ura3D0) obtained from EUROSCARF (Frankfurt, 
Germany). BY4742 cells were routinely cultured in YPD media (2% glucose; 2% peptone; 
1% yeast extract). BY4742 derived strains harboring selectable markers (URA3; LEU2; 
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HIS3) were grown in appropriate synthetic defined (SD) drop-out media (2% glucose; yeast 
nitrogen base (YNB); drop-out amino acid supplement). KanMX cassette harboring cells 
were selected at 200 mg/L G418. Cells were propagated at 30°C. All strains are listed in 
Tab. IV-1. 
Transformation of S. cerevisiae with previously generated plasmids was routinely 
performed by using the Frozen-EZ Yeast Transformation II kit (Zymo Research) according 
to manufacturer’s instructions. 
S. cerevisiae transformation for genomic integration of integration cassettes (promoter 
replacement cassette; knockout cassettes; GFP tag) via homologous recombination and 
plasmid uptake was routinely performed by the standard lithium acetate method [28]. For 
genomic integrations of PCR derived DNA fragments, PCR products from a reaction sample 
(400 µL) were concentrated by ethanol precipitation [29], dissolved in 20 µL sterile H2O and 
used for transformation. Replacement of the endogenous ERG9 promoter was performed 
by genomic integration of the doxycycline repressible promoter construct (kanMX-tTA-
tetO2-PCYC1), which was amplified by PCR from plasmid pCM224 (OneTaq DNA 
polymerase, NEB) with primers P1 and P2. Replacement of the endogenous OLE1 
promoter was previously described (section 2.3.2). TRP1 was knocked-out by replacing 
part of the ORF with the loxP-URA3-loxP marker cassette from plasmid pUG72 [30]. ERG6 
was knocked out by replacing the entire ORF with the loxP-LEU2-loxP cassette from 
plasmid pUG73 [30]. Knockout cassettes (KOCs) were routinely amplified by PCR (OneTaq 
DNA polymerase) using primers P3 & P4 (TRP1 KOC); P5 & P6 (ERG6 KOC). For GFP-
tagging of Can1p and Pma1p, the yEGFP-TADH1 cassette of plasmid pKT209 [31] was 
amplified by PCR (OneTaq DNA polymerase) using overhang primers (primers P7 & P8 for 
CAN1; P9 & P10 for PMA1) and was genomically integrated at the 3’-terminus of the CAN1 
ORF or PMA1 ORF, respectively, with simultaneous removal of the endogenous stop 
codons in order to allow for the expression of the fusion protein. Marker-free genomic 
integration of the yEGFP-TADH1 cassette was facilitated by the use of an all-in-one plasmid-
based CRISPR/Cas9 system using manually designed 20 bp protospacer sequences 
(TGGCGTGGAAATGTGATCAA for the CAN1 locus; TGATTAAATGCTACTTCAAC for the 
PMA1 locus). Successful genomic integrations were verified by colony PCR using a 
respective pair of primers suitable to amplify a DNA fragment containing the artificial 
integration border resulting from the homologous recombination event. Correct integration 
of the yEGFP encoding sequence into the CAN1 or PMA1 locus could also be monitored 
by fluorescence microscopy. 
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4.3.3. Plasmid construction 
Integration of yeast endogenous genes (UPC2; TAT2; CAN1; TOK1) in plasmid pGREG600 
[32] was done by recombination-based cloning. For that, plasmid pGREG600 was digested 
with SalI and the ORFs were amplified by PCR (Q5 DNA polymerase, NEB) using S228C 
genomic DNA as template. Flanking of PCR products with sequences homologous to the 
restricted plasmid backbone was achieved by using corresponding overhang primers 
(primers P11 & P12 for UPC2; P13 & P14 for CAN1; P15 & P16 for TAT2; P17 & P18 for 
TOK1; P19 & P20 for PIL1). Plasmid pGREG600 contains a GFP sequence downstream of 
the cloning site so that resulting plasmids encode for C-terminally GFP fused proteins, 
respectively. For generating plasmid pGREG505-PIL1-RedStar, the RedStar encoding 
sequence amplified (primer P21 & P22) from plasmid pYM38 [33] was inserted beforehand 
into XhoI-cleaved plasmid pGREG505 (LEU2 marker) by recombination-based cloning 
yielding a plasmid that can be analogously treated like pGREG600 for subsequent PIL1 
ORF integration. Integration of the UPC2 ORF into plasmid pGREG576 was done in an 
analogous manner using primers P11 and P23. Plasmid pGREG576 [32] contains a GFP 
sequence upstream of the cloning site so that the generated plasmid pGREG576-UPC2 
mediates the expression of an N-terminal GFP-Upc2p fusion protein. The TAT2 ORF 
(primers P24 & P25) was integrated into plasmid pGREG503 as previously described for 
drag-and-drop-cloning [32] with plasmids of the pGREG series. Plasmid pGREG600-PTAT2-
TAT2 for expressing a C-terminally GFP tagged Tat2p variant from the native TAT2 
promoter (PTAT2) was generated by replacing the GAL1 promoter (PGAL1) from plasmid 
pGREG600-TAT2. The yeast endogenous TAT2 promoter (PTAT2) was amplified from 
S228C genomic DNA by using appropriate overhang primers P26 and P27. PGAL1 from 
plasmid pGREG600-TAT2 was cut out using the restriction enzymes AscI and NotI and 
replaced by PCR amplified PTAT2 via in vivo recombination cloning. 
The construction of plasmid pCM188-OLE1 was previously described (section 2.3.3). 
Co-transformation of BY4742 and generated derivatives with linearized plasmid backbone 
and PCR product for recombination-based cloning in vivo were routinely carried out by using 
the Frozen-EZ Yeast Transformation II kit (Zymo Research) according to manufacturer’s 
instructions. PCR conditions were chosen according to manufacturer’s instructions. 
Plasmids and primers used in this study are listed in Tab. IV-S1 and Tab. IV-S2. 
4.3.4. Ergosterol analysis 
Total ergosterol was routinely extracted from yeast cells as described by Rodriguez et al. 
[34]. The amount of ergosterol (as µg·(mg cells, dry weight)-1) was determined by GC-MS 
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analysis using a defined amount of cholesterol (10 µg·mL-1) as internal sample standard. 
The measured amount of ergosterol was normalized to the detected cholesterol content 
presuming that the extraction efficiencies for both sterol species is highly similar.  1 µL of 
the extracts was analyzed on an Agilent 5973 – HP6890 GC-MS using a 30 m DB-5ms 
capillary column. The GC oven temperature was held at 80°C for 1 min, followed by a ramp 
of 20°C·min-1 to 280°C with a subsequent 20 min hold time at 280°C. A second temperature 
ramp of 20°C·min-1 to 300°C was applied with a following final hold time for 2 min [24]. The 
MS was operated in selected ion monitoring (SIM) mode using ions of m/z 386 and 396 
which represent the molecular ions of cholesterol and ergosterol, respectively. Abundance 
of molecular ions with m/z 386 and 396 were used for relative quantification of 
corresponding sterol species. 
4.3.5. Preparation of yeast spheroplasts and growth experiments 
Spheroplasts were generally prepared as described by Bertl et al. [35, 36]. For that, yeast 
cells were grown overnight in appropriate synthetic defined media or YPD (where 
applicable) at 30°C on a rotary shaker at 200 rpm. Cells from overnight cultures were 
harvested by centrifugation and resuspended in 3 mL incubation buffer (50 mM KH2PO4; 
40 mM beta-mercaptoethanol; pH7.2 with KOH) and incubated for 15 min at room 
temperature under continuous shaking (200 rpm). 3 mL of the spheroplasting buffer (50 mM 
KH2PO4; 2.4 M sorbitol; 40 mM beta-mercaptoethanol; 150 mg BSA; 1 mg zymolyase 20-T 
(nacalai tesque); pH7.2 with KOH) were added to the previously prepared cell suspension, 
gently vortexed and incubated at room temperature for at least 45 min. Spheroplasts were 
harvested by gentle centrifugation (500 x g), resuspended in 10 mL stabilizing buffer 
(230 mM KCl, 10 mM CaCl2; 5 mM MgCl2; 5 mM TRIS/MES at pH7.2) and supplemented 
with 1% glucose. 
In order to examine the growth of tetO2-PCYC-ERG9 spheroplasts, freshly isolated 
spheroplasts from cells grown in the presence (40 µg·mL-1) or absence of doxycycline were 
incubated for 5 days at 30°C in stabilizing buffer supplemented with 1% glucose as well as 
with doxycycline (40 µg·mL-1) when corresponding to respective pre-culture conditions. 
Microscopy images of the spheroplast cultures were taken every 24 h using a Canon 
EOS450D digital camera (Canon Inc., Tokyo, Japan) connected to a Zeiss IM100 inverted 
microscope (Carl Zeiss Microscopy, Göttingen, Germany). The diameter (d) of 100 
representative spheroplasts was determined using the line selection and analyzing tool of 
the ImageJ software (written by Wayne Rasband, NIH, Bethesda, Maryland) and the 
spheroplast surface area was calculated by using the formula for spherical geometrical 
objects (A = π·d2). 
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4.3.6. Microscopy 
Cells expressing N-terminal (GFP-Upc2p), C-terminal GFP-fusion proteins (Upc2p-GFP; 
Tat2p-GFP; Can1p-GFP; Pma1p-GFP; Tok1p-GFP) or Pil1p-RedStar were analyzed using 
a microscopy setup consisting of a Leica TCS SP5 II spectral confocal laser scanning 
microscope (Leica Microsystems, CLSM) equipped with a 100-x oil objective (HCX PL APO 
CS 100x/1.44). GFP was excited at 488 nm and emission was detected between 510 – 
585 nm. RedStar was excited at 561 nm and emission was detected between 580 – 700 nm. 
Prior to microscopy analysis, cells were grown to exponential phase (OD600 = 1.0) in 
appropriate synthetic defined drop out medium. Expression from GAL1 promoter was 
guaranteed in glucose-free galactose containing medium (2%). For DNA staining with DAPI, 
1 mL of a cell culture grown to exponential phase was mixed with 2.5 µL of a DAPI (Sigma 
Aldrich) stock solution (1 mg·mL-1) to a final concentration of 2.5 µg·mL-1. Afterwards, cells 
were incubated for 30 min at 30°C, harvested by centrifugation, washed 2 times with 1XPBS 
und used for microscopy analysis. DAPI was excited at 405 nm and emission was detected 
between 435 – 485 nm. To evaluate the pattern of protein distribution within the plasma 
membrane, cells were scanned along the z-axis (z-stack) by collecting sets of multiple 
optical sections ~300 nm apart from each other and single images were merged into a 2D 
stack for maximum intensity projections (MIP) with the Leica “LAS AF Lite” software. Single 
images of the z-stacks showing the tangential confocal section (TCS) as well as the 
equatorial confocal section (ECS) of the cell were also used to evaluate the protein 
distribution within the plasma membrane (Fig. IV-11). 
4.3.7. Growth assays on agar medium 
Growth assays were performed as previously described (section 3.3.6). 
These growth assays were applied to evaluate physiological effects of doxycycline-
mediated repression of ERG9 expression and to verify proper biological function of GFP-
tagged Can1p by uptake of the toxic L-arginine analogue L-canavanine. Defined volumes 
of sterile filtered doxycycline (4 mg·mL-1 in H2O) or L-canavanine (4 mg·mL-1 in H2O) stock 
solutions were added to already autoclaved agar (~50°C) to adjust final concentrations as 
respectively indicated. 
4.3.8. Electrophysiological measurements of plasma membrane capacitance 
Electrophysiological measurements were performed with freshly isolated spheroplasts of 
BY4742; tetO2-PCYC1-ERG9 cells previously grown in the presence (40 µg·mL-1) or absence 
of doxycycline to feature an altered membrane lipid composition. Endo- and exocytosis in 
these yeast spheroplasts were analyzed by patch-clamp techniques as described 
elsewhere [37].  
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4.4. Results and Discussion 
4.4.1. Construction and characterization of a strain featuring a controllable 
ergosterol content 
To gain experimental control of the transcription level of ERG9 which has proven to be an 
essential ergosterol synthesis gene in yeast [24, 38], a strategy that includes the exchange 
of the native ERG9 promoter (PERG9) was followed. For that, a promoter system mediating 
tetracycline-controlled transcriptional activation, that was adopted for yeast [39, 40], was 
tested. The tetracycline responsive promoter system used in this study represents a tet-off 
system, meaning that the presence of the effector molecule tetracycline or synthetic 
derivatives such as doxycycline prevent transcription (turn-off). In the absence of the 
effector, transcription is mediated by the transcription activating effect of the artificial tTA 
(tetracycline transactivator). tTA is an artificial fusion protein that binds the TRE (tetracycline 
response element) upstream of the CYC1 minimal (*) promoter (PCYC1*; includes the TATA 
region) that has lost its native transcription mediating function and just provides essential 
sequences required for binding of the RNA polymerase II containing transcription machinery 
[41] and determines the starting point of transcription. The tTA fusion protein comprises the 
E. coli TetR (Tet repressor) and VP16, a transcription activator in eukaryotes that origins 
from the herpes simplex virus. The TetR domain of tTA recognizes and binds 19 bp 
sequences (2 repeats in the tetO2 construct) adopted from the E. coli endogenous 
tetracycline operon (tetO) within the TRE, thereby fixing the VP16 domain in close proximity 
of PCYC1*. VP16 recruits the yeast endogenous transcription machinery and mediates 
transcription. Doxycycline in the medium is taken up by cells and gets intracellularly bound 
by TetR which subsequently undergoes a conformational change, thus preventing proper 
binding to the TRE. This way, the transcription activating effect of VP16 to ERG9 is omitted 
[42] and ERG9 expression is strongly decreased. Potential remaining ERG9 expression 
may arise from residual basal transcription activing properties of PCYC1* or leakiness of 
repression. 
The promoter substitution strategy should result in a strain that features a wide range of its 
ergosterol as well as of its total sterol content. A complete knockout of ERG9 which worked 
for other genes (e.g. ERG2 [43]; ERG6 [44] and ERG24 [45]) whose gene products are 
involved in later steps of the ergosterol biosynthetic pathway could not be exploited to 
monitor effects of an altered total sterol content as ERG9 is an essential gene and 
conditional mutation leads to strict ergosterol auxotrophy.   
Substitution of the endogenous ERG9 promoter (PERG9) by the artificial doxycycline 
repressible promoter system (Fig. IV-2A) resulted in a strain whose total ergosterol content 
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could be varied in a range from ~80 to ~20 µg·(mg cells, dw)-1 depending on the external 
doxycycline concentration (Fig. IV-2B).  Growth of this strain was strongly reduced on agar 
plates as well as in liquid media supplemented with doxycycline (Fig. IV-2C,D). A slight 
reduction of growth in liquid media was observed even in the absence of the repressor (Fig. 
IV-2D). A similar study that put ERG9 transcription under control of the methionine 
repressible MET3 promoter also showed that repression of ERG9 resulted in drastically 
lowered specific growth rates and also reduced the final biomass concentration [38]. 
 
Fig. IV-2: Effect of ERG9 repression on exponential growth. (A) The native ERG9 promoter was 
replaced by a tetracycline/doxycycline repressible promoter system. The promoter replacement 
cassette encodes for the tetracycline transactivator (tTA), an artificial fusion protein that binds the tet 
operator sequences (tetO; 2x) and recruits the endogenous transcription machinery to the CYC1 
minimal (*) promoter via its C-terminal viral transcription activation domain (VP16) thereby mediating 
ERG9 transcription. Binding of tTA to tetO is prevented in the presence of tetracycline or synthetic 
analogues such as doxycycline. This way, the transcription activating effect of VP16 is inhibited. (B) 
Ergosterol content of tetO2-PCYC1-ERG9 cells (W303 background) at given doxycycline 
concentrations as determined from GC-MS data. The ergosterol level of wild-type cells is indicated 
as a dashed line for comparison. The bars represent the range of two measured values displayed as 
arithmetic mean. n = 2 (C) The growth phenotype of tetO2-PCYC1-ERG9 cells is shown via spotting of 
a 10-fold dilution series in the presence (40 µg·mL-1) or absence of doxycycline in the medium. 
Growth of tetO2-PCYC1-ERG9 cells was strongly impaired in the presence of doxycycline whereas 
growth of the wild-type background (BY4742; PERG9-ERG9) was unimpaired by doxycycline. (D) 
Growth of the tetO2-PCYC1-ERG9 strain was also strongly reduced in liquid media supplemented with 
doxycycline (40 µg·mL-1). However, a slight reduction of growth was observed even in the absence 
of the repressor.  
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The regulatory effects of the artificial tetO2-PCYC1 promoter system on transcription do not 
depend on any yeast endogenous regulatory proteins and do not involve effector molecules 
that can be metabolized by yeast. By this way, basic conditions that allow for a fully 
independent, orthogonal control of transcription of two independent genes by both promoter 
systems are fulfilled. To test whether both promoter systems can be used to orthogonally 
control gene expression, a strain combining the PMET3-OLE1 and tetO2-PCYC-ERG9 genetic 
modifications was constructed. Both modifications were already analyzed individually and 
featured an obvious phenotypic output (Fig. II-3A; Fig. IV-2). Upon methionine or 
doxycycline supplementation of the medium, the double-modified strain behaved exactly as 
the respective strain featuring the single promoter substitution (Fig. IV-3). Since both 
effectors and especially methionine had already strong growth repressing effects under the 
tested conditions, potential additive effects of simultaneous repression of OLE1 and ERG9 
could not be revealed. However, both promoter systems have proven to be controlled 
independently and allow for an orthogonal control of genes important in lipid biosynthesis. 
 
Fig. IV-3: Individual control of OLE1 and ERG9 expression in the same cell by employing 
orthogonal gene expression tools. Growth of a BY4742 background (wt) and strains featuring an 
individual and a double OLE1- and ERG9-promoter substitution, respectively, under control 
conditions (-met, -dox) was compared to growth in media supplemented with methionine (5 mM), 
doxycycline (40 µg·mL-1) or both. The native OLE1 promoter was replaced by the methionine-
repressible MET3 promoter (PMET3), whereas the ERG9 promoter was replaced by the doxycycline 
repressible tetO2-PCYC1* promoter construct.  
The strong growth defect upon sterol depletion shown here, emphasizes that yeast cells 
must have evolved regulatory systems to maintain sterol/ergosterol homeostasis. This 
regulatory system controls the ergosterol biosynthesis on the level of transcription as a 
response to reduced ergosterol synthesis caused by environmental stimuli such as hypoxia 
[46] or antimycotic agents impairing the synthesis of ergosterol. This regulatory system 
involves ergosterol sensing proteins, Upc2p and its paralogue Emc22p, that recognize 
ergosterol as the final product of the ergosterol biosynthetic pathway and subsequently 
extract single ergosterol molecules from the lipid bilayers, mainly the plasma membrane. 
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Upc2p and Emc22p are zinc finger motif containing transcription factors that have been 
suggested to bind and activate genes involved in ergosterol biosynthesis and sterol uptake 
upon intracellular sterol depletion. Ergosterol associated Upc2p features a characteristic 
conformation that hides and masks the intrinsic N-terminal NLS of the protein’s DNA binding 
domain. Dissociation of ergosterol from the lipid binding domain (LBD) of Upc2p results in 
a conformational change thereby unmasking the NLS, eventually leading to nuclear 
localization of Upc2p. In the nucleus, Upc2p shows its transcription activating properties 
and upregulates the ergosterol biosynthetic pathway and sterol uptake. The exact 
mechanism of Upc2p-mediated transcription activation as well as potential coactivators are 
still under investigation. The reversible shuttling of Upc2p between cytosol and nucleus is 
used in this study to monitor ergosterol depletion upon ERG9 repression on a cell biological 
level. For that GFP-tagged versions of Upc2p were expressed form a plasmid. This way, it 
should be possible to easily monitor subcellular localization of Upc2p by confocal 
fluorescence microscopy. N-terminal tagging of Upc2p was considered to have a lesser 
influence on the subcellular protein localization patterns since C-terminal tagging could 
mask the NLS, thereby impairing nuclear targeting. However, N-terminal GFP-Upc2p fusion 
proteins located exclusively in the nucleus of tetO2-PCYC1 cells even in the absence of the 
repressor (Fig. IV-4A), thus not allowing to monitor changes in of Upc2p localization upon 
ergosterol depletion.  
 
Fig. IV-4: Subcellular localization of GFP-UPC2p and Upc2p-GFP in a tetO2-PCYC1-ERG9 
background. (A) Images show representative yeast cells expressing GFP-tagged variants of Upc2p 
(top: N-terminal GFP-fusion; bottom: C-terminal GFP-fusion). (B) Nuclear localization of Upc2p-GFP 
was confirmed by co-localization studies with DAPI stained nuclear chromatin. The channel overlay 
image of fluorescence channels shows subcellular co-localization of both fluorophores. 
Although N-terminally GFP-tagged Upc2p was used for similar studies [47], it was tested 
whether C-terminal tagging could prevent potential LBD impairment resulting from GFP-
tagging and could restore expected cytosolic protein residency. Deletion of the LBD was 
previously shown to lead to strong nuclear localization, independent from the ergosterol 
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status of the cell [47]. Surprisingly, C-terminal Upc2p-GFP fusion proteins located 
exclusively in the nucleus as well (Fig. IV-4A), as confirmed by co-localization studies with 
DAPI stained nuclear chromatin (Fig. IV-4B), even though it was shown elsewhere that C-
terminal tagging of Upc2p does not impair its proper biological function [48]. Identical 
nuclear protein localization was also overserved in the genetic background of BY4742 (data 
not shown) thus ruling out that manipulation of ERG9 expression is somehow involved in 
the unusual subcellular protein distribution. Single point mutations that have shown to cause 
strong nuclear targeting of Upc2p [47] were also ruled out, since plasmid incorporated ORF 
did not feature any mutations as confirmed by sequencing. Thus, an Upc2p localization 
assay could not be used to monitor ergosterol depletion on a cell biological level. 
4.4.2. Tryptophan permease Tat2p is mistargeted in ergosterol depleted yeast cells 
Modifications of the physicochemical properties and lipid composition of biological 
membranes can severely influence the integrity of membrane associated processes such 
as proper protein sorting and protein delivery via the secretory pathway. A number of 
studies identified lipid rafts and incorporated ergosterol as being involved in and important 
for membrane trafficking and correct intracellular delivery of raft-associated plasma 
membrane proteins thereby also ensuring their proper biological function [11, 21, 49-51]. A 
well-studied example for controlling the overall protein activity by regulated sorting of 
membrane traffic rather than by de novo protein synthesis is the delivery of the tryptophan 
permease Tat2p to the plasma membrane in response to environmental factors. In wild-
type cells grown at low tryptophan, Tat2p is targeted to the plasma membrane via the 
secretory pathway [52] or via an exocytic pathway including the trans-Golgi and early 
endosomes [53] whereas at high tryptophan, Tat2p goes directly to the vacuole via an 
unconventional route leading from the trans-Golgi to early endosomes to late endosomes 
and is not recycled from the plasma membrane via endocytosis [51]. In a ERG6 knockout 
mutant (∆erg6) that is defective in producing ergosterol but instead accumulates other 
sterols up to the stage of zymosterol [54], Tat2p is not properly delivered to the plasma 
membrane anymore. In this case, Tat2p is targeted to the vacuole instead or even 
accumulates in late endosomes [51]. The missorting in ∆erg6 cells is moreover 
accompanied by an inability to take up tryptophan efficiently. Knockout of ERG2 whose 
gene product accepts the sterol intermediate synthesized by Erg6p as substrate, also 
results in missorting of Tat2p and subsequent vacuolar degradation [43]. Depletion of total 
sterols by using a mevalonate auxotrophic ∆erg13 strain disrupted detergent-insoluble 
membrane domains (lipid rafts) and prevented proper Tat2p targeting to the plasma 
membrane. These finding are in line with missorting of Tat2p in cells treated with the Erg9p-
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inhibitor zaragozic acid (ZA) [55], in which the metabolite flux towards the ergosterol 
biosynthetic pathway and the total sterol synthesis gets limited. All these observations 
support a model in which Tat2p is missorted to the vacuole in the absence of (∆erg13) or 
mal-organized (unusual sterol composition in ∆erg6 and ∆erg2) lipid rafts. Interestingly, 
Tat2p was found to be not sorted to the vacuole anymore in strains defective in Rsp5p 
complex-mediated ubiquitination (∆bul1) even upon altered sterol composition [51]. 
Therefore, it seems likely that Rsp5p-mediated ubiquitination (which is also involved in 
Spt23p proteolytic processing (section 1.5)) directs Tat2p towards the vacuole instead of to 
the plasma membrane. Although Rsp5p seems to be resident in lipid rafts as well as in non-
lipid raft membrane compartments, there is evidence that protein ubiquitination by Rsp5p 
occurs predominantly in phospholipid-enriched non-raft membrane areas. Taking together, 
a model is supported in which Tat2p resident in the bulk lipid fraction is ubiquitinated and 
directed the late endosomes and to the vacuole, whereas Tat2p escapes from ubiquitination 
when located in a lipid-raft environment. Since lipid raft forming ergosterol and sphingolipids 
are progressively enriched along the secretory pathway and reach their highest level within 
the plasma membrane so that raft-associated Tat2p is practically dragged along to the cell 
surface. This model therefore assumes that intracellular Tat2p sorting is regulated in the 
trans-Golgi (where ubiquitination takes place) and thus late within the secretory pathway 
[56]. Factors that may be responsible for the lipid-raft association of Tat2p might be related 
to the chemical structure of sterols incorporated in lipid rafts. Sterols that accumulate in 
∆erg6- (zymosterol) and ∆erg2-cells (fecosterol) differ from ergosterol regarding the main 
alkyl chain as well as regarding the main sterol scaffold. 
The tetO2-PCYC1-ERG9 strain which features controllable expression of ERG9 and thus a 
reduced total sterol biosynthesis is distinctively different from ∆erg6 and ∆erg2 strains used 
for Tat2p localization studies as these are defective in late steps of the ergosterol 
biosynthetic pathway. Reduction of overall cellular ERG9 activity rather resembles the ZA-
mediated Erg9p inhibition or the controlled feeding of mevalonate to an ∆erg13 strain for 
which Tat2p missorting was also observed. To test the effects of genetically reduced ERG9 
expression on the subcellular localization of Tat2p and the Tat2p-mediated tryptophan 
uptake related thereto, a strict tryptophan auxotrophic strain was constructed in the genetic 
background of tetO2-PCYC1-ERG9.  
For that, TRP1 was knocked-out and the requirement of tryptophan uptake from the medium 
for growth of this strain was confirmed. Growth of the resulting tetO2-PCYC1-ERG9; ∆trp1 
strictly relied on the availability and uptake of external tryptophan at high concentrations 
(200 µg·mL-1) (Fig. IV-5). 
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Fig. IV-5: Knocking-out TRP1 yields a strict tryptophan auxotrophic strain whose growth 
depends on externally available tryptophan. Growth of a wild-type background (BY4742), the 
tetO2-PCYC1-ERG9 mutant and a strain featuring an additional TRP1 knockout (tetO2-PCYC1-ERG9; 
∆trp1) was compared in the presence or absence of doxycycline (dox; 40 µg·mL-1) and tryptophan 
(trp; 200 µg·mL-1). Only growth of the ∆trp1 strain was inhibited in the absence of tryptophan, 
whereas both other strain grew unimpaired (left). Growth of the ∆trp1 strain was restored by 
tryptophan supplementation of the medium (middle). Upon repression of ERG9, both strain with 
tetO2-PCYC1-ERG9 genetic background grew poorly even in the presence of tryptophan (right). 
In contrast, growth of the ∆trp1 cells could not be restored at low external tryptophan 
concentrations  (Fig. IV-6B) being two orders of magnitude lower (2 µg·mL-1) than the 
concentrations used for strain characterization (Fig. IV-5). However, intermediate 
tryptophan concentrations (20 µg·mL-1) were sufficient to allow for growth of an comparable 
strain (tetO2-PCYC1-ERG9; ∆trp1 (e.v.)) under equivalent growth conditions (0 µg·mL-1 dox) 
(Fig. IV-6A; bottom).  
Increasing doxycycline concentrations (0.4 and 4 µg·mL-1) which reduced ERG9 
expression, successively impaired growth on intermediate tryptophan medium (Fig. IV-6A; 
left column), though growth on high tryptophan was completely unaffected by repressed 
ERG9 expression (Fig. IV-6A; right column). Growth inhibition was comparable to that 
observed in previous growth assays, which used 40 µg·mL-1 doxycycline (Fig. IV-S1). These 
findings suggest a Tat2p loss-of-function effect that might be caused by altered 
ergosterol/sterol biosynthesis upon ERG9 repression, as was previously observed for 
similar cellular systems using zaragozic acid treated cells or an ∆erg13 background. 
Intermediate tryptophan concentrations (20 µg·mL-1) revealed this loss-of-function effect, 
whereas high tryptophan masked detrimental effects of potential Tat2p mislocalization.  
This is likely due to compensation of Tat2p malfunction by unspecific amino acid permeases 
(e.g. Gap1p [57]) or by other uptake systems that are able to deliver tryptophan 
intracellularly only when large chemical gradients are present. In contrast, growth at 
intermediate tryptophan seems to be dependent on sufficient overall cellular activity of 
Tat2p.  To trace the doxycycline-mediated growth effect specifically back to reduced cellular 
Tat2p activity, it was tested whether additional plasmid-based TAT2 expression could 
restore growth at intermediate tryptophan and simultaneous ERG9 repression. 
Indeed, growth of cells under these conditions was restored when cells were enabled for 
additional strong TAT2 expression from the GAL1 promoter, while cells that contained an 
empty vector (e.v.) grew still impaired (Fig. IV-6C). This experiment indicates clearly Tat2p 
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loss-of-function upon ERG9 repression. These findings further suggest that growth defects 
upon ERG9 repression, as shown in Fig. IV-2C and Fig. IV-3 are also caused (at least to a 
great extent) by the Tat2p loss-of-function, since standard tryptophan concentrations in 
synthetic medium are in the same concentration range as those used for growth assays 
with intermediate tryptophan (20 vs. 50 µg·mL-1). 
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Fig. IV-6: Repression of ERG9 expression converts ∆trp1 cells to tryptophan auxotrophs in 
the presence of intermediate external tryptophan concentrations. (A) Growth of plasmid 
harboring (empty pGREG503 (e.v.) or pGREG503-TAT2) ∆trp1 cells in wild-type (BY4742) and 
tetO2-PCYC1-ERG9 genetic background was compared at intermediate (20 µg·mL-1) and high 
(200 µg·mL-1) tryptophan concentrations as well as in the additional presence (0.4 or 4 µg·mL-1) or 
absence of doxycycline (dox). Since TAT2 in pGREG503-TAT2 is expressed under control of the 
GAL1 promoter (PGAL1-TAT2), growth on glucose medium is not affected by the respectively harbored 
plasmid, since plasmid-based expression is only activated on galactose medium as shown in (C). 
Growth of tetO2-PCYC1-ERG9; ∆trp1 strains was severely impaired at intermediate tryptophan 
concentrations when ERG9 expression was repressed (+dox) whereas cells grew unimpaired on 
high tryptophan medium even with repressed ERG9 expression. (B) Growth of strains introduced in 
(A) was compared on low tryptophan (2 µg·mL-1) as well as on tryptophan-free medium. Low 
tryptophan medium did not allow for growth of ∆trp1 strains. (C) Influence of additional plasmid-based 
expression of TAT2 on impaired growth of tetO2-PCYC1-ERG9; ∆trp1 cells on intermediate tryptophan 
medium and upon simultaneous ERG9 expression was tested. Plasmid-based TAT2 expression was 
able to restore growth of tetO2-PCYC1-ERG9; ∆trp1 under the conditions indicated. (D) Controls to rule 
out, that high tryptophan conditions directly influence doxycycline-regulated gene expression using 
the artificial tetO2-PCYC1 promoter construct. High external tryptophan levels did not reduce growth 
inhibiting effects of doxycycline repressed OLE1 expression (from a plasmid) in a strain background 
with repressed OLE1 expression from the genomic gene copy (PMET3-OLE1 at 5 mM met; see Fig. 
II-3A). 
The range of doxycycline concentrations used for the experiment shown in Fig. IV-6 did not 
correspond to the range for which a notable change of the ergosterol content could be 
measured (Fig. IV-2B). These observations indicate that cells grown in liquid media are 
more sensitive to external doxycycline probably due to a more efficient uptake of the 
repressor from the surrounding milieu. 
Potential concerns that high tryptophan conditions could directly weaken the repressing 
effect of doxycycline were ruled out by using an equivalent cellular system whose growth 
performance does not rely on the intracellular delivery of tryptophan. For that, plasmid-
based OLE1 expression was placed under control of the tetO2-PCYC1 promoter construct. 
Cells were only able to grow when plasmid-based expression was active in the PMET3-OLE1 
background with OLE1 expression repressed in the presence of 5 mM methionine. The 
presence of high tryptophan (200 µg·mL-1) did not influence the doxycycline-mediated 
repression of OLE1 expression and growth was prevented (repression of genomic OLE1 at 
5 mM met) to the same extent as in the absence of tryptophan (Fig. IV-6D).  
To investigate the subcellular localization of Tat2p upon normal and decreased ERG9 
expression, plasmids were constructed that mediate expression of a C-terminally GFP-
tagged Tat2p variant whose localization can be monitored by confocal fluorescence 
microscopy.  
The expression was placed under control of the native TAT2 promoter (PTAT2) to circumvent 
artifacts that may result from unnaturally high expression levels. Higher expression levels 
mediated by the strong GAL1 promoter lead to a less contrasted protein distribution pattern 
than observed at lower expression from PTAT2 as Tat2p was still located to a large extend in 
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the plasma membrane even under high tryptophan conditions (Fig. IV-S2). When grown 
under low tryptophan conditions, Tat2p was located to a large extent in the plasma 
membrane in BY4742; tetO2-PCYC1-ERG9 in the absence of doxycycline (resembles wild-
type conditions regarding ERG9 expression levels) as it is also usual for wild-type cells 
(data not shown) [51]. In contrast, high external tryptophan concentrations targeted Tat2p 
mostly to the vacuole and hardly any Tat2p remained in the plasma membrane (Fig. IV-7; 
left). Under conditions that resemble those that caused a severe growth defect in ∆trp1 cells 
(-trp; 40 µg·mL-1 dox), Tat2p was not detected in the plasma membrane but accumulated in 
internal vacuolar structures when ERG9 was repressed. 
 
Fig. IV-7: Subcellular localization of the tryptophan permease Tat2p in dependence of 
tryptophan concentration and ERG9 expression. Tat2p localization was examined in the 
presence (200 µg·mL-1) and absence of external tryptophan as well as in the presence (40 µg·mL-1) 
and absence of doxycycline that represses the expression of ERG9 in the tetO2-PCYC1-ERG9 
background. Tat2p located to a large extend in the plasma membrane under wild-type conditions (-
dox) in tryptophan-free medium whereas Tat2p-GFP did not stain the plasma membrane in the 
presence of doxycycline. High tryptophan medium caused predominant delivery of Tat2p to the 
vacuole. Representative images are shown. 
These results support the observed growth defect in intermediate tryptophan conditions in 
combination with ERG9 repression (Fig. IV-6) and identify protein mislocalization as the 
cause for a loss of Tat2p-mediated tryptophan uptake activity as it was previously reported 
for other mutant strains also defective in the ergosterol biosynthesis [51]. 
4.4.3. Sterols are required for proper endocytic activity in yeast 
Because ergosterol was identified to be required for proper endocytic function in yeast [15, 
54], it was reasoned elsewhere [55] that an involvement of endocytosis in the extensive 
delivery of Tat2p to the vacuole observed upon ergosterol depletion is unlikely and protein 
missorting in the secretory pathway is rather responsible for vacuolar Tat2p localization. 
Studies evaluating the effect of ergosterol on endocytosis used double deletion strains 
featuring various combinations of knockouts of non-essential genes ERG2, ERG3, ERG4, 
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ERG5 and ERG6 [15, 54]. Although these erg mutants are just defective in late parts of the 
ergosterol biosynthesis, severe impairment of endocytosis was observed partially leading 
to internalization defects, where especially the initial internalization step was affected and 
further downstream trafficking remained nearly uninfluenced [58]. These findings suggest 
that ergosterol is required for the internalization step in yeast. Identification of genes that 
were previously identified as END genes (ENDocytosis defective) being the same as ERG 
genes (ERGosterol biosynthesis), e.g. END11 corresponds to ERG2, further emphasized a 
crucial role of ergosterol for endocytosis. Endocytosis defects arising in viable erg mutants 
indicate that impairment of internalization may correlate with changes in the sterol structure 
rather than with the total sterol content of the membranes. However, studies in animal cells 
using drugs that block cholesterol biosynthesis or chelating agents that sequester and thus 
reduce the total cholesterol amount, also detected defects in endocytosis and geometry of 
clathrin coated vesicles [59, 60] as well as a loss of invaginated caveolae [61, 62] for which 
a role in endocytosis is also discussed. These findings, in turn, also suggest a model in 
which the total sterol content plays a critical role for the full integrity of the endocytic process.  
 
Fig. IV-8: Endocytosis in yeast is severely impaired upon ERG9 repression. (A) Spheroplasts 
of BY4742 and of its derivative strain with controllable ERG9 expression (tetO2-PCYC1-ERG9) were 
grown for 120 h in saline buffer supplemented with glucose (1%). Cells of tetO2-PCYC1-ERG9 used 
for zymolyase treatment where grown in the presence (40 µg·mL-1) or absence of doxycycline and 
spheroplasts were subsequently incubated under identical conditions. Diameters of ~100 
spheroplasts for each strain and each condition were measured and the mean cells surface area 
was calculated. Black bars represent the mean cell surface area at t = 0 whereas white bars show 
the mean cell surface area after t = 120 h. Spheroplasts with repressed ERG9 expression (+dox) 
increased much stronger in cell surface area (~900 µm2) than spheroplasts with normal ERG9 
expression levels (BY4742; tetO2-PCYC1-ERG9, -dox) (~400 µm2) as also indicated by representative 
microscopy images. (B) An altered ergosterol content affects endocytosis in yeast. Repression of 
ERG9 expression shifted the ratio of exo- to endocytic events from ~1.5 (observed for BY4742 and 
tetO2-PCYC1-ERG9, -dox) to ~2.6. Black bars represent the frequency of exocytic events whereas 
white bars indicate the frequency of endocytic events. 
The tetO2-PCYC1-ERG9 system allows to reduce the total sterol/ergosterol content in vivo by 
genetic control and thereby to examine the in vivo requirement of a natural total sterol 
content for endo- and exocytosis without the use of externally supplemented drugs. In an 
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equivalent approach as previously described for OLE1 repression [63], the effect of ERG9 
repression on endo- and exocytic activity was examined by electrophysiological capacity 
measurements and determination of changes in cell size using spheroplasts which have 
lost the ability for cell division due to the lack of their cell wall [64]. 
Depletion of the total sterol/ergosterol content, resulting from inhibition of ERG9 expression, 
stimulated cell expansion (measured as increase of cell diameter and calculated cell surface 
area) of spheroplasts after 120 h incubation in glucose-containing medium much stronger 
than observed for tetO2-PCYC1-ERG9 with unrepressed ERG9 (-dox) or the wild-type 
background (BY4742) (Fig. IV-8A). A continuous increase of spheroplast size in the 
presence of glucose was previously described. In this study, enlargement of the cell surface 
area was traced back on energy dependent endo- and exocytic activity taking place even 
in spheroplasts when glucose is available (not in the absence of glucose) with a nearly 
balanced however slightly higher frequency of exocytic over endocytic events. This 
imbalance with an excess of exocytic activity results in a net delivery of new membrane 
material realized by fusion of secretory vesicles with the plasma membrane, finally leading 
to a slight cell expansion [37]. A slight excess of exocytic events was also detected for the 
BY4742 wild-type background used for this study as well as for the tetO2-PCYC1-ERG9 strain, 
when cultured in the absence of doxycycline (-dox; unrepressed ERG9 expression). A 
similar ratio of exo- to endocytic frequencies (fexo/fendo of 1.6 and 1.5) was observed for both 
strains and conditions (Fig. IV-8B), accounting for the similar increase of respective 
spheroplasts sizes.  However, this balance was strongly disturbed by repressing the 
expression of ERG9 (tetO2-PCYC1-ERG9; +dox) leading to an exo- to endocytosis ratio of 
2.6 (Fig. IV-8B) which is exclusively caused by a significant reduction of endocytic activity 
(42 vs. 24 events/ h and membrane patch). This strong inhibition of endocytosis caused, in 
turn, the much stronger growth of spheroplasts upon ERG9 repression with an increase of 
membrane surface area of ~900 µm2 compared to ~400 µm2 observed for spheroplasts with 
natural ERG9 expression (Fig. IV-8A). 
The significant decrease of endocytic activity upon sterol/ergosterol depletion in yeast 
observed here, is in line with effects upon sterol/cholesterol depletion described for animal 
cells and further highlights the requirement of sterols for proper endocytosis. Even though 
a crucial role for sterols in endocytosis is apparent, little is known on how sterols participate 
in endocytosis in general or in its initial internalization step in particular. However, several 
different scenarios can be discussed. Ergosterol or ergosterol-enriched membrane 
microdomains (lipid rafts) could serve as anchor-points and interaction sites for the 
endocytosis machinery with the plasma membrane (e.g. eisosomes). In this model, lipid 
rafts recruit specific membrane-resident or membrane-associated proteins (probably due to 
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beneficial thermodynamic protein-lipid interactions or direct interaction of ergosterol and 
proteins via a sterol-binding domain [65, 66]) that are involved in endocytosis themselves, 
recruit further proteins that promote endocytosis or even serve as receptors of receptor-
mediated endocytosis. However, erg mutants (∆erg2; ∆erg6) also showed severe 
impairment of fluid phase endocytosis (pinocytosis) [54], suggesting a more fundamental 
role for sterols in endocytosis. This role might comprise basic physicochemical membrane 
parameters such as membrane fluidity or membrane curvature that have to fulfill certain 
criteria and have to lie within a certain physiological range to support proper function. It is 
well known that strains defective in sterol/ergosterol biosynthesis feature unnaturally low 
membrane fluidity (high rigidity) [67] and an increase in membrane rigidity was reported to 
be correlated with the severity of internalization defects [54]. These findings are perfectly in 
line with a study showing that an unnaturally saturated lipidome, resulting from OLE1 
repression, strongly decreased membrane fluidity and thereby severely impaired 
endocytosis and shifted the ratio of exo- to endocytosis from 1.6 to 3.6 [63]. Furthermore, it 
was shown that depletion of cholesterol in membranes of animal cells causes flattening of 
clathrin-coated pits [59, 60] whose formation is an essential step of the initial internalization 
during endocytosis and present in both, receptor-mediated and fluid-phase endocytosis. 
Assuming that ergosterol features a similar function in yeast membranes as cholesterol in 
animal bilayers, it could be suggested that the amount of sterols within biological 
membranes or membrane fluidity in general affect the morphology and curvature of the 
plasma membrane. Unnatural membrane lipid composition and non-physiologically high 
membrane rigidity could then directly counteract and impede the specific curvature of 
membranes inherent for coated-pits and vesicles whose three-dimensional geometry is 
generally determined by the architecture of the clathrin coat [68]. That is why only relatively 
small deviations from the ideal membrane curvature can be tolerated. However, the role of 
ergosterol for endocytosis might be also a combination of discussed functions. 
4.4.4. Membrane compartmentation is disturbed upon ergosterol depletion as 
detected by membrane localization of marker proteins Can1p and Pma1p 
The plasma membrane of S. cerevisiae is laterally compartmented, consisting of distinct 
domains hosting different proteins and membrane lipids. GFP-staining of marker proteins 
occupying these plasma membrane compartments revealed at least three different modes 
of distinctive protein distribution patterns. A patchy compartment containing the arginine 
permease Can1p (membrane compartment of Can1p; MCC) concentrates proteins in 
discrete patches estimated to be ~300 nm in diameter, whereas a mesh-shaped 
compartment accommodates one of the most abundant proteins within the plasma 
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membrane, the H+-ATPase Pma1p and is therefore called MCP (membrane compartment 
of Pma1p). Colocalization studies using marker proteins Can1p and Pma1p could show that 
both compartments, MCC and MCP, are non-overlapping, exclude each other and cover 
together the whole plasma membrane surface [50]. A third protein distribution mode is 
characterized by an even and homogenous dispersion of proteins through the cell surface 
which is e.g. occupied by the glucose transporter Hxt1p and the general amino acid 
permease Gap1p. The phenomenon of lateral protein compartmentation within the plasma 
membrane was identified as being associated with the inhomogeneous distribution of 
membrane lipids and the formation of membrane microdomains enriched in ergosterol and 
sphingolipids (lipid rafts) as the ergosterol binding agent filipin stained preferentially MCC 
domains [69]. Lipid rafts feature a dense lipid packing as well as a high order parameter 
which makes them resistant to detergents, but still allow for free diffusion of membrane 
proteins and support their proper function. The resistance towards membrane disrupting 
detergents was exploited to isolate intact lipid rafts thereby also pulling out membrane 
proteins that are stably associated with or even embedded within them. This way it could 
be shown that Can1p [50] is associated with lipid rafts and that the lateral membrane protein 
compartmentation is connected to an uneven lipid distribution. Additionally, it was found 
that the knockout of genes whose gene products are involved in lipid biogenesis, e.g. ERG2, 
ERG5, ERG6 and ERG24, strongly affected the wild-type pattern of protein segregation 
[69]. However, it is still unclear, whether the separation of membrane lipids creates distinct 
lipid environments that are preferentially occupied by certain proteins or alternatively, if 
protein-protein interactions are the primary determinant of lateral membrane lipid 
compartmentation [69]. 
The previously characterized strain BY4742; tetO2-PCYC1-ERG9 that has proven to allow for 
a considerable reduction of the ergosterol/sterol content upon ERG9 repression with striking 
impairment of proper protein sorting and delivery as well as endocytosis, was used as a 
model to monitor ergosterol (lipid raft) dependent lateral protein segregation within the 
plasma membrane.  
For that, marker proteins of both prominent membrane compartments, MCC and MCP, were 
C-terminally tagged with GFP to allow for visualizing protein compartmentation in vivo by 
fluorescence microscopy. C-terminal fusion proteins proved to be fully functional. Strains 
expressing Can1p-GFP (from a plasmid) are sensitive to the toxic L-arginine analogue L-
canavanine just like the wild-type background (BY4742) whereas a strain expressing a non-
functional Can1p mutant version (BMA64-1A) grew unimpaired on L-canavanine containing 
medium (Fig. IV-9A). Moreover, Can1p-GFP was properly endocytosed and subsequently 
delivered to the vacuole at high extracellular arginine concentrations as is was also reported 
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for the wild-type protein [70] (Fig. IV-9B). This experiment illustrates that the lateral Can1p 
distribution within the plasma membrane should ideally be examined in cells grown in 
arginine-free medium that allows for extensive plasma membrane staining. The proper 
functionality of Pma1p-GFP was obvious from the pure viability of transformants since loss 
of Pma1p function is lethal [71]. The typical patchy distribution of Can1p was maintained 
within the plasma membrane even in spheroplasts (Fig. IV-9C), indicating that lateral protein 
compartmentation is not stabilized by the cell wall but is a pure membrane associated effect 
or if at all, is supported by internal structures such as the cortical actin network which, 
however, couldn’t be confirmed by experimental data shown elsewhere [72]. 
 
Fig. IV-9: C-terminal GFP-tagging of Can1p does not impair protein functionality. (A) Growth 
assays to examine Can1p transport activity by sensitivity to the toxic L-arginine analogue L-
canavanine. Growth of strains (wild-type BY4742 and tetO2-PCYC1-ERG9) expressing Can1p-GFP 
was inhibited on L-arginine-free medium in the presence of L-canavanine (60 µg·mL-1) as it was also 
true for BY4742 expression the wild-type protein (positive control) whereas growth was unimpaired 
on L-canavanine-free medium. A strain (BMA64-1A) expressing no functional Can1p grew 
unimpaired on both media (negative control). (B) Fluorescence image showing the subcellular 
localization of Can1p-GFP within cells grown in the presence of high arginine concentrations 
(60 µg·mL-1) and corresponding bright-field image. In the presence of high external arginine 
concentrations, Can1p is targeted to the vacuole and plasma membrane staining disappears, which 
is present when grown in arginine-free medium (C). The patchy distribution of Can1p is retained even 
in spheroplasts lacking their cell wall. 
The membrane compartment MCC is not exclusively occupied by the introduced marker 
protein Can1p. In addition, integral membrane proteins such as Fur4p and Sur7p, among 
others, also serve as established marker proteins for MCC. Also cytosolic proteins Pil1p 
and Lsp1p that are components of the so called eisosome, a multiprotein complex 
hypothesized to be involved in endocytosis, colocalize with Can1p and MCC [73]. To test 
whether the C-terminal Can1p-GFP variant is distributed within the plasma membrane in its 
natural way and allows for native intermolecular interactions suggested to be involved in 
the formation of eisosomes, colocalization studies of Can1p-GFP and Pil1p-RedStar were 
performed.  
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Fig. IV-10: Colocalization of 
Can1p-GFP and Pil1p-RedStar. 
Representative images of BY4742 
cells expressing Can1p-GFP and 
Pil1-RedStar (from a plasmid, 
pGREG600) under control of PGAL1 
are shown. White color in the 
overlay image of fluorescence 
channels display subcellular co-
localization of both fluorophores. 
Fluorescence intensity profiles 
along the plasma membrane (see 
white arrows) for both proteins 
were tracked. Traces were 
normalized to the same maximal 
intensity. The overlay of both 
traces shows that places of 
accumulation for both proteins 
correspond to each other as 
indicated (see black arrows). 
Both proteins colocalized (at least partially) - several local maxima of fluorescence intensity 
profiles along the plasma membrane of both proteins matched well (Fig. IV-10) and clearly 
indicated the occupation of identical membrane compartments in general. However, a few 
patches with only GFP fluorescence and some with only RedStar fluorescence could be 
identified. Based on all these results, it was concluded that Can1p-GFP featured wild-type 
protein behavior and could be used to study changes in protein distribution upon ergosterol 
depletion. 
To prevent effects that might result from unnatural expression characteristics (e.g. 
expression level or timing of expression) a chromosomal C-terminal Can1p-GFP fusion was 
constructed. This allows for expression of the fusion protein from the natural genetic 
context. Protein distribution patterns within the plasma membrane of yeast were examined 
by confocal fluorescence microscopy. For that, yeast cells were scanned along the z-axis 
by collecting single images of multiple optical sections (Fig. IV-11A). 
Single images of the z-stack were merged into a 2D stack by maximum intensity projection 
(MIP) reflecting the protein distribution over the entire membrane (Fig. IV-11B). Single 
images such as the tangential confocal section (TCS) representing the top/bottom of the 
cell as well as the equatorial confocal section (ECS) were also used to evaluate the pattern 
of protein compartmentation and potential changes upon ergosterol depletion. 
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Fig. IV-11: Confocal fluorescence microscopy used for evaluating the distribution patter of 
proteins within the plasma membrane of yeast. (A) Yeast cells were scanned along the z-axis by 
vertically moving the focal plane thereby imaging multiple confocal section of the cell. The tangential 
confocal section (TCS) as well as the equatorial confocal section (ECS) were used to evaluate the 
protein distribution pattern. (B) Single images (~25) were merged into a 2D-stack by maximum 
intensity projection (MIP) to illustrate the protein distribution over the entire cell surface. 
Can1p-GFP expressed from the genome in the wild-type background (BY4742) localized 
well to the plasma membrane and displayed the characteristic clustered pattern all over the 
cell surface. The same was true for tetO2-PCYC1-ERG9 cells when grown in the absence of 
doxycycline thus allowing for expressing ERG9 in a physiological range (Fig. IV-12; top & 
middle). Can1p-GFP fluorescence bleached rapidly, indicating relatively small protein-
fluorophore levels within the plasma membrane as also briefly mentioned elsewhere [50].  
In contrast to the observed characteristic protein distribution pattern of Can1p-GFP, imaging 
of the GFP-tagged potassium channel Tok1p revealed a homogenous signal within the 
plasma membrane (Fig. IV-S3A) as also observed for the previously mentioned proteins 
Hxt1p and Gap1p [50]. The characteristic distribution pattern of Tok1p-GFP was considered 
as being stereotypical for non-laterally segregated proteins and further used for 
comparison. 
The characteristic pattern of Can1p-GFP accumulating in MCC patches within the plasma 
membrane serves as a sensitive marker for MCC integrity. To check for MCC integrity upon 
ergosterol depletion, tetO2-PCYC1-ERG9; can1::CAN1-GFP cells were grown in the presence 
of doxycycline, thus repressing ERG9 expression, and confocal fluorescence microscopy 
analysis was performed as previously described (Fig. IV-11) to evaluate changes of protein 
distribution.  
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Fig. IV-12: Patterns of Can1p distribution within the plasma membrane of cells with natural or 
decreased ERG9 expression. Fluorescence microscopy images of the tangential (TCS) equatorial 
(ECS) confocal sections as well as corresponding maximum intensity projections (MIP) and bright-
field images are shown. The characteristic patchy pattern of Can1p-GFP distribution observed in the 
wild-type background (BY4742; top) and tetO2-PCYC1-ERG9 cells grown in the absence of 
doxycycline (middle) changed to a more homogenous protein distribution in the plasma membrane 
upon doxycycline-mediated (40 µg·mL-1) repression of ERG9 in the tetO2-PCYC1-ERG9 background 
(bottom). 
The distribution of Can1p-GFP was affected in cells grown in the presence of doxycycline 
manifested in such that protein accumulation was less discrete and fluorescence foci were 
less separated from the neighboring membrane sections (Fig. IV-12; bottom). For semi-
quantitative analysis, fluorescence intensity along the membrane was tracked, normalized 
to the same maximal intensity, and compared for representative tetO2-PCYC1-ERG9 cells 
grown in the presence or absence of doxycycline. Cells that were grown in the absence of 
doxycycline and showed the wild-type pattern of Can1p distribution in MCC patches yielded 
a fluorescence intensity plot characterized by sharp peaks ranging from minimal to maximal 
relative fluorescence intensities. Due to this distribution, the set of fluorescence intensity 
values is characterized by a relatively low mean fluorescence intensity and a large 
deviation. In contrast to that, proteins that are homogeneously distributed within the 
membrane yield a pattern of fluorescence intensity exhibiting a relatively high mean 
fluorescence intensity and a decreased deviation as shown for Tok1p (Fig. IV-S3B).   
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Fig. IV-13: Characteristic intensity profiles of Can1p-GFP fluorescence along the plasma 
membrane of cells with natural or disturbed ERG9 expression. The fluorescence intensity 
profiles were tracked from the corresponding ECS images (left) and normalized to the same maximal 
fluorescence intensity and track length. The mean fluorescence intensity (continuous red line) as 
well as standard deviations (dashed red line) were calculated for each total set of fluorescence 
intensity values and are indicated for comparison. Can1p-GFP intensity profile patterns changed 
upon ERG9 repression showing an elevated mean fluorescence intensity and a decreased standard 
deviation. 
For tetO2-PCYC1-ERG9 cells grown in the presence of doxycycline, properties of the Can1p-
GFP fluorescence intensity profile were shifted towards an elevated mean fluorescence and 
a decreased deviation, which is characteristic for evenly distributed proteins. The altered 
distribution pattern upon ERG9 repression strongly suggests that lipids and the lipid 
composition, particularly ergosterol and sterols, play a crucial role in the lateral segregation 
of the plasma membrane and are inseparably linked to each other. 
Representative images (Fig. IV-12; bottom) show a vacuolar GFP straining in cells with 
disturbed MCC localization of Can1p that was not observed for cells with a regular Can1p 
pattern in the plasma membrane. This observation supports the assumption that protein 
compartmentation is linked to protein stability and protein turnover and that the basal Can1p 
turnover is faster when the protein is not localized in MCC patches. Experiments presented 
elsewhere [69] could show that Can1p was more accessible to liberation from the 
membrane by mild detergents when the wild-type pattern of protein distribution was 
disturbed. Moreover, Can1p internalization in arginine-rich medium occurred much faster 
upon knockout of NCE102 which also strongly disturbs proper membrane 
compartmentation and MCC formation. Since Can1p delivery to the vacuole induced by an 
excess of external arginine is mediated by classical endocytosis, one could argue that MCC 
localization protects Can1p from initialization by endocytosis. However, this hypothesis is 
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in conflict with the observed colocalization of Can1p and Pil1p, a component of the 
eisosome which is believed to be involved in the initialization of endocytosis [74], unless 
coating of MCCs by cytosolic Pil1p inhibits endocytosis and directs the endocytic activity to 
neighboring membrane areas. In this model, eisosomes would mark membrane sites with 
silenced endocytic activity [73]. 
The equatorial confocal section (ECS) of BY4742 wild-type cells also showed an 
inhomogeneous distribution for Pma1p-GFP within the plasma membrane. However, the 
extension of areas occupied by Pma1p was much larger and the pattern was significantly 
different from that housed by Can1p-GFP. This became especially evident from the 
tangential confocal section (TCS) as well as from the maximal intensity projection (MIP) 
(Fig. IV-14; top). The observed pattern corresponds well to the previously described mesh-
shaped pattern of Pma1p in the plasma membrane of yeast. The characteristic Pma1p 
pattern shown here also supports the previously reported non-overlapping of both 
membrane compartments [50], MCC and MCP, as the distribution of dark holes within the 
mesh of Pma1p fits well to the general distribution of membrane spots occupied by Can1p. 
Moreover, the fluorescence of Pma1p-GFP was much stronger compared to the one 
observed for Can1p-GFP which is consistent with the high abundance of Pma1p in the 
plasma membrane [75]. This ratio also emphasizes that expression rates for both GFP-
tagged proteins were at natural levels. The general Pma1p distribution pattern in tetO2-
PCYC1-ERG9 cells grown in the absence of doxycycline was equivalent to the one observed 
for the wild-type background showing the characteristic dark patches missing the protein 
(Fig. IV-14; middle). The observation that membrane compartments covered by Can1p and 
Pma1p exclude each other [50] compared with the fact that Can1p is associated with 
ergosterol-rich lipid rafts indicates that Pma1p just occupies the membrane areas (MCP) 
that are mainly composed of bulk lipids (glycerophospholipids) and that surround MCCs. 
This way, the rigorous exclusion of Pma1p from MCCs shows how the non-homogenous 
membrane lipid composition and ergosterol/sphingolipid patches provide a mechanism for 
negatively controlling the membrane protein segregation. This functional exclusion must, 
however, include a controlling mechanism that is based e.g. on protein properties itself or 
the mechanism that delivers proteins to the plasma membrane, since not all membrane 
proteins such as Tok1p (Fig. IV-S3), Hxt1p and Gap1p are either excluded from or 
accumulated in lipid-raft structures. 
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Fig. IV-14: Patterns of Pma1p distribution within the plasma membrane of cells with natural 
or decreased ERG9 expression. Fluorescence microscopy images of the tangential (TCS) 
equatorial (ECS) confocal sections as well as corresponding maximum intensity projections (MIP) 
and bright-field images are shown. The characteristic mesh-shaped pattern of Pma1p-GFP 
distribution leading to dark holes within the cell surface was observed in the wild-type background 
(BY4742; top) and tetO2-PCYC1-ERG9 cells grown in the absence of doxycycline (middle). This pattern 
changed to a more homogenous Pma1p distribution in the plasma membrane upon doxycycline-
mediated (40 µg·mL-1) repression of ERG9 in the tetO2-PCYC1-ERG9 background (bottom). 
Disruption of MCCs, resulting from ERG9 repression, as previously shown by an altered 
Can1p-GFP distribution (Fig. IV-12) should consequently also modify Pma1p distribution, if 
Pma1p is actively excluded from ergosterol/sphingolipid patches. Changes in lateral Pma1p 
segregation would be evident from a decrease of Pma1p-free membrane spots by infiltration 
of Pma1p as well as by a more homogenous protein distribution within the plasma 
membrane. Indeed, when Pma1p-GFP expressing tetO2-PCYC1-ERG9 cells were grown in 
the presence of doxycycline, Pma1p distribution became much more homogenous as 
evident from TCS, ECS and MIP images (Fig. IV-14; bottom). These results strongly support 
the hypothesis of plasma membrane segregation by active exclusion as well as the 
involvement of ergosterol-rich membrane microdomains in this mechanism. Control 
experiments showing that the patchy distribution of Can1p as well as the complementary 
network-like Pma1p distribution are also strongly affected in the ergosterol biosynthesis 
mutant ∆erg6 (Fig. IV-S4) further support this hypothesis and suggest that not just the total 
ergosterol/sterol content but also the chemical sterol structure play a crucial role for lateral 
membrane segregation [73]. 
B
Y4
74
2;
 
te
tO
2-P
C
YC
1-E
R
G
9
B
Y4
74
2;
 
te
tO
2-P
C
YC
1-E
R
G
9
TCS ECS MIP bright-field
Pma1p-yEGFP 5 µm
Pma1p-yEGFP
B
Y4
74
2
Pma1p-yEGFP
+ dox
− dox
− dox
• Chapter IV: Ergosterol is essential for protein sorting, endocytosis and protein compartmentation within the 
plasma membrane of yeast cells 
 120 
However, basic question of lateral membrane compartmentation such as the mechanism 
how proteins are directed to specific membrane compartments as well as the functional 
significance of plasma membrane compartmentation could not be answered so far. To 
target the first mentioned question, different mechanisms including the protein structure 
itself can be discussed. Membrane compartments rich in ergosterol and sphingolipids are 
significantly thicker than membrane areas with a high glycerophospholipid content [76] as 
it is also generally true for highly ordered membranes compared to bilayers featuring a low 
ordering parameter [1]. Studies on the prokaryotic membrane fluidity sensor DesK from 
Bacillus subtilis clearly show that membrane proteins are able to sense the thickness of lipid 
bilayers in which they are embedded in [77] and change/lose their structure and function 
[78] in dependence of their lipid environment. In this scenario, the overall length of 
transmembrane domains would be the crucial factor that directs proteins to membrane 
partitions of different thickness [79]. This way, the driving force of lateral protein segregation 
would be of thermodynamic nature with the goal of maximizing beneficial hydrophobic 
protein-bilayer interactions and preventing hydrophobic mismatches that would be e.g. 
assured for longer transmembrane helices only in thicker membrane areas. On a second 
level, protein-protein interactions might direct further proteins to these membrane 
compartments. On the functional level, protein segregation within the plasma membrane 
might be relevant for clustering of proteins whose functions are coupled or at least beneficial 
for each other. This way membrane microdomains would form microenvironments with 
particular biological functions. On the other hand, proteins whose functions negatively affect 
each other or even work in the opposite direction could be functionally separated by 
membrane microdomains. The two proteins, Can1p and Pma1p, shown here might even 
serve as an example for that model: The plasma membrane H+-ATPase pumps protons out 
from the cells thereby generating a proton gradient that can drive the uptake of nutrients 
against the corresponding (electro)chemical gradient mediated by proton symporters like 
Can1p in a secondary-active transport process [80, 81]. This way, proton gradient 
generating and consuming processes would be spatially separated by membrane 
microdomains. 
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4.5. Conclusions 
This study introduces a metabolic engineering approach for regulating the yeast 
endogenous sterol biosynthetic activity by controlling the expression of ERG9, the gate 
keeper enzyme determining the flux of intermediates towards the ergosterol biosynthetic 
pathway. This cellular model was used to monitor physiological effects of ergosterol and 
total sterol depletion. Besides a general impairment of the cell’s general viability, it was 
shown that sterol depletion causes cellular mislocalization of Tat2p, a plasma membrane-
resident tryptophan permease, to the vacuole thereby severely impairing the ability of 
tryptophan uptake from the extracellular environment. Furthermore, it was shown that sterol 
depletion significantly decreases the general endocytic activity of yeast as evaluated by 
electrophysiological capacity measurements. Plasma membrane compartmentation 
characterized by the inhomogeneous distribution of marker proteins Can1p and Pma1p was 
affected upon ERG9 repression and down-regulation the cell’s ergosterol biosynthetic 
activity. The cellular system allowing for genetically controlling the ergosterol biosynthesis 
has proven to be a suitable model to monitor physiological effects of sterol depletion and 
was used to emphasize essential roles of sterols for fundamental cellular processes and 
properties.  
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4.7. Supporting information 
Tab. IV-S1: Plasmids used in this study. The table summarizes basic characteristics and 
properties of indicated plasmids. 
Plasmid description reference 
pUG72 - [30] 
pUG73 - [30] 
pKT203 - [31] 
pGREG503 - [32] 
pGREG600 - [32] 
pCM224 - [39] 
pCM188-OLE1 CEN/ARS; URA3; amp
R; doxycycline 
repressible expression of Ole1p This study 
pGREG576-UPC2 
CEN/ARS; URA3; kanMX; ampR; 
expression of N-terminally GFP-tagged 
Upc2p from galactose inducible GAL1 
promoter 
This study 
pGREG600-UPC2 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally GFP-tagged 
Upc2p from galactose inducible GAL1 
promoter 
This study 
pGREG503-TAT2 
CEN/ARS; HIS3; kanMX; ampR; 
expression of Tat2p from galactose 
inducible GAL1 promoter 
This study 
pGRE600-TAT2 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally GFP-tagged 
Tat2p from galactose inducible GAL1 
promoter 
This study 
pGREG600-PTAT2-TAT2 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally GFP-tagged 
Tat2p from native TAT2 promoter 
This study 
pGREG600-CAN1 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally GFP-tagged 
Can1p from galactose inducible GAL1 
promoter 
This study 
pGREG600-TOK1 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally GFP-tagged 
Tok1p from galactose inducible GAL1 
promoter 
This study 
pGREG505-PIL1-RedStar 
CEN/ARS; URA3; kanMX; ampR; 
expression of C-terminally RedStar-
tagged Pil1p from galactose inducible 
GAL1 promoter 
This study 
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Tab. IV-S2: Primers used in this study. Underlined sequence parts represent homology regions of 
overhang primers used in recombination-based cloning approaches. 
Primer sequence (5’ → 3’) amplicon 
P1 (fw) GCCTAAACGAGCAGCGAGAACACGACCACGGGCTATATAAATGGAAAGTTAGGACAGGGGCCAGCTGAAGCTTCGTACGC 
tetO2-PCYC1 
PRC 
P2 (rv) CAGCTTCAAAGCTGCCTTCATCTCGACCGGATGCAATGCCAATTGTAATAGCTTTCCCATCGCATAGGCCACTAGTGGATCTG 
tetO2-PCYC1 
PRC 
P3 (fw) GCATTGGTGACTATTGAGCACGTGAGTATACGTGATTAAGCACACAAAGGCAGCTTGGAGTCTGAAGCTTCGTACGCTGCAG TRP1 KOC 
P4 (rv) CCAATCCAAAAGTTCACCTGTCCCACCTGCTTCTGGGTAATCAAACAAGGGAATAAACGAATGAGCATAGGCCACTAGTGGATCTG TRP1 KOC 
P5 (fw) CGATTTAAGTTTTACATAATTTAAAAAAACAAGAATAAAATAATAATATAGTAGGCAGCATAAGCTGAAGCTTCGTACGCTGCAG ERG6 KOC 
P6 (rv) CTGCATATATAGGAAAATAGGTATATATCGTGCGCTTTATTTGAATCTTATTGATCTAGTGAATGCATAGGCCACTAGTGGATCTG ERG6 KOC 
P7 (fw) GGGAAGATCATGAACCAAAGACTTTTTGGGACAAATTTTGGAATGTTGTAGCAGGTGACGGTGCTGGTTTA   
yEGFP 
(CAN1) 
P8 (rv) GATCCCTTAAACTTTCTTTTCGGTGTATGACTTATGAGGGTGAGAATGCGAAACGAGGCAAGCTAAACAGATC 
yEGFP 
(CAN1) 
P9 (fw) AAGACTTCATGGCTGCTATGCAAAGAGTCTCTACTCAACACGAAAAGGAAACCGGTGACGGTGCTGGTTTA 
yEGFP 
(PMA1) 
P10 (rv) GCGGCTTATTCTTGTTGGCTCCTAATTCTTTTTAGTGTATCAGTTCCCATTGATCGAGGCAAGCTAAACAGATC 
yEGFP 
(PMA1) 
P11 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGAGCGAAGTCGGTATACAG UPC2 ORF 
P12 (rv) GTTCTTCTCCTTTACTCATTCTCGAGTCGACTAACGAAAAATCAGAGAAATTTGTTGTTG UPC2 ORF 
P13 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGACCGAAGACTTTATTTCTTCTGTC TAT2 ORF 
P14 (rv) GTTCTTCTCCTTTACTCATTCTCGAGGTCGACAAACACCAGAAATGGAACTGTCTC TAT2 ORF 
P15 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGACAAATTCAAAAGAAGACG  CAN1 ORF 
P16 (rv) GTTCTTCTCCTTTACTCATTCTCGAGGTCGACGCTGCTACAACATTCCAAAATTTG  CAN1 ORF 
P17 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGACAAGGTTCATGAACAGC  TOK1 ORF 
P18 (rv) GTTCTTCTCCTTTACTCATTCTCGAGGTCGAAAGTGTCTTTCTATGCTCAC  TOK1 ORF 
P19 (rv) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGCACAGAACTTACTCTTTAAGAAATT PIL1 ORF 
P20 (fw) GCTCCAGCACCAGCACCAGCACCTGCTCCCATCTCGAGAGCTGTTGTTTGTTGGGGAAG PIL1 ORF 
P21 (rv) GTTCTTATGTAGTGACACCGATTATTTAAAGCTGCAGGTCGACCTCGAGATGGGAGCAGGTGCTGGTGC RedStar ORF 
P22 (fw) GTGGGGGGAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGACTCGAGTTACAAGAACAAGTGGTGTCTAC RedStar ORF 
P23 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTCATAACGAAAAATCAGAGAAATTTGTTGTTG UPC2 ORF 
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Primer sequence (5’ → 3’) amplicon 
P24 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGACCGAAGACTTTATTTC TAT2 ORF 
P25 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTTAACACCAGAAATGGAACTG TAT2 ORF 
P26 (fw) AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCCCTTACCAATGGGTGCGCTTA PTAT2 
P27 (rv) CTTGACAGAAGAAATAAAGTCTTCGGTCATATGAGAGTGTGTTGCGTAATTTG PTAT2 
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Fig. IV-S1: Growth of ∆trp1 at intermediate and high tryptophan and strong doxycycline-
mediated ERG9 repression. Growth of plasmid harboring (empty pGREG503 (e.v.) or pGREG503-
TAT2) ∆trp1 cells in wild-type (BY4742) and tetO2-PCYC1-ERG9 genetic background was compared 
at intermediate (20 µg·mL-1) and high (200 µg·mL-1) tryptophan concentrations as well as in the 
additional presence of 40 µg·mL-1 doxycycline (dox). Since TAT2 in pGREG503-TAT2 is expressed 
under control of the GAL1 promoter (PGAL1-TAT2), growth on glucose medium is not affected by the 
respectively harbored plasmid, since plasmid-based expression is only activated on galactose 
medium as shown in (Fig. IV-6C). Growth of the tetO2-PCYC1-ERG9; ∆trp1 strains was severely 
impaired at intermediate tryptophan concentrations when ERG9 expression was repressed (+dox) 
whereas cells grew unimpaired on high tryptophan medium even with repressed ERG9 expression. 
 
 
Fig. IV-S2: Tat2p is targeted to a great extent to the plasma membrane at high expression 
levels even under high tryptophan conditions. C-terminally GFP-tagged Tat2p was expressed 
from the strong GAL1 promoter and subcellular localization was investigated in the presence 
(200 µg·mL-1) and absence of tryptophan. Besides vacuolar delivery, Tat2p localized to the plasma 
membrane when expressed from the PGAL1 even at high external tryptophan concentrations. 
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Fig. IV-S3: Tok1p-GFP is homogeneously distributed within the plasma membrane of yeast 
cells. (A) Fluorescence microscopy images of the tangential (TCS) equatorial (ECS) confocal 
sections as well as corresponding maximum intensity projections (MIP) and bright-filed images are 
shown. All images clearly show a homogeneous distribution of Tok1p-GFP within the plasma 
membrane of yeast. (B) Characteristic intensity profile of Tok1p-GFP fluorescence along the plasma 
membrane. The fluorescence intensity profile was tracked from the indicated ECS image and 
normalized to the maximal fluorescence intensity and track length. The mean fluorescence intensity 
(continuous red line) as well as standard deviations (dashed red line) were calculated for the total 
set of fluorescence intensity values and is indicated for comparison. 
 
 
Fig. IV-S4: Lateral protein segregation within the plasma membrane as well as MCC and MCP 
integrity are disturbed upon knockout of ERG6. Fluorescence microscopy images of the 
tangential (TCS) equatorial (ECS) confocal sections as well as corresponding maximum intensity 
projections (MIP) and bright-field images are shown. BY4742 cells lacking Erg6p lose their 
characteristic punctuate pattern of Can1p-GFP distribution as well as the mesh-shaped pattern of 
Pma1p-GFP distribution within their plasma membrane. 
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5. Chapter V: Preloading budding yeast with all-in-one CRISPR/Cas9 vectors 
for easy and high-efficient genome editing 
5.1. Abstract 
Previous chapters included many experiments using genetically modified yeast strains 
featuring gene knockouts, promoter replacements and genomically integrated gene 
expression cassettes. Generation of those strains is time consuming and even often fails 
when applying established genetic engineering techniques due to the limited efficiency of 
homologous recombination-based genomic manipulations in S. cerevisiae. The 
CRISPR/Cas9 technology has greatly improved genome editing in S. cerevisiae over recent 
years. However, current CRISPR/Cas9 systems also suffer from work-intensive cloning 
procedures and the requirement of co-transforming target cells with multiple system 
components at once which can reduce the effectivity of such applications. To overcome 
previously described limitations, a new set of all-in-one CRISPR/Cas9 vectors that mediate 
constitutive gRNA expression whereas Cas9 expression can be either driven from a 
constitutive or an inducible promoter was constructed. The introduction of desired gRNA 
targeting sequences into the here introduced inducible single gRNA vector relies simply on 
homologous recombination-mediated one-step assembly of overlapping single-stranded 
oligonucleotides, thus reducing efforts of plasmid cloning to an absolute minimum. By 
employing the inducible system, yeast cells can be easily preloaded with plasmids encoding 
for a functional CRISPR/Cas9 system, thereby chronologically separating the cloning 
procedure from the genome editing step. The CRISPR/Cas9 vectors were tested for 
conventional marker-based genome editing applications. Gene knockouts could be 
achieved with high efficiency and effectivity by simply transforming preloaded cells with a 
selectable disruption cassette without the need of co-introducing any CRISPR/Cas9 system 
component. Furthermore, the feasibility of efficient gene knockouts even when multiple 
gene copies were present such as in industrial (non-haploid) strain backgrounds is 
demonstrated. Simultaneous deletion of two different genes in a haploid genetic 
background was also possible by using a multiplex variant of the inducible all-in-one vector. 
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5.2. Introduction 
The CRISPR/Cas9 technology has become an important and powerful tool in yeast genome 
editing and is by now a routinely used biomolecular technique in yeast laboratories all over 
the world. Daily routine benefits from a fast and affordable technique that is additionally 
easy in application. Thus, the „yeast community” has developed a number of variants of the 
CRISPR/Cas9 technology that allow for a convenient application of the system [1].  
A functional CRISPR/Cas9 system consists of two components – the Cas9 endonuclease 
and a guide RNA (gRNA). The Cas9 protein binds the gRNA, which contains a 5’-terminal 
20 bp targeting sequence, to form a functional protein-RNA complex. By this means, Cas9 
is enabled to scan DNA targets such as genomic DNA in an gRNA-guided manner for 
sequences (so-called protospacer sequences) that are identical to the specific gRNA-
targeting sequence. Identified target sequences are cleaved by the Cas9 endonuclease if 
a protospacer adjacent motif (PAM) follows the protospacer sequence within the genome. 
Early plasmid-based approaches employed separate vectors for expressing Cas9 and the 
gRNA. Thereby, gRNA cassette-encoding plasmids had to be cloned every time from 
scratch to target a new gene locus, resulting in an inconvenient overall procedure. 
Consecutive transformations of the Cas9 expression plasmid and the gRNA-encoding 
plasmid (plus donor DNA where applicable) were necessary to yield efficient gene 
disruption or genomic integration of the donor DNA since the overall efficiency suffers from 
the multiplicative linking of the efficiency of the individual transformation events. These 
restrictions could be avoided by stably integrating a Cas9 expression cassette into the 
genome so that only the gRNA has to be expressed from an episomal plasmid [2]. This 
way, genetic modifications can be performed efficiently by just co-transforming a respective 
gRNA-encoding plasmid together with the donor DNA. Nevertheless, this approach requires 
previous time-consuming genetic modifications of the desired background strain which also 
limits its simple use. 
Recently, various approaches were published that allow for a simultaneous expression of 
Cas9 and the gRNA from a single plasmid as well as convenient introduction of the 20 bp 
gRNA protospacer sequence. This were either introduced by restriction free cloning [3], 
PCR-based amplification of the whole vector backbone combined with Gibson Assembly 
[4], Gibson Assembly-mediated introduction of oligonucleotides [5], Golden Gate Assembly 
with protospacer sequence containing gBlocks [6] or by classical restriction ligation-based 
cloning using hybridized oligonucleotides as an insert [7]. One-step transformation of all 
CRISPR/Cas9 system components together with the donor DNA yielded genomic editing in 
all cases. Although these approaches already allow for an easy application of the 
CRISPR/Cas9 technology additional improvements can help for further streamlining the 
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workflow by simultaneously further increasing the effectivity of CRISPR/Cas9-mediated 
genomic editing in S. cerevisiae. One improvement was inspired by the “synthesis of DNA 
fragments in yeast by one-step assembly of overlapping oligonucleotides” [8] which should 
be an appropriate method for a straightforward introduction of the 20 bp protospacer 
sequence into the expression vector. By using this method, plasmid cloning relies solely on 
the robust yeast-endogenous homologous recombination (HR) machinery without the need 
for any PCR applications or any other conventional in vitro cloning method. A second 
improvement should help to overcome limitations of transformation efficiency that result 
from co-transforming of multiple system components (donor DNA and gRNA/Cas9 
encoding elements) which is an essential step of all so far published CRISPR/Cas9 
technology variants. In the system presented here, the gRNA protospacer sequence is 
introduced into the plasmid by in vivo recombination-based cloning and subsequently uses 
yeast cells derived from a single clone for a second transformation with the respective donor 
DNA. Thus, every single yeast cell used for this second transformation should be already 
preloaded with all essential CRISPR/Cas9 components and the overall efficiency relies 
solely on the transformation efficiency regarding the donor DNA and is not a multiplicative 
product of single transformation efficiencies of different system components. By exploiting 
the tightly controllable yeast endogenous GAL1 promoter for expression of the Cas9 
endonuclease, the CRISPR/Cas9 system is kept inactive until donor DNA is delivered and 
intracellularly available, thus preventing induction of DSBs without proper repair using donor 
DNA as a template for homology directed repair.  
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5.3. Materials and Methods 
5.3.1. Yeast strains 
Experiments were performed with the haploid yeast strain CEN.PK2-1C [9], its diploid 
derivative CEN.PK2 [9] and the tetraploid yeast strain YCC78 (Y558) [10]. CEN.PK2 strains 
were obtained from EUROSCARF. Detailed information on the respective genotypes are 
available in Tab. V-1. 
Wild-type strains were routinely cultured in YPD media (2% glucose, 2% peptone, 1% yeast 
extract). Strains harboring plasmids with the URA3 marker were grown in appropriate 
synthetic defined drop-out media (2% glucose or 2% galactose, yeast nitrogen base (YNB), 
amino acid supplement without uracil). Cells were routinely propagated at 30°C. 
Tab. V-1: Yeast strains used in this study. The table lists all strains with corresponding genotypes. 
Plasmids harbored by respective strains are named as indicated in Tab. V-S1. 
strain genotype reference 
CEN.PK2-1C MATa; his3∆1; leu2-3,112; ura3-52; trp1-289; MAL2-8c; SUC2 [9] 
CEN.PK2-1D MATa; his3∆1; leu2-3,112; ura3-52; trp1-289; MAL2-8c; SUC2 [9] 
CEN.PK2 MATa/ MATα; his3∆1/ his3∆1; leu2-3,112/ leu2-3,112; ura3-52/ 
ura3-52; trp1-289/ trp1-289; MAL2-8c/ MAL2-8c; SUC2/ SUC2 [9] 
YCC78 (Y558) 
MATa/ MATa/ MATa/ MATa; 
ura3-52/ ura3-52/ ura3-52/ ura3-52; 
LYS2/ lys2-801/ LYS2/ lys2-801; 
ade2-101/ ade2-101/ ade2-101/ ade2-101; 
HIS3/ his3∆200/ his3∆200/ his3∆200; 
trp1∆1/ trp1∆1/ trp1∆1/ trp1∆1; 
TYR1/ tyr1/ TYR1/ TYR1 
[10] 
BY4741 MATa; his3D1; leu2D0; met15D0; ura3D0 [11] 
SV-1 CEN.PK2-1C; pCAS9i-antiADE2 This study 
SV-2 CEN.PK2-1C; ade2::loxP-LEU2-loxP; pCAS9i-antiADE2 This study 
SV-3 CEN.PK2-1C; pCAS9i (empty) This study 
SV-4 CEN.PK2-1C; pCAS9id-antiADE2/CAN1 This study 
SV-5 CEN.PK2; pCAS9i-antiADE2 This study 
SV-6 YCC78; pCAS9i-antiADE2 This study 
SV-7 CEN.PK2-1C; pCAS9id-anitMATx/MATz This study 
SV-8 BY4741; pCAS9id-anitMATx/MATz This study 
SV-9 CEN.PK2-1C; pGREG506 This study 
SV-10 BY4741; pGREG506 This study 
SV-11 CEN.PK2-1D; pGREG506 This study 
• Chapter V: Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient 
genome editing 
 136 
5.3.2. Plasmid construction and yeast transformation 
The 2-micron (2µ) sequence of plasmid pRS425 was amplified with the primers P1 and P2 
and used to replace the CEN/ARS sequence of the BglII/NheI (NEB) cleaved plasmid 
pCM188 [12] via recombination-based cloning resulting in plasmid pCM188(2µ). The gRNA 
expression cassette from plasmid p425-SNR52p-gRNA.HIS3-SUP4t (is equivalent to p426-
SNR52p-gRNA.CAN1.Y-SUP4t [13] but with pRS426 backbone and antiHIS3-gRNA; kindly 
provided by Dr. Christopher Schneider; Technische Universität Darmstadt) was amplified 
with two individual PCRs (Q5 DNA polymerase, NEB) using overhang primers P3 & P4 (for 
PSNR52) and P5 & P6 (for gRNA scaffold sequence - TSUP4). The overhang primers were 
designed in a way that introduces a gRNA stuffer sequence (contains unique KpnI & MssI 
restriction sites) between PSNR52 and the gRNA scaffold sequence and allows for integrating 
the gRNA expression cassette into AvrI (NEB) cleaved vector pCM188(2µ). Assembly of 
the universal gRNA cassette and simultaneous integration into pCM188(2µ) were 
performed by in vivo recombination-based cloning. The URA3 marker-2µ-universal gRNA 
cassette from the yielded plasmid was amplified (Q5 DNA polymerase, NEB) with the 
primers P7 & P8 and introduced into the KpnI & SnaBI cleaved plasmid p414-TEF1p-Cas9-
CYC1t [13] by recombination-based cloning with simultaneous removal of the TRP1 marker 
and the CEN/ARS sequence. The resulting plasmid was called pCAS9c (constitutive). To 
generate pCAS9i (inducible), PTEF1 from plasmid pCAS9c was replaced by PGAL1. For that, 
pCAS9c was linearized with SpeI (NEB) and PGAL1 amplified (Q5 DNA polymerase, NEB) 
from plasmid pGREG504 [14] with primers P9 & P10 was introduced by recombination-
based cloning. Multiplex plasmids pCAS9cd und pCAS9id (duplex) were generated by 
introducing a second gRNA expression cassette into NotI-cleaved plasmids pCAS9c and 
pCAS9i. The gRNA expression cassette was PCR-amplified (Q5 DNA polymerase, NEB) 
with primers P34 and P35 from plasmid pCAS9c or pCAS9i, respectively. All cloning 
products were checked by PCRs using pairs of primers that amplify a DNA fragment 
containing the artificial integration border that results from the HR event. 
Transformation of CEN.PK2-1C for recombination-based cloning in vivo was routinely 
carried out by using the Frozen-EZ Yeast Transformation II kit (Zymo Research) according 
to the manufacturer’s instructions. PCRs were performed according to the manufacturer’s 
instructions. Primers and oligonucleotides used in this study are listed in Tab. V-1. 
5.3.3. gRNA protospacer sequences 
The anti-ADE2 protospacer sequence (AATTGTAGAGACTATCCACA) was taken from the 
previously described CasEMBLR approach [15]. The anti-CAN1 protospacer sequence 
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(GATACGTTCTCTATGGAGGA) was adopted from DiCarlo et al. [13]. The protospacer 
sequences anti-ADE8 (GAGAACAAGCCTCTGACGGC), anti-MATx (TCTTCTGTTGTTAC 
ACTCTC) and anti-MATz (CACTCTACAAAACCAAAACC) were designed by using the 
ATUM gRNA Design Tool (https://www.atum.bio/eCommerce/cas9/input). 
5.3.4. Assembly PCR 
A full-length gRNA expression cassette that contains an ADE2 targeting protospacer 
sequence was constructed via assembly PCR. First, two individual fragments were 
amplified (Q5 DNA polymerase): P11 & P12 were used to amplify PSNR52 (F1; 311 bp) and 
P13 & P14 were used to amplify the gRNA scaffold - TSUP4 sequence (F2; 211 bp) from 
vector pCAS9c, respectively. P12 & P13 are overhang primers that introduce the 20 bp 
ADE2 targeting protospacer sequence to one end of both fragments, respectively, that also 
functions as overlapping regions for the assembly reaction. F1 and F2 were gel purified 
(Zymoclean Gel DNA Recovery Kit, Zymo Research) and 3 µL of each gel purified fragment 
were used as a template for a second PCR (assembly reaction; Q5 DNA polymerase, NEB) 
employing primers P11 & P14. The resulting assembly product (AP; 502 bp) was checked 
via gel electrophoretic analysis (Fig. V-S1). 
5.3.5. Introduction of gRNA protospacer sequences into plasmids pCAS9c(d) and 
pCAS9i(d) 
Different methods (A; B; C) were used to introduce the respective gRNA protospacer 
sequence into plasmids pCAS9c(d) and pCAS9i(d):  
Method A: Co-transformation of KpnI & PmeI (NEB) cleaved plasmid pCAS9c/pCAS9i 
(250 ng) with oligonucleotides (500 pmol each; P12 & P13 for ADE2; P28 & P29 for ADE8) 
carrying the protospacer sequence or the complementary sequence, respectively, at their 
5’ ends. 
Method B: Co-transformation of KpnI & PmeI (NEB) cleaved plasmid pCAS9c/pCAS9i 
(250 ng) with the anti-ADE2 gRNA expression cassette (10 µL) generated via assembly 
PCR. 
Method C: The entire vector backbone was amplified (Q5 DNA polymerase, NEB) with 
primers carrying the protospacer sequence or the complementary sequence, respectively, 
at their 5’ ends (P12 & P13 for ADE2; P28 & P29 for ADE8) using KpnI & PmeI cleaved 
pCAS9c/pCAS9i as the template. 20 µL of the unpurified PCR product were directly used 
for transformation. In case of pCAS9cd/pCAS9id, the plasmids were amplified by two 
individual PCRs with overhang primers adding different gRNA protospacer sequences to 
the ends of each plasmid fragment (pCAS9id-antiADE2/CAN1: P12 & P36 for the large 
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fragment, P13 & P37 for the short fragment; pCAS9id-antiMATx/MATz: P41 & P42 for the 
large fragment, P40 & P43 for the short fragment). The large fragments are amplified from 
NotI-cleaved template plasmids whereas StuI & SalI cleaved plasmids serve as templates 
for amplifying the short fragments. 10 µL of each PCR product were used for transformation. 
Circularization of the plasmids should be achieved for all methods via homologous 
recombination in yeast without requiring any other in vitro cloning method. This keeps the 
systems as simple as possible. 
As a proof of principle, successful introduction of the ADE2 targeting protospacer sequence 
into plasmid pCAS9i with methods A, B or C was proved with colony PCR. A pair of primers 
was used with one primer (P25) binding within the protospacer sequence and the other one 
(P26) within the plasmid backbone. 
5.3.6. Assays for testing functionality and efficiency of pCAS9c- and pCAS9i-based 
approaches 
For testing plasmid pCAS9c, yeast cells were inoculated at OD600 = 0.2 – 0.3 in YPD and 
grown to OD600 = 0.9 – 1.0 at 30°C with continuous shaking (200 rpm). Cells from 4 mL of 
this suspension were used for transformation using a commercial kit (Frozen-EZ Yeast 
Transformation II kit; Zymo Research). Depending on the method (A; B; C) employed for 
introducing the gRNA protospacer sequence, cells were transformed with the respective 
DNA components and PCR-amplified donor DNA (loxP-LEU2-loxP for ADE2 locus: 1 µg 
(20 µL); loxP-LEU2-loxP as 500 bp fragments for ADE2 locus: 0.5 µg (10 µL) each; loxP-
kanMX-loxP for ADE8 locus: 1 µg (20 µL); HIS3 for CAN1: 1µg (20µL)).  
The respective gRNA targeting sequence was introduced in plasmid pCAS9i using method 
A (for pCAS9id with method C) and cells harboring pCAS9i with introduced gRNA targeting 
sequence were selected on SD-ura agar plates. Single colonies were inoculated in SD-ura 
and grown over night at 30°C. From the overnight cultures, fresh cultures were set up at 
OD600 = 0.2 – 0.3 in SD-ura and grown to OD600 = 0.9 – 1.0 at 30°C with continuous shaking 
(200 rpm). Cells from 4 mL suspension were washed once with sterile water, transferred to 
4 mL SGal-ura medium and incubated for 1 h at 30°C. These cells were transformed with 
PCR-amplified donor DNA (see above) using the Frozen-EZ Yeast Transformation II kit 
(Zymo Research). 
To enhance transformation efficiency, cells were resuspended in 1 mL YPD (pCAS9c) or 
YPGal (pCAS9i) after incubation in EZ3 solution (1 h) and incubated at 30°C for 2 h for 
recovery. After the recovery period, cells transformed with loxP-LEU2-loxP donor DNA were 
spread on SD-ura-leu or SGal-ura-leu agar plates, respectively. YCC78 cells that were 
transformed with loxP-kanMX-loxP donor DNA were plated on YPD+G418 (200 µg·mL-1) or 
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YPGal+G418, respectively, to select for positive transformants. G418 resistant 
transformants were replica plated on SD-ura plates to screen for the presence of pCAS9 
plasmids. Cells that were disrupted in the CAN1 locus were selected in arginine-free (-arg) 
canavanine-containing (60 µg/L) medium. 
For gRNA negative control experiments (-gRNA), unmodified plasmids pCAS9c or pCAS9i 
(250 ng) harboring no proper gRNA targeting sequence were employed for previously 
described approaches. 
loxP-LEU2-loxP donor DNA for integration into the ADE2 locus was amplified from plasmid 
pUG73 [16] by PCR (OneTaq DNA polymerase, NEB) using primers P15 and P24. 
Fragmented loxP-LEU2-loxP donor DNA was PCR-amplified as five separate 500 bp 
fragments (F1: P15 & P16; F2: P17 & P18; F3: P19 & P20; F4: P21 & P22; F5: P23 & P24). 
loxP-kanMX-loxP donor DNA for integration into the ADE8 locus was amplified from plasmid 
pUG6 [17] by PCR (OneTaq DNA polymerase, NEB) using primers P30 and P31. HIS3 
donor DNA for integration into the CAN1 locus was amplified from plasmid pGREG504 [14] 
by PCR (OneTaq DNA polymerase, NEB) using primers P38 and P39. PCR-amplified donor 
DNA had approx. concentrations of 50 ng·µL-1 as determined by comparison to DNA marker 
ladder so that 1 µg of donor DNA in total (20 µL) was typically employed for each 
transformation. 
Assays to determine plasmid functionality and efficiency were performed as at least 
biological triplicates. The arithmetic mean was calculated to determine the average number 
of positive transformants. 
5.3.7. Colony PCR 
Colony PCRs were performed in order to confirm the integration of donor DNA into the 
respective locus. A pair of primers was used with one primer binding within the genomic 
locus and the other one within the integrated donor DNA cassette so that a PCR product 
(loxP-LEU2-loxP in ADE2: P27 & P16; loxP-kanMX-loxP in ADE8: P32 & P33) only appears 
when the right cassette was integrated into the right locus. For preparing the PCR template, 
yeast cells were suspended in 30 µL of 0.2% SDS and incubated for 10 min at 95°C. 0.5 µL 
of the cell suspension was used as template for a 25 µL PCR mix. Colony PCRs were 
conducted with the Taq polymerase (OneTaq 2X Master Mix with Standard Buffer; NEB).  
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5.4. Results and Discussion 
5.4.1. General design of the system 
The aim was to develop a CRISPR/Cas9 system for application in S. cerevisiae that is 
based on a single plasmid and especially allows for a simple introduction of a gRNA 
protospacer sequence for targeting any desired gene or locus of the yeast (nuclear) 
genome. For that, plasmid pCAS9c was constructed that harbors a 38 bp stuffer within its 
gRNA expression cassette which serves as a placeholder for the protospacer sequence to 
be introduced. The stuffer can be easily removed by simply double-cleaving pCAS9c with 
KpnI and PmeI (Fig. V-1A). The “synthesis of DNA fragments in yeast by one-step assembly 
of overlapping oligonucleotides” [8] was considered to be appropriate as a fast, easy and 
low-cost method for introducing a desired 20 bp gRNA protospacer sequence into the 
double-cleaved plasmid. By using this method, protospacer introduction and plasmid 
recircularization would rely solely on the robust yeast-endogenous homologous 
recombination (HR) machinery without the need for any PCR applications or any other 
conventional in vitro cloning method. Just commercially available short oligonucleotides that 
not even need to be hybridized beforehand would be required to introduce and determine 
any desired protospacer sequence. 
 
Fig. V-1: Schematic representation of the all-in-one gRNA-Cas9 expression vectors pCAS9c 
and pCAS9i. (A) Both plasmids contain identical backbone elements such as an URA3 selection 
marker, a 2-micron (2 µ) sequence and an ampR bacterial selection marker (not shown) as well as 
a universal gRNA expression cassette consisting of the yeast-endogenous SNR52 promoter, the 
constant guide RNA scaffold sequence and the SUP4 terminator sequence. A stuffer sequence 
serves as a placeholder for the respective gRNA targeting (protospacer) sequence. Both plasmids 
differ in the promoter that is driving the expression of the Cas9 gene. Cas9 is either expressed from 
the constitutive TEF1 promoter (pCAS9c) or from the inducible GAL1 promoter (pCAS9i). (B) Both 
plasmids harbor specific restriction sites that allow for an easy exchange of the URA3 selection 
marker (StuI, NcoI) and the respective promoter sequences (PTEF1: SpeI; PGAL1: AgeI) via gap repair 
cloning. 
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Plasmid pCAS9c was furthermore designed to support its convenient application: Plasmid 
pCAS9c harbors a 2µ ORI (Fig. V-1A) that allows for a high copy number and promotes 
high expression levels of gRNA and Cas9. Additionally, 2µ plasmids show decreased 
segregational stability as compared to centromeric plasmids [18] which benefits the loss of 
pCAS9c after genome editing operations. The URA3 selection marker allows for positive 
selection of cells, that have lost pCAS9c plasmids, on 5-FOA containing media [19]. 
However, the application of pCAS9c is not limited to the use of URA3 as selection marker 
since pCAS9 plasmids contain unique restriction sites (Fig. V-1B) that allow for a fast and 
easy exchange of boths, the selection marker as well as the TEF1 promoter via gap repair 
cloning. This way, these plasmids provide a good basis for generating derivative plasmids 
harboring dominant antibiotic resistance markers (kanMX, natMX) that are useful to 
maintain pCAS9 plasmids in wild yeasts and industrial strains that do not support the use 
of standard selection markers. Promoter exchange might be desired if high Cas9 expression 
levels from pCAS9c severely impair growth of the background strain, as it was described 
elsewhere [4]. 
5.4.2. Single plasmid-mediated CRISPR/Cas9 genome editing 
The ADE2 locus was selected as target for site-specific cleavage and for subsequent 
integration of a donor DNA cassette (loxP-LEU2-loxP) that serves as a template for 
homologous recombination-based repair of gRNA-Cas9 induced DNA double-strand breaks 
(DSBs). The ADE2 locus was chosen since interruption of the adenine biosynthetic pathway 
at the stage of Ade2p leads to the intracellular accumulation of a red pigment (AIR) and 
accordingly to the formation of red colonies [20] which serves as an easy assay read-out. 
Red colony color in combination with a Leu+ phenotype indicates that the desired donor 
DNA was integrated in the right locus and therefore clearly characterizes positive 
transformants. 
To functionally test the pCAS9c plasmid construct, cells of the haploid laboratory strain 
CEN.PK2-1C were co-transformed with KpnI & PmeI cleaved pCAS9c, oligonucleotides 
carrying the ADE2 targeting protospacer sequence or the complementary sequence, 
respectively, at their 5’ ends (method A) as well as PCR-amplified loxP-LEU2-loxP donor 
DNA. Method A would serve as an extraordinarily straightforward approach if protospacer 
introduction into plasmid pCAS9c by assembling overlapping oligonucleotides would be 
efficient enough to allow for a single transformation to deliver all the required CRISPR/Cas9 
components (Cas9, gRNA, donor DNA) into a cell. However, no transformants could be 
obtained by using this approach (Fig. V-3A) which might be due to a low efficiency of 
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recombination between two individual ss-oligonucleotides and the linearized plasmid 
compared to when a single dsDNA fragment derived from two annealed ss-oligos is 
employed as protospacer insert that worked for other approaches [2]. To test the general 
functionality of plasmid pCAS9c, the previous transformation was repeated, but both ss-
oligonucleotides were replaced by a pre-assembled gRNA expression cassette (10 µL) 
(method B) constructed by assembly PCR (Fig. V-S1). This approach gave approximately 
30 positive transformants, whereas a control experiment without gRNA in which only 
uncleaved and unmodified pCAS9c was used (-gRNA control) yielded no transformants 
(Fig. V-3A;B). This demonstrates that anti-ADE2 gRNA and Cas9 were successfully 
expressed from pCAS9c and CRISPR/Cas9-mediated cleavage of ADE2 efficiently 
promoted genomic integration of the loxP-LEU2-loxP donor DNA. It was tested further, 
whether plasmid pCAS9c is also suitable for an approach where the gRNA protospacer 
sequence is introduced by amplifying the whole vector backbone with overhang primers 
carrying the anti-ADE2 protospacer sequence at their 5’ ends, respectively (method C). 
Circularization of the plasmid and thereby reconstitution of the functional gRNA expression 
cassette are obtained by in vivo homologous recombination. CEN.PK2-1C was co-
transformed with the PCR-amplified pCAS9c backbone and loxP-LEU2-loxP donor DNA. 
This approach yielded a similar number of transformants as the previously described 
approach that used a pre-assembled gRNA expression cassette (Fig. V-3A;B). 
5.4.3. High-efficient genome editing by preloading yeast with all-in-one 
CRISPR/Cas9 vectors 
To follow up on a straightforward approach that utilizes one-step assembly of overlapping 
single-stranded oligonucleotides for introducing the protospacer sequence, plasmid 
pCAS9c was further modified. For this, the constitutive TEF1 promoter of pCAS9c was 
replaced with the tightly controllable and inducible yeast endogenous GAL1 promoter, 
yielding plasmid pCAS9i (Fig. V-1A). A desired protospacer sequence can be introduced 
into pCAS9i via in vivo homologous recombination-based cloning by either using cloning 
method A, B or C without being at risk to generate lethal gRNA-Cas9 induced DNA DSBs. 
This way, plasmid assembly and CRISPR/Cas9-mediated genome editing (e.g. donor DNA 
integration) can be chronologically separated into two individual sequential steps. 
Cloning methods A, B and C (Fig. V-2) were proved to be suitable to introduce the ADE2 
gRNA targeting sequence into plasmid pCAS9i as confirmed by colony PCR (Fig. V-S2). 
Since cloning method A is the least labor-intensive and therefore most interesting approach, 
three randomly selected transformants generated with this method were used for further 
proceeding. All cells derived from a single transformant harbor plasmid pCAS9i that 
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encodes for the Cas9 endonuclease as well as the anti-ADE2 gRNA. By switching cells to 
galactose medium (SGal-ura) for 1 h prior to transformation with donor DNA (Fig. V-2), 
every single cell that is used for transformation should be already pre-loaded with anti-ADE2 
gRNA and Cas9, so that a functional CRISPR/Cas9 system is constituted, enabling 
introduction of DSBs in the ADE2 locus. Only those cells in which DSBs were repaired by 
correct integration of the loxP-LEU2-loxP cassette were selected on appropriate medium 
(SGal-leu-ura). 
 
Fig. V-2: General experimental procedure of pCAS9i-supported CRISPR/Cas9 genome editing 
in S. cerevisiae. The stuffer sequence of plasmid pCAS9i is removed by double-cleaving the vector 
with KpnI and PmeI (top left). A desired protospacer sequence can be introduced into the linearized 
vector pCAS9i by method A (one-step assembly of overlapping single-stranded oligonucleotides), 
method B (introduction of a gRNA expression cassette previously generated with assembly PCR) or 
method C (PCR amplification of pCAS9i backbone with overhang primers that add the protospacer 
sequence to both ends of the PCR product) (top row). The target strain is (co-)transformed with all 
plasmid components so that plasmid assembly and recircularization occurs in vivo by recombination-
based cloning. Positive transformants are selected on SD-ura agar plates (bottom left). Proper 
introduction of the desired gRNA protospacer sequence into plasmid pCAS9i can be checked 
optionally by colony PCR. A single transformant harboring the protospacer containing plasmid 
(pCAS9i-antiX) is grown overnight in SD-ura liquid medium and used for a second transformation 
with the respective donor DNA to be genomically integrated. Prior to this second transformation 
pCAS9-antiX harboring cells are shifted to SGal-ura medium for 1 h in order to introduce Cas9 
expression from the GAL1 promoter and preloading cells with gRNA and the Cas9 endonuclease. 
Transformed cells can be selected on appropriate SGal agar medium. If a donor DNA contains a 
selection marker, cells may be spread on SGal-ura medium that is lacking for a second nutrient 
(bottom row). 
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The pCAS9i-based approach was expected to be much more efficient than the one that 
uses pCAS9c, since negative effects resulting from the inevitable requirement of co-
transforming more than one system component, as well as of temporal timing of gRNA/Cas9 
expression and donor DNA delivery/ availability are not prejudicial to the overall efficiency 
anymore. Indeed, with an identical number of cells employed for transformation, obtained 
some 20-fold more positive transformants were obtained with the pCAS9i-based approach, 
as compared to the afore described approaches (Fig. V-3A,B). Obtained transformation 
efficiencies (Tab. V-2) were in the same range as for previously reported CRISPR/Cas9 
applications [13]. Identical results can be expected when strains are used that were derived 
from cloning methods B and C since both of them yield exactly the same plasmid pCAS9i-
antiADE2. A control strain harboring unmodified pCAS9i (without the anti-ADE2 
protospacer sequence) yielded no positive transformants after transformation with donor 
DNA (Fig. V-3A). 
Disruption of ADE2 by genomic integration of the loxP-LEU2-loxP cassette was confirmed 
by colony PCR with five randomly selected transformants obtained by using plasmids 
pCAS9c and pCAS9i-based approaches. All tested transformants were confirmed to be 
positive with no exception (Fig. V-S3).  
To characterize the efficiency of plasmid loss after genome editing, positive transformants 
were cultured for a single round in non-selective medium (YPD) overnight. Subsequently, 
cells were spread on YPD to obtain single colonies and colonies were picked and streaked 
on YPD and SD-ura agar plates. 94% (47 from 50) of the cells did not grow on uracil-free 
medium anymore which indicates a high frequency of plasmid loss. In daily lab applications, 
URA3 would also allow for a positive selection of plasmid-freed cells on 5-FOA containing 
medium. 
5.4.4. pCAS9i-mediated toxicity 
Unrepaired DNA DSBs are lethal in S. cerevisiae [21, 22] leading to a beneficial reduction 
of false positive clones in CRSIPR/Cas9 applications. Therefore, the degree of toxicity 
caused by the expression of a functional CRISPR/Cas9 system from plasmid pCAS9i-
antiADE2 should be determined. For that, plasmid pCAS9i-antiADE2 harboring cells were 
spotted in 10-fold serial dilutions on uracil-free glucose (SD-ura) or galactose (SGal-ura) 
containing medium that only selects for plasmid-carrying cells. On glucose containing 
medium, cells grew unaffected as Cas9 expression is repressed, whereas galactose 
containing medium, i.e. expression of a functional Cas9-gRNA complex, strongly impaired 
growth (Fig. V-3C). Cells that were either expressing a functional ADE2-targeting 
CRISPR/Cas9 system but provided no proper genomic target sequence that could be 
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addressed by the Cas9-gRNA complex (a strain that was already disrupted in ADE2 by 
previously CRISPR/Cas9-supported donor DNA integration) or that contained the native 
ADE2 locus but expressed no ADE2-targeting gRNA (empty pCAS9i harboring the 
protospacer stuffer sequence) served as controls that were expected to grow unaffected. 
 
Fig. V-3: Application of Cas9- and gRNA-encoding plasmids pCAS9c- and pCAS9i for 
CRISPR/Cas9-supported genome editing of yeast cells with different ploidy levels. (A) An 
ADE2 disruption (ade2::loxP-LEU2-loxP) was introduced in the haploid strain CEN.PK2-1C by 
pCAS9c- (grey bars) or pCAS9i- (black bars) based approaches and the number of positive 
(knockout) transformants was determined. gRNA negative controls (-gRNA; used unmodified 
plasmids pCAS9c or pCAS9i that do not encode for a functional anti-ADE2 gRNA) yielded no positive 
transformants. Mean values and standard deviations from at least triplicate experiments are 
indicated. The identical number of cells was employed for each transformation and approach. 
Efficiencies are indicated above the bars and represent the percentage of positive transformants of 
all cells that survived after transformation on the SGal-leu-ura selection media. n.d. = not detected 
(B) Representative agar plates showing the number of positive ADE2 knockout transformants of the 
haploid strain CEN.PK2-1C (see A) that were yielded with approaches that used pCAS9c (method 
B or method C) or pCAS9i (method A). Cells were selected on indicated media, respectively. (C) 
pCAS9i-mediated toxicity was investigated by spotting plasmid pCAS9i-antiADE2 harboring cells in 
10-fold serial dilutions on glucose and galactose containing media, respectively. Growth on galactose 
containing media was severely impaired as Cas9 expression is activated. Control strains that do not 
express a functional gRNA (empty pCAS9i without anti-ADE2 protospacer sequence) or that do not 
provide a proper genomic protospacer sequence (cells are already disrupted in ADE2 by previously 
CRISPR/Cas9-supported donor DNA integration) grew unimpaired on galactose containing medium. 
(D) Number of diploid CEN.PK2 cells with successfully disrupted ADE2 by pCAS9c- (grey bars) or 
pCAS9i- (black bars) based approaches. (E) For the tetraploid strain YCC78, CRISPR/Cas9-
supported disruption of ADE8 (ade8::loxP-kanMX-loxP) was performed with a pCAS9c- or a pCAS9i-
based approach and the number of positive transformants was determined. Unless specified 
differently (as for CEN.PK2-1C), anti-ADE2/ADE8 protospacer sequence was introduced into 
pCAS9c by method C and into pCAS9i by method A. For further explanations of the graphs see (A). 
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Both control strains grew unimpaired on galactose containing media (Fig. V-3C). These 
results indicate a high degree of CRISPR/Cas9-induced toxicity when no donor DNA for 
HR-mediated repair of DSBs is available and helps to select for positive transformants in 
the pCAS9i-based CRISPR/Cas9 approach. 
For a similar test, highly diluted suspensions of pCAS9i-antiADE2 harboring CEN.PK2-1C 
cells as well as of the previously described control strains were plated on glucose- (SD-ura) 
and galactose containing (SGal-ura) media to obtain single colonies. On glucose containing 
medium, colonies recovered from all plated cells for all tested strains (Fig. V-S4), whereas 
galactose strongly impaired the appearance of colonies when pCAS9i-antiADE2 was 
present in an unmodified CEN.PK2-1C genetic background (Fig. V-S4A). Only a small 
percentage of cells (2.7 ± 0.5%; n = 3) formed colonies with the same size as cells did on 
the reference media (SD-ura) (Fig. V-S4A). The vast majority (93.3 ± 2.5%; n = 3) of these 
cells that survived and grew unaffected on the SGal-ura medium turned out to be ade2 
knockout mutants as evaluated from their phenotype (red colony color; Ade- as confirmed 
by replica plating on SGal-ura-ade medium). ADE2 knockouts most probably resulted from 
NHEJ-mediated imperfect DNA repair and accompanying indel errors. Those errors 
additionally destroy the proper genomic gRNA-Cas9 targeting sequence thus protecting 
cells from further toxic DNA DSBs and simultaneously selecting for cells with imprecisely 
repaired DNA. This way, the pCAS9i-based approach provides an efficient tool to introduce 
gene knockouts that is extremely simple in application, just requires two approximately 
50 bp oligonucleotides and not even involves a single PCR step. 
5.4.5. Editing the genome of diploid and tetraploid yeast strains 
Unlike most laboratory strains, wild yeasts and industrial strains do not harbor a single set 
of chromosomes, but they are rather diploid [23-25] or even feature higher ploidy levels that 
can e.g. derive from allo- or autopolyploidization [26]. Since metabolic engineering 
approaches to improve fermentation performance or product yield of industrial strains often 
require the knockout of genes that are e.g. involved in competing metabolic pathways [27], 
highly efficient CRISPR/Cas9 systems are crucial as multiple copies of the same gene have 
to be addressed at once. Wild yeasts are usually not accessible to metabolic engineering 
approaches since they do not feature any auxotrophies [23] and therefore e.g. do not 
support plasmid maintenance. In this case, the deletion of all copies of a marker gene is 
required to generate auxotrophic mutants [28]. To test the plasmid-based systems for such 
purposes, the diploid (2n) strain CEN.PK2 as well as the tetraploid (4n) strain YCC78 were 
employed instead of the haploid strain CEN.PK2-1C. For diploid CEN.PK2, ADE2 was 
targeted the same way as previously described for its haploid strain derivative with the 
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difference that red coloring of colonies this time indicates the knockout of both ADE2 copies. 
However, the ADE2-based assay could not be applied for the tetraploid strain YCC78 since 
its four ADE2 copies already encode for a dysfunctional protein variant (Tab. V-1). Here, 
ADE8 was targeted instead, which encodes for a protein that acts upstream of Ade2p in the 
adenine biosynthetic pathway and exploited the epistatic relationship of ade8 over ade2 to 
select for white colonies [20]. White coloring of colonies indicates a knockout of all four 
ADE8 gene copies. 
For application in strain backgrounds with higher ploidy levels, the respective protospacer 
sequences was introduced into plasmid pCAS9c with method C and into plasmid pCAS9i 
with method A (Fig. V-2). By employing plasmid pCAS9c for disrupting ADE2 in diploid 
CEN.PK2 cells, only a few positive transformants were obtained, whereas the pCAS9i-
based approach yielded hundreds of transformants (Fig. V-3D) that could be evaluated as 
being positive based on their phenotype (red colony color; Leu+). Also for the tetraploid 
background strain, both plasmid-based approaches yielded quadruple ade8 knockout 
mutants, as clearly evident from the white appearance of the obtained colonies. Moreover, 
successful genomic integration of the loxP-kanMX-loxP donor DNA into the ADE8 locus 
was confirmed by colony PCR (Fig S5). The pCAS9i-approach yielded twice as much 
positive transformants of YCC78 as compared to the pCAS9c use, even though the 
absolute number of positive transformants was generally lower than for haploid or diploid 
strain backgrounds (Fig. V-3D). Measured transformation efficiencies emphasize highly 
efficient genome editing (Tab. V-2). A few single di- and tetraploid transformants appeared 
to feature the respective positive growth phenotype (Leu+ or G418 resistant), suggesting 
the integration of the marker cassette, but seem not to have all gene copies deleted as 
indicated by their colony coloring, e.g. white diploids or red tetraploids. Such false 
transformants arose at lower rate for pCAS9i- (2n: < 1%; 4n: < 2%) than for pCAS9c-based 
(2n: < 5% & 4n: < 6%) approaches. 
5.4.6. Multiplex genome editing 
To test the plasmid systems for multiplex genome editing applications a second gRNA 
expression cassette was inserted into plasmids pCAS9c and pCAS9i yielding plasmids 
pCAS9cd and pCAS9id (duplex) that allow for expression of two different gRNAs. Each 
plasmid can be amplified by two individual PCRs that add different protospacer sequences 
to one end of each fragment, respectively (similar to method C). These protospacer 
sequences function additionally as homology sequences for correct plasmid circularization 
by homologous recombination in vivo. Since both pairs of primers feature identical 
annealing sequences, NotI-digested (Primers PW & PZ; for large fragment) or StuI/SalI-
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cleaved (Primers PX & PY; for short fragment) plasmids have to be employed as PCR 
templates to prevent the amplification of the corresponding undesired part of the plasmid 
(Fig. V-4A). The CAN1 locus was chosen as second genomic target since its disruption 
allows for positive selection and therefore provides the possibility to select for the correct 
integration of the right donor DNA into the right locus as it is also true for the previously 
used ADE2-based assay. 
 
Fig. V-4: Multiplex genome editing and simultaneous assembly and CRISPR/Cas9-mediated 
integration of a fragmented donor DNA. (A) Plasmid pCAS9id is amplified by two individual PCRs 
to add both different protospacer sequences to one end of both fragments, respectively. Linearized 
plasmids are employed as PCR template to avoid the amplification of the undesired plasmid fragment 
(NotI-cleaved plasmid for use with primers PW & PZ; StuI/SalI-cleaved plasmid for use with primers 
PX & PY). Note: Primers PX & PZ and PW & PY, respectively, contain identical annealing sequences 
which would result in four different PCR products if uncut plasmid is employed as PCR template. The 
gRNA protospacer containing plasmid is subsequently circularized by homologous recombination-
based cloning in vivo. (B) Simultaneous disruption of ADE2 (ade2::loxP-LEU2-loxP) and CAN1 
(can1::HIS3) in the haploid strain CEN.PK2-1C was successfully achieved by using an pCAS9id-
based approach. The efficiency is indicated above the bar and represents the percentage of positive 
transformants of all cells that survived after transformation on the SGal-leu-ura-his-arg + canavanine 
(60 mg/L) selection media. (C) The pCAS9i-based approach was tested to support the in vivo 
assembly and simultaneous integration of multiple DNA fragments. The number of positive 
transformants was compared when the loxP-LEU2-loxP donor DNA was genomically integrated as 
a single fragment (single; data taken from Fig. 1A) or as five individual fragments (fragmented) that 
have to be assembled additionally. Efficiencies are indicated above the bars and represent the 
percentage of positive transformants of all cells that survived after transformation on the SGal-leu-
ura selection media. (D) The fragmented loxP-LEU2-loxP donor DNA (2.5 kbp) was split up into five 
500 bp fragments that share 40 bp of homology to each other, respectively (bottom). 
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Haploid CEN.PK2-1C cells were co-transformed with both pCAS9cd-antiADE2/CAN1 PCR 
fragments as well as with both donor DNA cassettes (loxP-LEU2-loxP for ADE2 and HIS3 
for CAN1) and plated cells on SD-ura-leu-his-arg + canavanine medium, however, yielding 
no transformants. In contrast, cells that were preloaded with pCAS9id-antiADE2/CAN1 and 
subsequently transformed with both donor DNA fragments were successfully deleted in 
both genes simultaneously with high efficiency (Fig. V-4B). Approximately 300 positive 
transformants were obtained as one could evaluate from their phenotype (red colony color; 
canavanine resistant; Leu+; His+). Due to its low-labor intensive workflow the all-in-one 
plasmid-based approach is considered as advantageous to previously described multiplex 
genome editing applications. For these, successful genome engineering was only possible 
when double gRNA expression vectors were assembled beforehand by standard cloning 
methods and employed for co-transformation together with donor DNA [2, 4]. 
Tab. V-2: Transformation efficiencies obtained for pCAS9i(d)-supported gene editing. 
Transformation efficiency values were defined as the ratio of positive transformants to all viable cells 
that were initially employed for transformation. (n = 3) 
strain ploidy plasmid transformation efficiency 
CEN.PK2-1C 1n pCAS9i-antiADE2 2.8 ± 0.6 x 10-5 
CEN.PK2-1C 1n pCAS9i-antiADE2/CAN1 1.2 ± 0.2 x 10-5 
CEN-PK2 2n pCAS9i-antiADE2 2.1 ± 0.5 x 10-5 
YCC78 4n pCAS9i-antiADE8 3.6 ± 1.6 x 10-6 
5.4.7. Simultaneous integration and assembly of multiple linear DNA fragments 
Site-specific genomic integration and simultaneous assembly of multiple fragments is the 
method of choice to introduce single gene expression cassettes or even whole biosynthetic 
pathways in metabolic engineering approaches. Several studies could show that support 
by the CRISPR/Cas9 technology strongly facilitates the introduction of heterologous 
metabolic pathways [5, 15, 29-31]. A limiting factor for combined assembly and integration 
of a large number of linear DNA fragments results from the fact that all fragments have to 
be delivered simultaneously into the same cells. The overall efficiency can suffer from poor 
individual transformation efficiencies and can get even worse when CRISPR/Cas9 system 
components would have to be delivered additionally as well. 
It should be tested if the plasmid-based system is suitable for such applications and it was 
tried to integrate and simultaneously reconstitute the previously used loxP-LEU2-loxP donor 
DNA by assembling five individual 500 bp fragments that share 40 bp homology to each 
other at their 3’- and 5’-ends, respectively (Fig. V-4D). Homology regions of 40 bp were 
considered as reasonable for a prove of principle experiment since they can be easily added 
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to any desired PCR product by commercially available and low cost overhang primers. The 
efficiency of integration and functional loxP-LEU2-loxP assembly was determined by a 
combination of red colony coloring and Leu+ phenotype, as described before. The pCAS9i-
approach (method A) yielded positive transformants with high effectivity even though the 
number of positive transformants was reduced compared to the integration of a single 
fragment loxP-LEU2-loxP donor DNA (Fig. V-4C). Based on this screening method, 100% 
efficiency for targeting and assembly in the right locus was found for the applied pCAS9i-
based approach. Five randomly selected clones were tested by colony PCR as positive, 
with no exception (Fig. V-S6). 
5.4.8. pCAS9id-mediated genome editing using yeast endogenous donor DNA 
Induction of a double strand break followed by homologous recombination-based repair of 
the cleaved and subsequently partially degraded genomic DNA is the core part of an 
inherent capacity of homothallic yeast cells to switch from one mating type to the other. 
Yeast cells either exist as MATa or MATα haploids as well as MATa/MATα diploids which 
are generated by the conjugation of two haploid cells with opposite mating types. The 
molecular basis for developing a mating type specific phenotype is genetically determined 
by two different alleles of the mating type (MAT) locus - MATa and MATα [32]. Each MAT 
allele encodes for specific transcription activators and repressors that on the one hand 
regulate distinct genetic programs that eventually lead to the phenotypic development of a 
certain mating type in haploid cells and on the other hand repress the development of any 
mating type specific characteristics in diploid cells [33]. The two MAT alleles differ in a 
~700 bp sequences, called Ya or Yα, that encode for the previously mentioned regulatory 
factors, whereas the flanking regions, designated as W, X, Z1 and Z2 are identical in both 
MAT alleles. Each haploid cell contains the genetic information of both Y regions (Ya and 
Yα) that are present in two cryptic and transcriptionally inactive copies of the MAT-locus 
referred to as HMLα (hidden MAT left carrying Yα) and HMRa (hidden MAT right carrying 
Ya) whereas only one of both Y regions additionally exists in the transcriptionally active 
MAT locus and determines the mating type of the haploid cell. Mating type switching is 
caused by replacing the Y region of the MAT locus against the opposite one – Ya against 
Yα or vice versa. This process is initiated by a double-strand break next to the Y/Z border 
mediated by the yeast endogenous HO endonuclease [34, 35]. Exonuclease activity further 
degrades the DNA of both sides of the cut side thereby eliminating the mating type specific 
information encoded in the Y region. The resulting gap within the MAT locus is repaired by 
a homologous recombination-based process either using HMLα or HMRa as donor DNA. 
In this process, the Y region flanking sequences X and Z1 shared by both hidden loci and 
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the MAT locus serve as homology regions for homology directed repair (W and Z2 are 
additionally shared by HMLα and MAT locus thus expanding homology regions) [32].  
Most laboratory strains are unable to switch their mating type because they either do not 
express a (functional) HO endonuclease [36] or feature so-called stuck mutations [37] within 
the native recognition sequence of HO. Whereas the first mentioned limitation can be simply 
overcome by e.g. plasmid-based expression of native HO [38], the letter case poses a more 
severe problem when mating type switching is desired for e.g. experimental purposes.  
 
Fig. V-5: Cas9 induced double 
strand breaks within the MAT 
locus are sufficient to induce 
mating type switching. (A) The 
schematic shows the organization of 
the mating type (MAT) locus 
containing the constant W, X, Z1 and 
Z2 regions as well as the mating type 
specific Y region. Plasmid pCAS9id-
antiMATx/MATz encodes for two 
different gRNAs targeting the X and 
Z1 region, respectively. Cas9-
mediated DSB complete excise the Y 
region resulting in a gap within the 
MAT locus that can be repaired by 
HDR. Hidden MAT loci can be used 
as donor templates for HDR thus 
leading to mating type switching. (C) 
Mating assays demonstrate that 
CRISPR/Cas9-mediated DSBs 
within the MAT locus successfully 
lead to mating type switching in 
CEN.PK2-1C (1C; MATa) and 
BY4741 (BY, MATa). Generation of 
diploids in a mixed culture (X) of both 
strains was only possible when at 
least one both expressed Cas9 from 
plasmid pCAS9id-MATx/MATz 
(+Cas) on galactose medium (SGal-
ura). Generation of diploids was 
tested by transferring mixed cultures 
to SD–ura-met-trp medium that 
selects for the combination of 
prototrophies (Met+ and Trp+) 
originating from one of the haploid 
strains, respectively (B). Empty 
vectors (e.v.) did not support mating 
type switching. 
The yeast endogenous mechanism of mating type switching resembles the aforementioned 
CRISPR/Cas9 experiments in many aspects: Double-strand breaks within genomic DNA 
are repaired by homologous recombination using specific donor DNA as template for HDR. 
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However, in contrast to the CRISPR/Cas9 experiments described here, HDR involved in 
mating type switching uses endogenous donor DNA and does not rely on intracellularly 
delivered external donor DNA. The inducible double-cleaving CRISPR/Cas9 system was 
tested to replace the native function of HO in ∆ho strains. Thus, mating type switching in 
genetic backgrounds featuring stuck mutations within the MAT locus (such as in S288c 
derived strains) should be enabled due to the easy adaptability of CRISPR/Cas9 cleavage 
sites. 
To induce double-strand breaks within the MAT locus, two different protospacer sequences 
were selected that address sequences of the invariable X (antiMATx) and Z1 (antiMATz) 
regions present in both MAT alleles, thereby mediating a complete excision of the 
respective Y region (Fig. V-5A). To test if the resulting gap within the MAT locus is repaired 
by the endogenous HDR using HMLα or HMRa as donor sequences, a mating assay was 
performed. For that, two different strains that have the same mating type, BY4741 (MATa) 
and CEN.PK2-1C (MATa), and that are therefore unable to mate with each other, were 
employed. Each of both strains possesses an auxotrophic mutation which does not apply 
to the other, thus featuring a unique growth phenotype, respectively – BY4741 grows on 
the medium lacking methionine (-met) (Fig. V-5B, top) whereas CEN.PK2-1C grows on 
medium freed from tryptophan (-trp) (Fig. V-5B, bottom). The generation of diploids from 
both different strains requires mating type switching in at least one of both strains. To test 
for a successful CRISPR/Cas9-mediated mating type switching, mixtures of both strains 
harboring either pCAS9id-antiMATx/MATz or an empty vector (e.v.; pGREG506) were 
plated on medium that selects for both plasmids and supports plasmid-based expression of 
Cas9 were applicable (SGal-ura) (Fig. V-5C, top). Resulting diploids might be subsequently 
selected on SD-ura-met-trp triple drop-out medium (Fig. V-5C, bottom). Indeed, diploids 
resulted from all combinations involving at least one strain that harbors a functional 
pCAS9id-antiMATx/MATz, thus clearly indicating that CRISPR/Cas9 induced DSB within 
the MAT locus can result in successful mating type switching. A negative control that used 
strains harboring empty vectors did not yield diploids whereas the positive control that used 
strains already featuring different mating types, BY4741 (MATa) and CEN.PK2-1D (MATα), 
led to mating and formation of diploids, as expected. Inducing DSB by CRISPR/Cas9 also 
helped to bypass impaired HO-mediated MAT cleavage due to stuck mutations as 
demonstrated by successful switching the mating type of S288c-derived BY4741. These 
results clearly indicate that CRISPR/Cas9-mediated DSB can be also repaired by using 
genomically encoded donor DNA for HDR and depends not on the delivery of external linear 
donor DNA elements.  
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5.5. Conclusions 
Here, a new set of all-in-one CRISPR/Cas9 plasmids is introduced that allow for a simple 
and convenient application of the technology in S. cerevisiae by combining beneficial 
features of different existing approaches in one system. Introduction of a desired gRNA 
protospacer sequence into these plasmids is possible via PCR-based methods or as in case 
of the inducible single gRNA system, it can be simply obtained by the assembly and 
integration of single-stranded oligonucleotides in a homologous recombination-mediated 
process. Cells that are preloaded with the inducible vectors express a functional gRNA-
Cas9 complex upon galactose induction. These cells just have to be transformed with a 
desired donor DNA to obtain highly efficient and effective genome editing without the need 
of co-introducing any of the CRISPR/Cas9 system components. Thus, the inducible 
CRISPR/Cas9 systems presented here can easily be integrated into established workflows 
for marker-based genome editing approaches that are commonly used in the community. 
The inducible system for preloading cells with CRISPR/Cas9 plasmids can also help to 
overcome problems that might result from low transformation efficiencies that have been 
observed for many industrial strains [31, 39], since delivery of CRISPR system DNA 
elements and donor DNA is sequentially separated. Furthermore, cells once preloaded with 
the inducible CRISPR/Cas9 vectors can serve as a universal platform for applications were 
genomic integrations of different DNA fragments or even whole DNA libraries into the same 
locus is required [39]. The easy architecture of the plasmids that has been disclosed in 
detail moreover allows to tailor the vectors for individual personal requirements e.g. by 
changing the selectable marker or the promoter driving Cas9 expression. Easy and simple 
Cas9 nickase applications would be furthermore enabled by introducing the nCAS9 
(nicking) encoding sequence into the successfully tested all-in-one multiplex vectors. 
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5.7. Supporting information 
 
Fig. V-S1: Gel-electrophoretic analysis of assembly PCR intermediates and the final assembly 
product. At first, both fragments that should be assembled were amplified individually. The SNR52 
promoter containing fragment (F1; 311 bp) was amplified by using primers P11 and P12. The gRNA-
scaffold and SUP4 terminator containing fragment (F2; 211 bp) was amplified by using primers P13 
and P14. Overhang primers P12 and P13 introduced the anti-ADE2 protospacer sequences (red) to 
the fragments, respectively, that function as overlapping regions in the following assembly PCR step. 
The assembly product (AP; 502 bp) was amplified with the outer primers P11 and P14. L1 = 1 kbp 
DNA ladder (Carl Roth); L2 = 2-Log DNA ladder (NEB). 
 
Fig. V-S2: Colony PCR products for confirming proper introduction of anti-ADE2 protospacer 
sequence in plasmid pCAS9i analyzed by agarose gel electrophoresis. The anti-ADE2 
protospacer sequence was introduced into PmlI & KpnI cleaved plasmid pCAS9i by method A (one-
step in vivo HR-mediated assembly of overlapping oligonucleotides P12 and P13; A), by method B 
(in vivo HR-mediated integration of ADE2 protospacer containing gRNA assembly PCR product; B) 
or method C (PCR amplification of pCAS9i backbone with primer P12 and P13 and subsequent in 
vivo HR-mediated recircularization of the plasmid; C). Positive transformants yield a PCR product of 
508 bp. L = 1 kbp DNA ladder (Carl Roth). 
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Fig. V-S3: Colony PCR products for confirming the disruption of ADE2 by integration of loxP-
LEU2-loxP donor DNA in an CEN.PK2-1C background analyzed by agarose gel 
electrophoresis. (A) Confirmation of pCAS9c-supported donor DNA integration of five randomly 
selected transformants (1-5). (B) Confirmation of pCAS9i-supported donor DNA integration of five 
randomly selected transformants (1-5). Positive transformants yield a PCR product of 598 bp. (C) 
PCR-negative control. Primers that were used to confirm the integration of loxP-LEU2-loxP into the 
ADE2 locus do not yield a PCR product for unmodified CEN.PK2-1C cells (1). The presence and 
quality of genomic DNA was checked by amplifying a 1 kbp fragment of the S. cerevisae genome 
(2). L = 1 kbp DNA ladder (Carl Roth). 
 
Fig. V-S4: A functional ADE2-targeting CRISPR/Cas9 system expressed from pCAS9i is toxic 
for yeast. Images show representative agar plates. The identical number (100 µL of OD600 = 0.002) 
of pCAS9i-antiADE2 harboring CEN.PK2-1C cells (A) was plated on uracil-free glucose (SD-ura) or 
galactose (SGal-ura) containing agar media. Glucose containing media (SD-ura) do not promote the 
expression of Cas9 from PGAL1 and cells grew unimpaired. On galactose containing media (SGal-
ura) cells express a functional ADE2-targeting CRISPR/Cas9 system. Colonies with the same size 
as on SD media recovered only from a small percentage of plated cells, whereas the majority of cells 
showed strongly impaired growth. Reference strains that do not express a functional ADE2-targeting 
gRNA (B) or that do not provide a genomic protospacer sequence that could be addressed by the 
gRNA-Cas9 complex (C) grew unaffected on galactose media. Colonies recovered from all plated 
cells with the same size as on glucose containing media. 
• Chapter V: Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient 
genome editing 
 158 
 
Fig. V-S5: Colony PCR products for confirming the disruption of ADE8 by integration of loxP-
kanMX-loxP donor DNA in an YCC78 background analyzed by agarose gel electrophoresis. 
(A) Confirmation of pCAS9c-supported donor DNA integration of five randomly selected 
transformants (1-5). (B) Confirmation of pCAS9i-supported donor DNA integration of five randomly 
selected transformants (1-5). Positive transformants yield a PCR product of 575 bp. L = 1 kbp DNA 
ladder (Carl Roth). 
 
Fig. V-S6: Colony PCR products for confirming the disruption of ADE2 by integration and 
proper assembly of fragmented loxP-LEU2-loxP donor DNA in an CEN.PK2-1C background 
analyzed by agarose gel electrophoresis. Confirmation of pCAS9i-supported donor DNA 
integration of five randomly selected transformants (1-5). Positive transformants yield a PCR product 
of 598 bp. L = 1 kbp DNA ladder (Carl Roth). 
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Tab. V-S1: Plasmids used in this study. The table summarizes basic characteristics and properties 
of indicated plasmids.  
Plasmid description reference 
p425-SNR52p-gRNA.HIS3-SUP4t 
is equivalent to p426-SNR52p-
gRNA.CAN1.Y-SUP4t [13] but with 
pRS426 backbone and antiHIS3-gRNA 
Dr. C. Schneider 
p414-TEF1p-Cas9-CYC1t - [13] 
pC188 - [12] 
pCM188(2µ) 
CEN/ARS sequence of pCM188 was 
replaced by the 2µ-ORI from plasmid 
pRS425 
This study 
pUG73 - [16] 
pUG6 - [17] 
pGREG504 - [14] 
pCAS9c 
2µ; URA3; ampR; expression of Cas9 
endonuclease from S. pyogenes from 
constitutive TEF1 promoter and gRNA 
from SNR52 promoter, gRNA expression 
cassette contains protospacer stuffer 
This study 
pCAS9i TEF1 promoter of plasmid pCAS9c was replaced by the inducible GAL1 promoter  This study 
pCAS9cd identical to pCASc but contains a second gRNA expression cassette This study 
pCAS9id identical to pCASi but contains a second gRNA expression cassette This study 
pGREG506 - [14] 
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Tab. V-S2: Primers used in this study. Underlined sequence parts represent homology regions of 
overhang primers used recombination-based cloning approaches. 
primer sequence (5’ → 3’) amplicon 
P1 (fw) CACAAATTGCAAAATTTAATTGCTTGCAAAAGGTCACATGCTGTATGATCCAATATCAAAGGAAATGATAGC 2-micron 
P2 (rv) GGAACTCGATTTCTGACTGGGTTGGAAGGCAAGAGAGCCCCGAGCCTGAACGAAGCATCTGTG 2-micron 
P3 (fw) CATGTGACCTTTTGCAAGCAATTAAATTTTGCTGATATCGAATTCGCTGGAGC PSNR52 
P4 (rv) GGTACCCTCGCAGATGTTGCTGATGTCGTCGTTTAAACGATCATTTATCTTTCACTGCGGAG PSNR52 
P5 (fw) GACGACATCAGCAACATCTGCGAGGGTACCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG scaffold – TSUP4 
P6 (rv) CGTCGTGACTGGGAAAACCCTGGCGTTACCCAATTAACCCTCACTAAAGGG scaffold – TSUP4 
P7 (fw) CATTATACTGAAAACCTTGCTTGAGAAGGTTTTGGGACGCTCGAAGGCTTTAATTTGCGGAGGCGTATCACGAGGCCC 
URA3-2µ-gRNA 
cassette 
P8 (rv) GAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCGGGAACAAAAGCTGGAGCTC 
URA3-2µ-gRNA 
cassette 
P9 (fw) CCCTCACTAAAGGGAACAAAAGCTGGAGCTGTACGGATTAGAAGCCGCC PGAL1 
P10 (rv) GTACTTCTTGTCCATTTTTCCCGGGGGATCCCGGGGTTTTTTCTCCTTGACG PGAL1 
P11 (fw) TGATATCGAATTCGCTGGAGC Assembly PCR; F1 
P12 (rv) TGTGGATAGTCTCTACAATTGATCATTTATCTTTCACTGCGGAG ADE2 oligo; F1 
P13 (fw) AATTGTAGAGACTATCCACAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG 
ADE2 oligo; 
F2 
P14 (rv) CGCAATTAACCCTCACTAAAGGG Assembly PCR; F2 
P15 (fw) CGGTTTAGTGTTTTCTTACCCAATTGTAGAGACTATCCCAGCTGAAGCTTCGTACGCTGCAG split LEU2 F1 
P16 (rv) TCATGGTTCTGCCCCAG 
split LEU2 F1; 
ColPCR 
Integration ADE2 
P17 (fw) GTTAACCTTGTTTGCTGGTAAATCT split LEU2 F2 
P18 (rv) TCGTTAGAGAATTGGTTGGTGG split LEU2 F2 
P19 (fw) CTTTCACCAAAGTAGATACCACC split LEU2 F3 
P20 (rv) GTAAGTACATCTGCTTTAACGCAT split LEU2 F3 
P21 (fw) CGAAGCAAATGTAGGAATGCG split LEU2 F4 
P22 (rv) CTGAAAATGCGCGAACAAAAC split LEU2 F4 
P23 (fw) AAATTTGACGAGTCTTCTTGTTTTG split LEU2 F5 
P24 (rv) GCAGGCGCATAACATAAGTCACAAATATTGTCCTTGGCCGCATAGGCCACTAGTGGATCTG split LEU2 F5 
P25 (fw) GATCAATTGTAGAGACTATCCACA ColPCR ADE2 gRNA 
P26 (rv) CTTCGGGGCGAAAACTCTC ColPCR ADE2 gRNA 
P27 (fw) CCGGAAGCTTTGGAAGTACTG ColPCR Integration ADE2 
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primer sequence (5’ → 3’) amplicon 
P28 (fw) GAGAACAAGCCTCTGACGGCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG ADE8 oligo 
P29 (rv) GCCGTCAGAGGCTTGTTCTCGATCATTTATCTTTCACTGCGGAG ADE8 oligo 
P30 (fw) GCATGGCGCAAATGTCAGGACGAGAACAAGCCTCTGACCAGCTGAAGCTTCGTACGCTGCAG kanMX 
P31 (rv) CGACCTCCTCGATGACATAGTGCACCATGCATCCGGGGCCGCATAGGCCACTAGTGGATCTG kanMX 
P32 (fw) GTTTCGATGGTACCACACACGC ColPCR Integration ADE8 
P33 (rv) CGGCCTCGAAACGTGAGTC ColPCR Integration ADE8 
P34 (fw) GAGTCATGTAATTAGTTATGTCACGCTCTAGAGCGGCCGCCACCGCTGATATCGAATTCGCTGG 2nd gRNA 
P35 (rv) CCGGGAACAAAAGCTGGAGCTCCACCGCGGTGTTACATGACTCGAAGACATAAAAAAC 2nd gRNA 
P36 (fw) GATACGTTCTCTATGGAGGAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG CAN1 oligo 
P37 (rv) TCCTCCATAGAGAACGTATCGATCATTTATCTTTCACTGCGGAG CAN1 oligo 
P38 (fw) CCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGCAGGGAAGTCATAACACAGTCC HIS3 
P39 (rv) TCTGTACTTCTCCTTCATCTTCATCACCTATGCCATGTTATTAGGTACCGGCCGC HIS3 
P40 (fw) TCTTCTGTTGTTACACTCTCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG MATx oligo 
P41 (rv) GAGAGTGTAACAACAGAAGAGATCATTTATCTTTCACTGCGGAG MATx oligo 
P42 (fw) CACTCTACAAAACCAAAACCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG MATz oligo 
P43 (rv) GGTTTTGGTTTTGTAGAGTGGATCATTTATCTTTCACTGCGGAG MATz oligo 
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6. Chapter VI: General discussion 
6.1. Employing metabolic engineering approaches to alter membrane lipid 
composition 
Systematic manipulation of membrane lipid composition is a challenging endeavor due to a 
limited set of tools to intervene in the cell’s sophisticated and fine-tuned lipid metabolism 
and lipid homeostasis. Standard approaches to manipulate the cellular lipid composition of 
both, mammalian cells as well as single-celled eukaryotes such as S. cerevisiae, include 
gene knockouts, drugs that specifically target enzymes involved in the lipid biosynthesis 
(e.g. fluconazole [1], zaragozic acid [2]) or chemical tools as, for instance, media 
supplements and lipid chelators [3]. Studies that addressed fatty acid unsaturation of 
S. cerevisiae either used OLE1 knockout strains or employed a ∆hem1 background that is 
defective in the synthesis of δ-aminolevulinate (ALA) which is an essential intermediate of 
the heme and porphyrin biosynthesis of yeast [4]. Since heme is required as prosthetic 
group of several enzymes involved in the ergosterol biosynthetic pathway as well as of 
Ole1p [5], both deletions provide an efficient strategy to impair and interrupt fatty acid 
unsaturation and the synthesis of sterols simultaneously. Those knockout strains are 
inviable and cells stop growing after a few cell divisions when cellular concentrations of 
essential lipids drop to the minimum limit [4] unless the medium is supplemented with 
unsaturated fatty acids (and ergosterol) or ALA to be able to deal with double-lipid depletion. 
However, cellular uptake of fatty acids and membrane lipids from the external environment 
is difficult to control, thus emphasizing that media supplementation provides limited 
stoichiometric control over lipid composition. Alternative strategies successfully used lipid 
chelators such as methyl-β-cyclodextrine (MβCD) to remove sterols from biological 
membranes of S. cerevisiae [6, 7] and mammalian cells [8]. Those strategies however 
feature similar limitations as it is challenging to exactly adjust concentrations of particular 
lipids in vivo with intermediate levels between native conditions and maximal depletion. 
Additionally, external lipid chelators provide only limited access to internal membrane 
structures of eukaryotic cells.  
The studies presented here used rational genetic manipulations of the expression of 
enzymes that play key roles in membrane lipid biosynthesis of the eukaryotic model 
organism S. cerevisiae such as Ole1p and Erg9p in order to allow for investigating 
physiological roles of membrane lipids. These genetic approaches are based on metabolic 
engineering strategies that help to overcome previously described limitation thus proving a 
system that allows for adjusting and fine-tuning levels of membrane lipids as shown for the 
fatty acid unsaturation (Chapter II and Chapter III) and ergosterol (Chapter IV). The 
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strategies used here only involved components of the yeast endogenous biosynthetic 
pathways thus manipulating the synthesis of membrane lipids in a system intrinsic way. 
This way, environmental factors and stimuli that affect physicochemical membrane 
parameters can be mimicked in an authentic and reliable manner. Depletion of total sterols 
and reduction of fatty acid unsaturation is e.g. a natural consequence of hypoxic growth 
conditions and is the only reason why S. cerevisiae cannot be grown under anoxic 
conditions [5].  Oxygen is an essential co-factor of the desaturase reactions catalyzed by 
Ole1p, Erg1p, Erg11p, Erg3p and Erg5p which is the reason why reduced (dissolved) 
oxygen concentrations strongly decrease the respective overall enzymatic activities and 
thus eventually the content of biosynthetic end products [5]. By down-regulating the 
expression of e.g. Ole1p, it is possible to deduce the effect of hypoxic growth conditions on 
membrane lipid unsaturation and closely related processes without subjecting cells to 
hypoxic stress in general. By this means, the interlinkage between oxygen availability, 
membrane lipid unsaturation and yeast flocculation could be elucidated [9] thereby also 
emphasizing the diversity of membrane lipid functions in cellular systems. 
6.2. Yeast as a model system to investigate physiological roles of membrane lipids 
The physiological effects of lipid modifications on cellular functions is very complex and they 
vary between species and even between different cell types of the same organism [10]. 
Therefore, it is almost impossible to predict how a cellular system will respond to different 
changes in membrane lipid composition. The studies presented here addresses 
fundamental parameters of biological membranes – phospholipid unsaturation, membrane 
fluidity, lipid packing, sterol content – which are crucial properties of all biological 
membranous systems thus being relevant for all types of cells and organisms. To study 
general effects of altered lipid composition and important membrane features on biological 
processes, model systems have to be employed that are on the one hand simple enough 
to allow for effectively influencing desired parameters and on the other hand, that are 
complex enough to provide the native cellular context for processes to be studied. Budding 
yeast is a valuable model organism to study lipid related cellular processes as it features a 
relatively simple lipid composition compared to more complex multicellular organisms but 
major properties are still comparable to the lipidome of other eukaryotic cells [11]. 
Furthermore, S. cerevisiae possesses only a limited diversity of enzymes involved in the 
synthesis of membrane lipids which reduces the complexity of the metabolic network: yeast 
e.g. only features one fatty acid desaturase gene in contrast to humans (2 SCD genes [12]) 
and the mouse model (4 SCD genes [13]) thus representing a minimal system to study 
effects of altered fatty acid unsaturation, membrane fluidity and lipid packing. This way, 
recent studies using budding yeast as model have provided new insights in basic principles 
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of lipid-dependent membrane organization in vivo [14], basic lipid-related cell physiology 
[15], the eukaryotic lipid metabolism [16, 17] and its interlinkage to other cellular pathways 
[18]. 
Large improvements of yeast genetic engineering by employing powerful, simple and 
affordable CRISPR/Cas9 applications (Chapter V) give easy access to metabolic 
engineering approaches involving promoter replacement strategies [9], gene deletions to 
direct the metabolite flux towards alternative or competing pathways [19, 20] and tools for 
heterologous expression of enzymes that replace functions of endogenous enzymes 
(Chapter II) or that even expand the yeast lipidome to e.g. unnatural polyunsaturated fatty 
acids [21-23], cyclopropanated species [24, 25] or cholesterol [26]. This way, limitations of 
genetic manipulations that result from time consuming, costly strategies and large technical 
efforts do not any longer apply to the budding yeast model. 
6.3. Widespread functions of membranes and membrane lipids in living organisms 
From a traditional point of view, cellular lipids fulfil three general functions: (i) lipids, 
especially triacylglycerols, serve as energy storing molecules, (ii) lipids are the main 
components of biological membranes, thus exhibiting the well-known barrier function and 
(iii) phospholipids such as phosphatidylinositol-4,5-bisphosphat (PIP2) and phosphatidyl-
1,4,5-triphosphat (PIP3) serve as second messengers and are key players of intracellular 
signaling cascades [10].  
However, there is striking evidence that membrane lipids feature much more functions in 
biological systems as usually expected. Lipids are an omnipresent class of molecules in 
cellular systems and seem to have big impact on a large variety of cellular processes. The 
mere fact that 20 – 30% of all ORFs from eubacterial, archaean or eukaryotic organisms 
are predicted to encode for membrane proteins [27] emphasizes the large influence of 
membrane lipids and physicochemical membrane properties on various cellular processes, 
even if only by indirectly influencing the activity [28-30], conformation [31, 32] or subcellular 
localization [33, 34] of membrane embedded proteins.  
Chapter I introduces a novel concept of lipid-depended oxygen sensing in S. cerevisiae. In 
this sensing system, the large pool of ER membrane lipid incorporated fatty acids serves 
as a “memory device” to integrate a long-term signal for oxygen availability [9, 35]. Short 
term, acute hypoxic conditions do not influence fatty acid unsaturation to an extend that 
activates Spt23p- and Mga2p-mediated gene expression as it might be unfavorable to 
change to an adaptive expression profile when cells are only exposed to hypoxic conditions 
for a short period of time. In contrast, long-term hypoxic conditions activate the system and 
activation remains until the membrane composition is diluted by new lipid synthesis. 
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Therefore, it is proposed that yeast has evolved its lipid homeostasis machinery to adjust 
enzyme expression levels in accordance to environmental conditions (oxygen availability), 
but has then adapted these sensors to regulate a wide range of molecular functions that 
are associated with these conditions. Prominent targets of the membrane fluidity regulon, 
mediated by Spt23p and Mga2p, were genes whose gene products are involved in the 
glycolytic metabolism (TDH1, PCK1, ENO1), metal homeostasis (IZH1, IZH2, IZH4, SIT1), 
hypoxic response (DAN4), mating [36], the meiotic cell cycle (CDC4, DMC1), sporulation 
(OSW2, SPS100), protein folding (HSP26) and flocculation (FLO1) – all being cellular 
processes that are not necessarily linked with each other or involved in the lipid metabolism 
at first sight nor that are classical membrane-associated cellular processes. This example 
clearly illustrates the close interlinkage between membrane lipids and a huge variety of 
cellular processes that is just about to be understood. 
 
Fig. VI-1: The membrane fluidity regulon adapts budding yeast to hypoxic conditions. 
Membrane lipid unsaturation drops as molecular oxygen gets limiting and growth conditions switch 
from normoxic to hypoxic conditions due to reduced Ole1p activity. Decreased membrane fluidity 
and dense lipid packing activate ER membrane-resident membrane fluidity sensors Spt23p and 
Mga2p by their rotation-based activation mechanism. Released p90 fragments translocate to the 
nucleus thus eventually activating a large set of genes. A prominent gene target of Spt23p is, among 
others, FLO1 whose gene product is a GPI-anchored cell wall mannose binding protein that induces 
cell aggregation (flocculation). 
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